{"PubmedArticle":[{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","IndexingMethod":"Curated","Owner":"NLM"},"PMID":"31647572","DateCompleted":{"Year":"2020","Month":"11","Day":"11"},"DateRevised":{"Year":"2020","Month":"11","Day":"11"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1099-1166","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"35","Issue":"1","PubDate":{"Year":"2020","Month":"01"}},"Title":"International journal of geriatric psychiatry","ISOAbbreviation":"Int J Geriatr Psychiatry"},"ArticleTitle":"Is there equity in initial access to formal dementia care in Europe? The Andersen Model applied to the Actifcare cohort.","Pagination":{"MedlinePgn":"45-52"},"ELocationID":"10.1002\/gps.5213","Abstract":{"AbstractText":["In the current study, the Anderson model is used to determine equitable access to dementia care in Europe. Predisposing, enabling, and need variables were investigated to find out whether there is equitable access to dementia-specific formal care services. Results can identify which specific factors should be a target to improve access.","A total of 451 People with middle-stage dementia and their informal carers from eight European countries were included. At baseline, there was no use of formal care yet, but people were expected to start using formal care within the next year. Logistic regressions were carried out with one of four clusters of service use as dependent variables (home social care, home personal care, day care, admission). The independent variables (predisposing, enabling, and need variables) were added to the regression in blocks.","The most significant predictors for the different care clusters are disease severity, a higher sum of (un)met needs, hours spent on informal care, living alone, age, region of residence, and gender.","The Andersen model provided for this cohort the insight that (besides need factors) the predisposing variables region of residence, gender, and age do play a role in finding access to care. In addition, it showed us that the numbers of hours spent on informal care, living alone, needs, and disease severity are also important predictors within the model's framework. Health care professionals should pay attention to these predisposing factors to ensure that they do not become barriers for those in need for care."],"CopyrightInformation":"\u00a9 2019 The Authors. International Journal of Geriatric Psychiatry published by John Wiley & Sons Ltd."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Kerpershoek","ForeName":"Liselot","Initials":"L","Identifier":"0000-0001-6774-3480","AffiliationInfo":{"Affiliation":"Maastricht University, Alzheimer Centrum Limburg, NL, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"de Vugt","ForeName":"Marjolein","Initials":"M","AffiliationInfo":{"Affiliation":"Maastricht University, Alzheimer Centrum Limburg, NL, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Wolfs","ForeName":"Claire","Initials":"C","AffiliationInfo":{"Affiliation":"Maastricht University, Alzheimer Centrum Limburg, NL, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Orrell","ForeName":"Martin","Initials":"M","AffiliationInfo":{"Affiliation":"Nottingham University, Institute of Mental Health, Nottingham, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Woods","ForeName":"Bob","Initials":"B","Identifier":"0000-0002-6781-651X","AffiliationInfo":{"Affiliation":"Bangor University, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Jelley","ForeName":"Hannah","Initials":"H","AffiliationInfo":{"Affiliation":"Bangor University, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Meyer","ForeName":"Gabriele","Initials":"G","AffiliationInfo":{"Affiliation":"Martin-Luther University Halle-Wittenberg, DE."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bieber","ForeName":"Anja","Initials":"A","AffiliationInfo":{"Affiliation":"Martin-Luther University Halle-Wittenberg, DE."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stephan","ForeName":"Astrid","Initials":"A","AffiliationInfo":{"Affiliation":"Martin-Luther University Halle-Wittenberg, DE."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Selbaek","ForeName":"Geir","Initials":"G","AffiliationInfo":[{"Affiliation":"Norwegian National Advisory Unit on Ageing and Health, Vestfold Hospital, T\u00f8nsberg, Norway."},{"Affiliation":"Dept of Geriatric Medicine, Oslo University Hospital, Oslo, Norway."},{"Affiliation":"Faculty of medicine, University of Oslo, Oslo, Norway, NO."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Michelet","ForeName":"Mona","Initials":"M","AffiliationInfo":[{"Affiliation":"Norwegian National Advisory Unit on Ageing and Health, Vestfold Hospital, T\u00f8nsberg, Norway."},{"Affiliation":"Dept of Geriatric Medicine, Oslo University Hospital, Oslo, Norway."},{"Affiliation":"Faculty of medicine, University of Oslo, Oslo, Norway, NO."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Wimo","ForeName":"Anders","Initials":"A","AffiliationInfo":{"Affiliation":"Department of Neurobiology, Care sciences and Society, Karolinska Institutet, Stockholm, SE."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Handels","ForeName":"Ron","Initials":"R","AffiliationInfo":[{"Affiliation":"Maastricht University, Alzheimer Centrum Limburg, NL, The Netherlands."},{"Affiliation":"Department of Neurobiology, Care sciences and Society, Karolinska Institutet, Stockholm, SE."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Irving","ForeName":"Kate","Initials":"K","AffiliationInfo":{"Affiliation":"School of Nursing, Psychotherapy and Community Health, Dublin City University, IE."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hopper","ForeName":"Louise","Initials":"L","Identifier":"0000-0002-9382-5241","AffiliationInfo":{"Affiliation":"School of Nursing, Psychotherapy and Community Health, Dublin City University, IE."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gon\u00e7alves-Pereira","ForeName":"Manuel","Initials":"M","AffiliationInfo":{"Affiliation":"CEDOC, Nova Medical School|Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, PT."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Balsinha","ForeName":"Concei\u00e7\u00e3o","Initials":"C","AffiliationInfo":{"Affiliation":"CEDOC, Nova Medical School|Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, PT."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"IRCSS Istituto Centro S. Giovanni di Dio Fatebenefratelli, Brescia, IT."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Portolani","ForeName":"Daniel","Initials":"D","AffiliationInfo":{"Affiliation":"IRCSS Istituto Centro S. Giovanni di Dio Fatebenefratelli, Brescia, IT."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Verhey","ForeName":"Frans","Initials":"F","AffiliationInfo":{"Affiliation":"Maastricht University, Alzheimer Centrum Limburg, NL, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"Actifcare Consortium"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2019","Month":"11","Day":"06"}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"Int J Geriatr Psychiatry","NlmUniqueID":"8710629","ISSNLinking":"0885-6230"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"Dementia","QualifierName":"therapy"},{"DescriptorName":"Europe"},{"DescriptorName":"Female"},{"DescriptorName":"Health Equity","QualifierName":"statistics & numerical data"},{"DescriptorName":"Health Services Accessibility","QualifierName":"statistics & numerical data"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Models, Theoretical"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Andersen model","access to care","equity","middle-stage dementia","service use"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2019","Month":"04","Day":"08"},{"@attributes":{"PubStatus":"accepted"},"Year":"2019","Month":"09","Day":"15"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2019","Month":"10","Day":"28","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2020","Month":"11","Day":"12","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2019","Month":"10","Day":"25","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["31647572","10.1002\/gps.5213","PMC6916585"]},"ReferenceList":{"Reference":[{"Citation":"J Am Geriatr Soc. 2012 Aug;60(8):1487-92","ArticleIdList":{"ArticleId":"22881367"}},{"Citation":"Arch Neurol. 2008 Aug;65(8):1091-5","ArticleIdList":{"ArticleId":"18695059"}},{"Citation":"J Psychiatr Res. 1975 Nov;12(3):189-98","ArticleIdList":{"ArticleId":"1202204"}},{"Citation":"Alzheimers Dement. 2013 Jul;9(4):429-435.e17","ArticleIdList":{"ArticleId":"23142433"}},{"Citation":"Soc Sci Med. 2001 Nov;53(9):1149-62","ArticleIdList":{"ArticleId":"11556606"}},{"Citation":"Aging Ment Health. 2018 Jul;22(7):897-902","ArticleIdList":{"ArticleId":"29068697"}},{"Citation":"Med Care. 2009 Feb;47(2):191-8","ArticleIdList":{"ArticleId":"19169120"}},{"Citation":"Alzheimers Dement. 2017 Jan;13(1):1-7","ArticleIdList":{"ArticleId":"27583652"}},{"Citation":"Int J Geriatr Psychiatry. 2005 Jun;20(6):537-46","ArticleIdList":{"ArticleId":"15920707"}},{"Citation":"J Health Soc Behav. 1995 Mar;36(1):1-10","ArticleIdList":{"ArticleId":"7738325"}},{"Citation":"BMC Health Serv Res. 2016 Aug 23;16(1):423","ArticleIdList":{"ArticleId":"27550084"}},{"Citation":"Dement Geriatr Cogn Disord. 2008;26(1):65-78","ArticleIdList":{"ArticleId":"18617737"}},{"Citation":"J Epidemiol Community Health. 2004 Aug;58(8):655-8","ArticleIdList":{"ArticleId":"15252067"}},{"Citation":"J Am Med Dir Assoc. 2015 Dec;16(12):1104.e1-7","ArticleIdList":{"ArticleId":"26593306"}},{"Citation":"Health Soc Care Community. 2014 Jan;22(1):1-12","ArticleIdList":{"ArticleId":"23530738"}},{"Citation":"Int J Geriatr Psychiatry. 2011 Jan;26(1):56-64","ArticleIdList":{"ArticleId":"20661877"}},{"Citation":"Int Psychogeriatr. 2002;14 Suppl 1:7-26","ArticleIdList":{"ArticleId":"12636178"}},{"Citation":"Soc Sci Med. 2002 Oct;55(7):1255-66","ArticleIdList":{"ArticleId":"12365535"}},{"Citation":"Alzheimer Dis Assoc Disord. 2012 Jul-Sep;26(3):197-204","ArticleIdList":{"ArticleId":"22075941"}},{"Citation":"CMAJ. 2006 Jan 17;174(2):177-83","ArticleIdList":{"ArticleId":"16415462"}},{"Citation":"Gerontologist. 2005 Apr;45(2):177-85","ArticleIdList":{"ArticleId":"15799982"}},{"Citation":"Health Soc Care Community. 2008 Jan;16(1):42-53","ArticleIdList":{"ArticleId":"18181814"}},{"Citation":"Neurology. 1993 Nov;43(11):2412-4","ArticleIdList":{"ArticleId":"8232972"}},{"Citation":"Aging Ment Health. 2002 Aug;6(3):255-65","ArticleIdList":{"ArticleId":"12217094"}},{"Citation":"Health Soc Care Community. 2004 Nov;12(6):504-16","ArticleIdList":{"ArticleId":"15717897"}},{"Citation":"Eur J Public Health. 2016 Apr;26(2):213-9","ArticleIdList":{"ArticleId":"26338722"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","IndexingMethod":"Curated","Owner":"NLM"},"PMID":"31595452","DateCompleted":{"Year":"2020","Month":"03","Day":"27"},"DateRevised":{"Year":"2020","Month":"03","Day":"27"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1573-2649","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"29","Issue":"1","PubDate":{"Year":"2020","Month":"Jan"}},"Title":"Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation","ISOAbbreviation":"Qual Life Res"},"ArticleTitle":"A validation study of the ICECAP-O in informal carers of people with dementia from eight European Countries.","Pagination":{"MedlinePgn":"237-251"},"ELocationID":"10.1007\/s11136-019-02317-3","Abstract":{"AbstractText":["The pressure on healthcare budgets remains high, partially due to the ageing population. Economic evaluation can be a helpful tool to inform resource allocation in publicly financed systems. Such evaluations frequently use health-related outcome measures. However, in areas such as care of older people, improving health outcomes is not necessarily the main focus of care interventions and broader outcome measures, including outcomes for those providing informal care, may be preferred when evaluating such interventions. This paper validates a recently introduced well-being measure, the ICECAP-O, in a population of informal carers for people with dementia from eight European countries.","Convergent and discriminant validity tests were performed to validate the ICECAP-O using data obtained in a sample of 451 respondents from Germany, Ireland, Italy, the Netherlands, Norway, Portugal, Sweden and the UK. These respondents completed a number of standardized questionnaires within the framework of the Actifcare project.","The ICECAP-O performed well among informal carers, in terms of both convergent and discriminant validity. In the multivariate analysis, it was found to be significantly associated with the age of the person with dementia, EQ-5D-5L health problem index of the person with dementia, carer-patient relationship, care recipient CDR, carer LSNS Score, the PAI score, and Perseverance Time.","The ICECAP-O appears to be a valid measure of well-being in informal carers for people with dementia. The ICECAP-O may therefore be useful as an outcome measure in economic evaluations of interventions aimed at such informal carers, when these aim to improve well-being beyond health."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Perry-Duxbury","ForeName":"Meg","Initials":"M","Identifier":"http:\/\/orcid.org\/0000-0001-5293-2457","AffiliationInfo":{"Affiliation":"Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. perryduxbury@eshpm.eur.nl."}},{"@attributes":{"ValidYN":"Y"},"LastName":"van Exel","ForeName":"Job","Initials":"J","Identifier":"http:\/\/orcid.org\/0000-0002-4178-1777","AffiliationInfo":[{"Affiliation":"Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands."},{"Affiliation":"Erasmus School of Economics, Erasmus University Rotterdam, Rotterdam, The Netherlands."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Brouwer","ForeName":"Werner","Initials":"W","Identifier":"http:\/\/orcid.org\/0000-0002-0476-8397","AffiliationInfo":{"Affiliation":"Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Sk\u00f6ldunger","ForeName":"Anders","Initials":"A","Identifier":"http:\/\/orcid.org\/0000-0001-8439-2248","AffiliationInfo":{"Affiliation":"Karolinska Institutet, Department for Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Solna, Sweden."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gon\u00e7alves-Pereira","ForeName":"Manuel","Initials":"M","Identifier":"http:\/\/orcid.org\/0000-0003-1419-1306","AffiliationInfo":{"Affiliation":"CEDOC, Chronic Diseases Research Centre NOVA Medical School\/Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Irving","ForeName":"Kate","Initials":"K","AffiliationInfo":{"Affiliation":"School of Nursing and Human Sciences, Dublin City University, Dublin, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Meyer","ForeName":"Gabriele","Initials":"G","AffiliationInfo":{"Affiliation":"Medical Faculty, Institute for Health and Nursing Science, Martin Luther University Halle-Wittenberg, Magdeburger Stra\u00dfe 8, 06112, Halle (Saale), Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Selb\u00e6k","ForeName":"Geir","Initials":"G","Identifier":"http:\/\/orcid.org\/0000-0001-6511-8219","AffiliationInfo":[{"Affiliation":"Norwegian National Advisory Unit ON Ageing and Health, Vestfold Health Trust, T\u00f8nsberg, Norway."},{"Affiliation":"Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway."},{"Affiliation":"Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Woods","ForeName":"Bob","Initials":"B","AffiliationInfo":{"Affiliation":"Dementia Services Development Centre Wales (DSDC), Bangor University, Bangor, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Verhey","ForeName":"Frans","Initials":"F","Identifier":"http:\/\/orcid.org\/0000-0002-8307-8406","AffiliationInfo":{"Affiliation":"Alzheimer Center Limburg, Faculty of Health, Medicine and Life Sciences, School for Mental Health and Neuroscience, Department of Psychiatry and Neuropsychology, Maastricht University Medical Center +, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Wimo","ForeName":"Anders","Initials":"A","Identifier":"http:\/\/orcid.org\/0000-0003-0963-5750","AffiliationInfo":[{"Affiliation":"Karolinska Institutet, Department for Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Solna, Sweden."},{"Affiliation":"Centre for Research & Development, Uppsala University\/County Council of G\u00e4vleborg, G\u00e4vle, Sweden."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Handels","ForeName":"Ron L H","Initials":"RLH","Identifier":"http:\/\/orcid.org\/0000-0002-8663-0630","AffiliationInfo":[{"Affiliation":"Karolinska Institutet, Department for Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Solna, Sweden."},{"Affiliation":"Alzheimer Center Limburg, Faculty of Health, Medicine and Life Sciences, School for Mental Health and Neuroscience, Department of Psychiatry and Neuropsychology, Maastricht University Medical Center +, Maastricht, The Netherlands."}]},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"Actifcare Consortium"}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2019","Month":"10","Day":"08"}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"Qual Life Res","NlmUniqueID":"9210257","ISSNLinking":"0962-9343"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Caregivers","QualifierName":"psychology"},{"DescriptorName":"Dementia","QualifierName":"epidemiology"},{"DescriptorName":"Europe"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Patient Care","QualifierName":"methods"},{"DescriptorName":"Quality of Life","QualifierName":"psychology"},{"DescriptorName":"Surveys and Questionnaires"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Construct validity","Dementia","ICECAP-O","Informal care","Well-being"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"accepted"},"Year":"2019","Month":"09","Day":"24"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2019","Month":"10","Day":"9","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2020","Month":"3","Day":"28","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2019","Month":"10","Day":"10","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["31595452","10.1007\/s11136-019-02317-3","10.1007\/s11136-019-02317-3","PMC6962282"]},"ReferenceList":{"Reference":[{"Citation":"Appl Health Econ Health Policy. 2011 Sep 1;9(5):317-29","ArticleIdList":{"ArticleId":"21875162"}},{"Citation":"Health Econ. 2013 Oct;22(10):1230-49","ArticleIdList":{"ArticleId":"23225741"}},{"Citation":"J Am Geriatr Soc. 2000 Dec;48(12):1646-54","ArticleIdList":{"ArticleId":"11129756"}},{"Citation":"J Alzheimers Dis. 2018;66(3):1027-1040","ArticleIdList":{"ArticleId":"30372674"}},{"Citation":"Soc Sci Med. 2008 Jul;67(1):111-21","ArticleIdList":{"ArticleId":"18436359"}},{"Citation":"PLoS One. 2014 Mar 14;9(3):e92016","ArticleIdList":{"ArticleId":"24632775"}},{"Citation":"J R Soc Promot Health. 2006 May;126(3):134-42","ArticleIdList":{"ArticleId":"16739619"}},{"Citation":"Value Health. 2012 Mar-Apr;15(2):346-56","ArticleIdList":{"ArticleId":"22433767"}},{"Citation":"Health Technol Assess. 2012;16(16):1-166","ArticleIdList":{"ArticleId":"22459668"}},{"Citation":"Soc Sci Med. 2008 Sep;67(5):874-82","ArticleIdList":{"ArticleId":"18572295"}},{"Citation":"Qual Life Res. 2012 Jun;21(5):801-12","ArticleIdList":{"ArticleId":"21894489"}},{"Citation":"Neurology. 1993 Nov;43(11):2412-4","ArticleIdList":{"ArticleId":"8232972"}},{"Citation":"Eur J Health Econ. 2014 Apr;15(3):281-8","ArticleIdList":{"ArticleId":"23553075"}},{"Citation":"Aging Ment Health. 2020 Jan;24(1):162-170","ArticleIdList":{"ArticleId":"30381955"}},{"Citation":"Qual Life Res. 2006 Aug;15(6):1005-21","ArticleIdList":{"ArticleId":"16900281"}},{"Citation":"Qual Life Res. 2012 Feb;21(1):167-76","ArticleIdList":{"ArticleId":"21598064"}},{"Citation":"Med Decis Making. 2014 Jan;34(1):84-96","ArticleIdList":{"ArticleId":"23771881"}},{"Citation":"Health Qual Life Outcomes. 2013 Apr 08;11:57","ArticleIdList":{"ArticleId":"23566342"}},{"Citation":"Value Health. 2017 Jul - Aug;20(7):936-944","ArticleIdList":{"ArticleId":"28712623"}},{"Citation":"Br J Psychiatry. 2000 May;176:444-52","ArticleIdList":{"ArticleId":"10912220"}},{"Citation":"Qual Life Res. 2008 Sep;17(7):967-76","ArticleIdList":{"ArticleId":"18622721"}},{"Citation":"Eur J Health Econ. 2015 May;16(4):437-50","ArticleIdList":{"ArticleId":"24760405"}},{"Citation":"Health Technol Assess. 2013 Feb;17(5):v-xv, 1-140","ArticleIdList":{"ArticleId":"23402232"}},{"Citation":"J Alzheimers Dis. 2014;40(3):631-42","ArticleIdList":{"ArticleId":"24496076"}},{"Citation":"J Nutr Health Aging. 2010 Oct;14(8):685-90","ArticleIdList":{"ArticleId":"20922346"}},{"Citation":"BMC Health Serv Res. 2016 Aug 23;16(1):423","ArticleIdList":{"ArticleId":"27550084"}},{"Citation":"Ann Med. 2001 Jul;33(5):337-43","ArticleIdList":{"ArticleId":"11491192"}},{"Citation":"Int J Geriatr Psychiatry. 1999 Sep;14(9):784-8","ArticleIdList":{"ArticleId":"10479751"}},{"Citation":"Qual Life Res. 2011 Dec;20(10):1727-36","ArticleIdList":{"ArticleId":"21479777"}},{"Citation":"Lancet. 1999 Feb 20;353(9153):627-31","ArticleIdList":{"ArticleId":"10030328"}},{"Citation":"Adv Health Econ Health Serv Res. 2014;24:161-202","ArticleIdList":{"ArticleId":"25244909"}},{"Citation":"J Clin Nurs. 2009 Feb;18(4):492-501","ArticleIdList":{"ArticleId":"19191998"}},{"Citation":"PLoS One. 2017 Jan 9;12(1):e0169354","ArticleIdList":{"ArticleId":"28068375"}},{"Citation":"Qual Life Res. 2019 Mar;28(3):761-770","ArticleIdList":{"ArticleId":"30417206"}},{"Citation":"Health Econ. 2018 Jan;27(1):23-38","ArticleIdList":{"ArticleId":"28833854"}},{"Citation":"J Health Econ. 2010 Jul;29(4):549-56","ArticleIdList":{"ArticleId":"20579755"}},{"Citation":"Soc Sci Med. 2006 Apr;62(8):1891-901","ArticleIdList":{"ArticleId":"16168542"}},{"Citation":"Gerontologist. 2006 Aug;46(4):503-13","ArticleIdList":{"ArticleId":"16921004"}},{"Citation":"Alzheimer Dis Assoc Disord. 2003 Oct-Dec;17(4):209-14","ArticleIdList":{"ArticleId":"14657784"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","IndexingMethod":"Curated","Owner":"NLM"},"PMID":"31293018","DateCompleted":{"Year":"2020","Month":"06","Day":"08"},"DateRevised":{"Year":"2020","Month":"06","Day":"08"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1365-2524","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"27","Issue":"5","PubDate":{"Year":"2019","Month":"09"}},"Title":"Health & social care in the community","ISOAbbreviation":"Health Soc Care Community"},"ArticleTitle":"Optimizing access to and use of formal dementia care: Qualitative findings from the European Actifcare study.","Pagination":{"MedlinePgn":"e814-e823"},"ELocationID":"10.1111\/hsc.12804","Abstract":{"AbstractText":"This paper reports on qualitative data from the Actifcare study investigating experiences, attitudes, barriers and facilitators concerning access to and use of formal care. A total of 85 semi-structured in-depth interviews were conducted in eight European countries. Results were analysed with a deductive content analysis, first within country and then integrated in a cross-national analysis. Overall, analysis of the in-depth interviews revealed two major themes with five subcategories. The results can be summarised in an optimal pathway for access to dementia care. This pathway includes fixed factors such as disease-related factors and system-related factors. In addition there are personal factors that are subject to change such as attitudes towards care. An important finding consisted of the necessity of having sufficient information about the disease and available care and having a key contact person to guide you through the process of finding suitable care while monitoring your needs. In addition, it is important to involve your social network as they can take on care-giving tasks. It is helpful to have a diagnosis (in most countries). Concerning decision-making, the person closest to the person with dementia is in the majority of cases the one who makes the ultimate decision to access and use services and he\/she should therefore be supported in this process. These results provide insight into the factors that influence the pathway to formal care use and help professionals to enhance access to formal dementia care by focusing on factors that can be modified.","CopyrightInformation":"\u00a9 2019 The Authors. Health and Social Care in the Community Published by John Wiley & Sons Ltd."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Kerpershoek","ForeName":"Liselot","Initials":"L","Identifier":"0000-0001-6774-3480","AffiliationInfo":{"Affiliation":"Alzheimer Centre Limburg, Maastricht University, Maastricht, Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Wolfs","ForeName":"Claire","Initials":"C","AffiliationInfo":{"Affiliation":"Alzheimer Centre Limburg, Maastricht University, Maastricht, Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Verhey","ForeName":"Frans","Initials":"F","AffiliationInfo":{"Affiliation":"Alzheimer Centre Limburg, Maastricht University, Maastricht, Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Jelley","ForeName":"Hannah","Initials":"H","AffiliationInfo":{"Affiliation":"Bangor University, Bangor, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Woods","ForeName":"Bob","Initials":"B","AffiliationInfo":{"Affiliation":"Bangor University, Bangor, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bieber","ForeName":"Anja","Initials":"A","AffiliationInfo":{"Affiliation":"Martin-Luther University Halle-Wittenberg, Halle, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bartoszek","ForeName":"Gabriele","Initials":"G","AffiliationInfo":{"Affiliation":"Martin-Luther University Halle-Wittenberg, Halle, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stephan","ForeName":"Astrid","Initials":"A","AffiliationInfo":{"Affiliation":"Martin-Luther University Halle-Wittenberg, Halle, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Selbaek","ForeName":"Geir","Initials":"G","AffiliationInfo":[{"Affiliation":"Norwegian National Advisory Unit on Ageing and Health, Vestfold Hospital, Tonsberg, Norway."},{"Affiliation":"Centre for Old Age Psychiatry Research, Innlandet Hospital Trust, Ottestad, Norway."},{"Affiliation":"Faculty of Medicine, University of Oslo, Oslo, Norway."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Eriksen","ForeName":"Siren","Initials":"S","AffiliationInfo":{"Affiliation":"Norwegian National Advisory Unit on Ageing and Health, Vestfold Hospital, Tonsberg, Norway."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Sj\u00f6lund","ForeName":"Britt-Marie","Initials":"BM","AffiliationInfo":[{"Affiliation":"Aging Research Center (ARC), Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet and Stockholm University, Stockholm, Sweden."},{"Affiliation":"Faculty of Health and Occupational Studies, Department of Health and Caring Sciences, University of G\u00e4vle, G\u00e4vle, Sweden."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Hopper","ForeName":"Louise","Initials":"L","AffiliationInfo":{"Affiliation":"School of Nursing and Human Sciences, Dublin City University, Dublin, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Irving","ForeName":"Kate","Initials":"K","AffiliationInfo":{"Affiliation":"School of Nursing and Human Sciences, Dublin City University, Dublin, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Marques","ForeName":"Maria J","Initials":"MJ","AffiliationInfo":{"Affiliation":"CEDOC, Nova Medical School, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gon\u00e7alves-Pereira","ForeName":"Manuel","Initials":"M","AffiliationInfo":{"Affiliation":"CEDOC, Nova Medical School, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Portolani","ForeName":"Daniel","Initials":"D","AffiliationInfo":{"Affiliation":"IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Vugt","ForeName":"Marjolein","Initials":"M","AffiliationInfo":{"Affiliation":"Alzheimer Centre Limburg, Maastricht University, Maastricht, Netherlands."}},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"Actifcare Consortium"}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":{"GrantID":"733051001","Agency":"JPND","Country":"International"}},"PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2019","Month":"07","Day":"10"}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"Health Soc Care Community","NlmUniqueID":"9306359","ISSNLinking":"0966-0410"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Caregivers"},{"DescriptorName":"Decision Making"},{"DescriptorName":"Dementia","QualifierName":"therapy"},{"DescriptorName":"Europe"},{"DescriptorName":"Female"},{"DescriptorName":"Health Services Accessibility","QualifierName":"organization & administration"},{"DescriptorName":"Humans"},{"DescriptorName":"Interviews as Topic"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Qualitative Research"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["access to care","dementia","in-depth interviews","informal care","service use"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2018","Month":"09","Day":"26"},{"@attributes":{"PubStatus":"revised"},"Year":"2019","Month":"05","Day":"27"},{"@attributes":{"PubStatus":"accepted"},"Year":"2019","Month":"06","Day":"04"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2019","Month":"7","Day":"12","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2020","Month":"6","Day":"9","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2019","Month":"7","Day":"12","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["31293018","10.1111\/hsc.12804","PMC6851600"]},"ReferenceList":{"Reference":[{"Citation":"Int Psychogeriatr. 2018 Jun;30(6):881-892","ArticleIdList":{"ArticleId":"28606195"}},{"Citation":"Dementia (London). 2019 May;18(4):1219-1236","ArticleIdList":{"ArticleId":"27852728"}},{"Citation":"Int Psychogeriatr. 2015 Jun;27(6):927-36","ArticleIdList":{"ArticleId":"25566686"}},{"Citation":"Dementia (London). 2014 Sep;13(5):642-61","ArticleIdList":{"ArticleId":"24339077"}},{"Citation":"Maturitas. 2015 Oct;82(2):162-9","ArticleIdList":{"ArticleId":"26271710"}},{"Citation":"J Adv Nurs. 2015 Jun;71(6):1405-16","ArticleIdList":{"ArticleId":"25430690"}},{"Citation":"BMC Health Serv Res. 2016 Aug 23;16(1):423","ArticleIdList":{"ArticleId":"27550084"}},{"Citation":"Health Soc Care Community. 2014 Jan;22(1):1-12","ArticleIdList":{"ArticleId":"23530738"}},{"Citation":"Int Psychogeriatr. 2013 Jun;25(6):949-61","ArticleIdList":{"ArticleId":"23510662"}},{"Citation":"Alzheimer Dis Assoc Disord. 2014 Oct-Dec;28(4):299-310","ArticleIdList":{"ArticleId":"25321607"}},{"Citation":"Ageing Res Rev. 2015 Jul;22:39-57","ArticleIdList":{"ArticleId":"25956016"}},{"Citation":"Eur J Health Econ. 2012 Aug;13(4):461-90","ArticleIdList":{"ArticleId":"21584815"}},{"Citation":"Z Gerontol Geriatr. 2018 Jul;51(5):530-536","ArticleIdList":{"ArticleId":"28616816"}},{"Citation":"BMC Geriatr. 2018 Jun 4;18(1):131","ArticleIdList":{"ArticleId":"29866102"}},{"Citation":"Home Health Care Serv Q. 2009;28(1):1-23","ArticleIdList":{"ArticleId":"19266368"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","IndexingMethod":"Curated","Owner":"NLM"},"PMID":"30729572","DateCompleted":{"Year":"2019","Month":"12","Day":"20"},"DateRevised":{"Year":"2019","Month":"12","Day":"20"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1099-1166","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"34","Issue":"5","PubDate":{"Year":"2019","Month":"05"}},"Title":"International journal of geriatric psychiatry","ISOAbbreviation":"Int J Geriatr Psychiatry"},"ArticleTitle":"Relationship quality and sense of coherence in dementia: Results of a European cohort study.","Pagination":{"MedlinePgn":"745-755"},"ELocationID":"10.1002\/gps.5082","Abstract":{"AbstractText":["Quality of life of people with dementia and their family carers is strongly influenced by interpersonal issues and personal resources. In this context, relationship quality (RQ) and sense of coherence (SOC) potentially protect and promote health. We aimed to identify what influences RQ in dyads of people with dementia and their carers and to examine differences in their perspectives.","Cross-sectional data were used from the Actifcare cohort study of 451 community-dwelling people with dementia and their primary carers in eight European countries. Comprehensive assessments included the Positive Affect Index (RQ) and the Orientation to Life Questionnaire (SOC).","Regression analyses revealed that RQ as perceived by people with dementia was associated with carer education, stress, and spouse caregiving. RQ as perceived by carers was associated with carer stress, depression, being a spouse, social support, reported neuropsychiatric symptoms of dementia, and carer SOC. Neuropsychiatric symptoms and carer stress contributed to discrepancies in RQ ratings within the dyad. The only factor associated with both individual RQ ratings and discrepancies was carer stress (negative feelings subscore). No significant differences in the overall perception of RQ were evident between spouses and adult children carers, but RQ determinants differed between the two.","In this European sample, carer SOC was associated with carer-reported RQ. RQ determinants differed according to the perspective considered (person with dementia or carer) and carer subgroup. A deeper understanding of RQ and its determinants will help to tailor interventions that address these distinct perspectives and potentially improve dementia outcomes."],"CopyrightInformation":"\u00a9 2019 John Wiley & Sons, Ltd."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Marques","ForeName":"Maria J","Initials":"MJ","Identifier":"0000-0001-9214-4180","AffiliationInfo":{"Affiliation":"CEDOC, NOVA Medical School\/Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Woods","ForeName":"Bob","Initials":"B","Identifier":"0000-0002-6781-651X","AffiliationInfo":{"Affiliation":"Dementia Services Development Centre (DSDC) Wales, Bangor University, Bangor, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hopper","ForeName":"Louise","Initials":"L","Identifier":"0000-0002-9382-5241","AffiliationInfo":{"Affiliation":"School of Nursing and Human Sciences, Dublin City University, Dublin, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Jelley","ForeName":"Hannah","Initials":"H","AffiliationInfo":{"Affiliation":"Dementia Services Development Centre (DSDC) Wales, Bangor University, Bangor, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Irving","ForeName":"Kate","Initials":"K","AffiliationInfo":{"Affiliation":"School of Nursing and Human Sciences, Dublin City University, Dublin, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Kerpershoek","ForeName":"Liselot","Initials":"L","Identifier":"0000-0001-6774-3480","AffiliationInfo":{"Affiliation":"Alzheimer Centre Limburg, School for Mental Health and Neurosciences, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Meyer","ForeName":"Gabriele","Initials":"G","AffiliationInfo":{"Affiliation":"Institute for Health and Nursing Science, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bieber","ForeName":"Anja","Initials":"A","AffiliationInfo":{"Affiliation":"Institute for Health and Nursing Science, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stephan","ForeName":"Astrid","Initials":"A","AffiliationInfo":{"Affiliation":"Institute for Health and Nursing Science, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Sk\u00f6ldunger","ForeName":"Anders","Initials":"A","AffiliationInfo":{"Affiliation":"Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Sj\u00f6lund","ForeName":"Britt-Marie","Initials":"BM","AffiliationInfo":[{"Affiliation":"Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden."},{"Affiliation":"Department of Health and Caring Sciences, University of G\u00e4vle, G\u00e4vle, Sweden."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Selbaek","ForeName":"Geir","Initials":"G","AffiliationInfo":[{"Affiliation":"Norwegian National Advisory Unit on Ageing and Health, Vestfold Hospital Trust, T\u00f8nsberg, Norway."},{"Affiliation":"Faculty of Medicine, University of Oslo, Oslo, Norway."},{"Affiliation":"Centre for Old Age Psychiatric Research, Innlandet Hospital Trust, Ottestad, Norway."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Rosvik","ForeName":"Janne","Initials":"J","AffiliationInfo":[{"Affiliation":"Norwegian National Advisory Unit on Ageing and Health, Vestfold Hospital Trust, T\u00f8nsberg, Norway."},{"Affiliation":"Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Portolani","ForeName":"Elisa","Initials":"E","AffiliationInfo":{"Affiliation":"IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"de Vugt","ForeName":"Marjolein","Initials":"M","AffiliationInfo":{"Affiliation":"Alzheimer Centre Limburg, School for Mental Health and Neurosciences, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Verhey","ForeName":"Frans","Initials":"F","AffiliationInfo":{"Affiliation":"Alzheimer Centre Limburg, School for Mental Health and Neurosciences, Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gon\u00e7alves-Pereira","ForeName":"Manuel","Initials":"M","Identifier":"0000-0003-1419-1306","AffiliationInfo":{"Affiliation":"CEDOC, NOVA Medical School\/Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal."}},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"Actifcare Consortium"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2019","Month":"03","Day":"11"}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"Int J Geriatr Psychiatry","NlmUniqueID":"8710629","ISSNLinking":"0885-6230"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Adult"},{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Caregivers","QualifierName":"psychology"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"Cross-Sectional Studies"},{"DescriptorName":"Dementia","QualifierName":"psychology"},{"DescriptorName":"Depression","QualifierName":"psychology"},{"DescriptorName":"Europe"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Interpersonal Relations"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Quality of Life","QualifierName":"psychology"},{"DescriptorName":"Regression Analysis"},{"DescriptorName":"Sense of Coherence"},{"DescriptorName":"Social Support"},{"DescriptorName":"Spouses","QualifierName":"psychology"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Alzheimer disease","dementia","dyadic perspective","family care","relationship quality","sense of coherence"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2018","Month":"08","Day":"08"},{"@attributes":{"PubStatus":"accepted"},"Year":"2019","Month":"02","Day":"03"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2019","Month":"2","Day":"8","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2019","Month":"12","Day":"21","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2019","Month":"2","Day":"8","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["30729572","10.1002\/gps.5082"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"30400096","DateCompleted":{"Year":"2019","Month":"11","Day":"14"},"DateRevised":{"Year":"2019","Month":"11","Day":"14"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1875-8908","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"66","Issue":"3","PubDate":{"Year":"2018"}},"Title":"Journal of Alzheimer's disease : JAD","ISOAbbreviation":"J Alzheimers Dis"},"ArticleTitle":"Impact of Untimely Access to Formal Care on Costs and Quality of Life in Community Dwelling People with Dementia.","Pagination":{"MedlinePgn":"1165-1174"},"ELocationID":"10.3233\/JAD-180531","Abstract":{"AbstractText":["Access to formal care is not always timely and a better understanding on the impact of untimely access is needed.","To examine, from a societal perspective, the impact of untimely access to formal care in terms of total costs and quality of life over one year in community dwelling people with dementia.","Within the Actifcare study, needs, resource use, and quality of life were observed for one year in a cohort of 451 community dwelling people with dementia in 8 European countries. Untimely access to care was operationalized as having at least one unmet need for care identified by the Camberwell Assessment of Need for the Elderly (CANE) instrument. Two regression models were built for both total costs and quality of life measured by the EQ-5D-5L, one using sum of unmet needs and one using a predefined selection of need items.","Unmet needs were not associated with higher total costs but they were associated with a lower quality of life of people with dementia. Of all CANE items, only an unmet need for \"company\" was significantly related to lower total costs.","Total costs did not seem to differ between participants with unmet and met needs. Only few associations between specific unmet needs and costs and quality of life were found. Furthermore, quality of life of people with dementia decreases when multiple unmet needs are experienced, indicating that assessing and meeting needs is important to improve quality of life."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Janssen","ForeName":"Niels","Initials":"N","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University Medical Center, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Handels","ForeName":"Ron L","Initials":"RL","AffiliationInfo":[{"Affiliation":"Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University Medical Center, Maastricht, The Netherlands."},{"Affiliation":"Department of Neurobiology, Care sciences and Society, Karolinska Institutet, Stockholm, Sweden."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Sk\u00f6ldunger","ForeName":"Anders","Initials":"A","AffiliationInfo":{"Affiliation":"Department of Neurobiology, Care sciences and Society, Karolinska Institutet, Stockholm, Sweden."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Woods","ForeName":"Bob","Initials":"B","AffiliationInfo":{"Affiliation":"Dementia Services Development Centre, Bangor University, Bangor, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Jelley","ForeName":"Hannah","Initials":"H","AffiliationInfo":{"Affiliation":"Dementia Services Development Centre, Bangor University, Bangor, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Edwards","ForeName":"Rhiannon Tudor","Initials":"RT","AffiliationInfo":{"Affiliation":"Centre for Health Economics and Medicines Evaluation (CHEME), Bangor University, Bangor, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Orrell","ForeName":"Martin","Initials":"M","AffiliationInfo":{"Affiliation":"Nottingham University, Institute of Mental Health, Nottingham, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Selb\u00e6k","ForeName":"Geir","Initials":"G","AffiliationInfo":{"Affiliation":"Norwegian National Advisory Unit on Ageing and Health, Vestfold Hospital Trust, T-nsberg, Norway."}},{"@attributes":{"ValidYN":"Y"},"LastName":"R\u00f8svik","ForeName":"Janne","Initials":"J","AffiliationInfo":{"Affiliation":"Norwegian National Advisory Unit on Ageing and Health, Vestfold Hospital Trust, T-nsberg, Norway."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gon\u00e7alves-Pereira","ForeName":"Manuel","Initials":"M","AffiliationInfo":{"Affiliation":"CEDOC, Nova Medical School\/Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Marques","ForeName":"Maria J","Initials":"MJ","AffiliationInfo":{"Affiliation":"CEDOC, Nova Medical School\/Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"Alzheimer's Research Unit - Memory Clinic - IRCCS Centro S.Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Portolani","ForeName":"Elisa","Initials":"E","AffiliationInfo":{"Affiliation":"Alzheimer's Research Unit - Memory Clinic - IRCCS Centro S.Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Irving","ForeName":"Kate","Initials":"K","AffiliationInfo":{"Affiliation":"School of Nursing and Human Sciences, Dublin City University, Dublin, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hopper","ForeName":"Louise","Initials":"L","AffiliationInfo":{"Affiliation":"School of Nursing and Human Sciences, Dublin City University, Dublin, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Meyer","ForeName":"Gabriele","Initials":"G","AffiliationInfo":{"Affiliation":"Martin Luther University Halle-Wittenberg, Medical Faculty, Institute of Health and Nursing Sciences, Halle, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bieber","ForeName":"Anja","Initials":"A","AffiliationInfo":{"Affiliation":"Martin Luther University Halle-Wittenberg, Medical Faculty, Institute of Health and Nursing Sciences, Halle, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stephan","ForeName":"Astrid","Initials":"A","AffiliationInfo":{"Affiliation":"Martin Luther University Halle-Wittenberg, Medical Faculty, Institute of Health and Nursing Sciences, Halle, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Kerpershoek","ForeName":"Liselot","Initials":"L","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University Medical Center, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Wolfs","ForeName":"Claire A G","Initials":"CAG","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University Medical Center, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"de Vugt","ForeName":"Marjolein E","Initials":"ME","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University Medical Center, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Verhey","ForeName":"Frans R J","Initials":"FRJ","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University Medical Center, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Wimo","ForeName":"Anders","Initials":"A","AffiliationInfo":{"Affiliation":"Department of Neurobiology, Care sciences and Society, Karolinska Institutet, Stockholm, Sweden."}},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"Consortium Actifcare"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"J Alzheimers Dis","NlmUniqueID":"9814863","ISSNLinking":"1387-2877"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Cost of Illness"},{"DescriptorName":"Dementia","QualifierName":["economics","therapy"]},{"DescriptorName":"Female"},{"DescriptorName":"Geriatric Assessment"},{"DescriptorName":"Health Care Costs"},{"DescriptorName":"Health Services Accessibility"},{"DescriptorName":"Health Services Needs and Demand"},{"DescriptorName":"Humans"},{"DescriptorName":"Independent Living"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Needs Assessment"},{"DescriptorName":"Quality of Life"},{"DescriptorName":"Time-to-Treatment"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Access to care","costs","dementia","quality of life","unmet needs","untimely\n"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2018","Month":"11","Day":"8","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2019","Month":"11","Day":"15","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2018","Month":"11","Day":"8","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["30400096","JAD180531","10.3233\/JAD-180531"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"30372674","DateCompleted":{"Year":"2019","Month":"11","Day":"14"},"DateRevised":{"Year":"2019","Month":"11","Day":"14"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1875-8908","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"66","Issue":"3","PubDate":{"Year":"2018"}},"Title":"Journal of Alzheimer's disease : JAD","ISOAbbreviation":"J Alzheimers Dis"},"ArticleTitle":"Quality of Life, Care Resource Use, and Costs of Dementia in 8 European Countries in a Cross-Sectional Cohort of the Actifcare Study.","Pagination":{"MedlinePgn":"1027-1040"},"ELocationID":"10.3233\/JAD-180275","Abstract":{"AbstractText":["With 10.5 million people with dementia in Europe and $301 billion associated costs, governments face challenges organizing access to care.","To examine the costs related to formal and informal care use and quality of life for people with dementia in eight European countries, and explore the association with unmet needs.","Cross-sectional data from 451 persons with dementia and their informal caregivers of the Actifcare cohort study were obtained. Formal and informal care use was multiplied by country specific unit prices of services. Needs were measured using the CANE and health-related quality of life (HRQOL) of the person with dementia (both self- and proxy-rated) and informal caregiver's quality of life using EQ-5D-5L, ICECAP-O, DEMQOL-U, and CarerQol utility scores. The association between costs and country, European region, and unmet needs was assessed using multi-level linear regression.","Self-rated EQ-5D-5L utility score was higher than proxy-rated (0.84 and 0.71, respectively). Informal caregivers' utility score was 0.84. Across eight countries annual mean costs of formal and informal care were approximately \u20ac 17,000. Unmet needs were not associated with annual costs of care, nor with proxy-rated HRQOL, but were associated with self-rated HRQOL.","We found varying relationships between unmet needs and quality of life, and no association between unmet needs and care costs, although the results were sensitive to various factors. Future research should further investigate the relation between unmet needs, quality of life and costs to generate a better understanding of the effects of (un)timely access to care."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Handels","ForeName":"Ron L H","Initials":"RLH","AffiliationInfo":[{"Affiliation":"Department of Psychiatry and Neuropsychology, Alzheimer Centre Limburg, School for Mental Health and Neurosciences, Maastricht University, Maastricht, The Netherlands."},{"Affiliation":"Department of Neurobiology, Care Science and Society, Division of Neurogeriatrics, Karolinska Institute, Stockholm, Sweden."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Sk\u00f6ldunger","ForeName":"Anders","Initials":"A","AffiliationInfo":{"Affiliation":"Department of Neurobiology, Care Science and Society, Division of Neurogeriatrics, Karolinska Institute, Stockholm, Sweden."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bieber","ForeName":"Anja","Initials":"A","AffiliationInfo":{"Affiliation":"Martin Luther University Halle-Wittenberg, Medical Faculty, Institute for Health and Nursing Science, Halle (Saale), Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Edwards","ForeName":"Rhiannon Tudor","Initials":"RT","AffiliationInfo":{"Affiliation":"Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gon\u00e7alves-Pereira","ForeName":"Manuel","Initials":"M","AffiliationInfo":{"Affiliation":"CEDOC, Chronic Diseases Research Centre, NOVA Medical School\/Faculdade de Ci--ncias M\u00e9dicas, Universidade Nova de Lisboa, Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hopper","ForeName":"Louise","Initials":"L","AffiliationInfo":{"Affiliation":"School of Nursing and Human Sciences, Dublin City University, Dublin, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Irving","ForeName":"Kate","Initials":"K","AffiliationInfo":{"Affiliation":"School of Nursing and Human Sciences, Dublin City University, Dublin, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Jelley","ForeName":"Hannah","Initials":"H","AffiliationInfo":{"Affiliation":"Dementia Services Development Centre Wales (DSDC), Bangor University, Bangor, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Kerpershoek","ForeName":"Liselot","Initials":"L","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Neuropsychology, Alzheimer Centre Limburg, School for Mental Health and Neurosciences, Maastricht University, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Marques","ForeName":"Maria J","Initials":"MJ","AffiliationInfo":{"Affiliation":"CEDOC, Chronic Diseases Research Centre, NOVA Medical School\/Faculdade de Ci--ncias M\u00e9dicas, Universidade Nova de Lisboa, Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Meyer","ForeName":"Gabriele","Initials":"G","AffiliationInfo":{"Affiliation":"Martin Luther University Halle-Wittenberg, Medical Faculty, Institute for Health and Nursing Science, Halle (Saale), Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Michelet","ForeName":"Mona","Initials":"M","AffiliationInfo":[{"Affiliation":"Norwegian National Advisory Unit on Ageing and Health, Vestfold Health Trust, T--nsberg, Norway."},{"Affiliation":"Faculty of Medicine, Institute of Health and Society, University of Oslo, Oslo, Norway."},{"Affiliation":"Department of Geriatric Medicine, Oslo University Hospital, Norway."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Portolani","ForeName":"Elisa","Initials":"E","AffiliationInfo":{"Affiliation":"Alzheimer's Unit - Memory Clinic, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"R\u00f8svik","ForeName":"Janne","Initials":"J","AffiliationInfo":[{"Affiliation":"Norwegian National Advisory Unit on Ageing and Health, Vestfold Health Trust, T--nsberg, Norway."},{"Affiliation":"Department of Geriatric Medicine, Oslo University Hospital, Norway."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Selbaek","ForeName":"Geir","Initials":"G","AffiliationInfo":[{"Affiliation":"Norwegian National Advisory Unit on Ageing and Health, Vestfold Health Trust, T--nsberg, Norway."},{"Affiliation":"Centre for Old Age Psychiatric Research, Innlandet Hospital Trust, Ottestad, Norway."},{"Affiliation":"Faculty of Medicine, Institute of Health and Society, University of Oslo, Oslo, Norway."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Stephan","ForeName":"Astrid","Initials":"A","AffiliationInfo":{"Affiliation":"Martin Luther University Halle-Wittenberg, Medical Faculty, Institute for Health and Nursing Science, Halle (Saale), Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"de Vugt","ForeName":"Marjolein","Initials":"M","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Neuropsychology, Alzheimer Centre Limburg, School for Mental Health and Neurosciences, Maastricht University, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Wolfs","ForeName":"Claire","Initials":"C","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Neuropsychology, Alzheimer Centre Limburg, School for Mental Health and Neurosciences, Maastricht University, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Woods","ForeName":"Bob","Initials":"B","AffiliationInfo":{"Affiliation":"Dementia Services Development Centre Wales (DSDC), Bangor University, Bangor, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"Alzheimer's Unit - Memory Clinic, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Verhey","ForeName":"Frans","Initials":"F","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Neuropsychology, Alzheimer Centre Limburg, School for Mental Health and Neurosciences, Maastricht University, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Wimo","ForeName":"Anders","Initials":"A","AffiliationInfo":[{"Affiliation":"Department of Neurobiology, Care Science and Society, Division of Neurogeriatrics, Karolinska Institute, Stockholm, Sweden."},{"Affiliation":"Centre for Research & Development, Uppsala University\/County Council of G\u00e4vleborg, G\u00e4vle, Sweden."}]},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"Actifcare consortium"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"J Alzheimers Dis","NlmUniqueID":"9814863","ISSNLinking":"1387-2877"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Cross-Sectional Studies"},{"DescriptorName":"Dementia","QualifierName":["economics","psychology"]},{"DescriptorName":"Europe"},{"DescriptorName":"Female"},{"DescriptorName":"Health Care Costs"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Patient Care","QualifierName":"economics"},{"DescriptorName":"Quality of Life","QualifierName":"psychology"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Access to care","costs","dementia","health-economics","quality of life","unmet needs\n"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2018","Month":"10","Day":"30","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2019","Month":"11","Day":"15","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2018","Month":"10","Day":"30","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["30372674","JAD180275","10.3233\/JAD-180275"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"30248105","DateCompleted":{"Year":"2019","Month":"04","Day":"09"},"DateRevised":{"Year":"2019","Month":"04","Day":"09"},"Article":{"@attributes":{"PubModel":"Electronic-eCollection"},"Journal":{"ISSN":"1549-1676","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"15","Issue":"9","PubDate":{"Year":"2018","Month":"09"}},"Title":"PLoS medicine","ISOAbbreviation":"PLoS Med"},"ArticleTitle":"Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.","Pagination":{"MedlinePgn":"e1002660"},"ELocationID":"10.1371\/journal.pmed.1002660","Abstract":{"AbstractText":["This study reports the findings of the first large-scale Phase III investigator-driven clinical trial to slow the rate of cognitive decline in Alzheimer disease with a dihydropyridine (DHP) calcium channel blocker, nilvadipine. Nilvadipine, licensed to treat hypertension, reduces amyloid production, increases regional cerebral blood flow, and has demonstrated anti-inflammatory and anti-tau activity in preclinical studies, properties that could have disease-modifying effects for Alzheimer disease. We aimed to determine if nilvadipine was effective in slowing cognitive decline in subjects with mild to moderate Alzheimer disease.","NILVAD was an 18-month, randomised, placebo-controlled, double-blind trial that randomised participants between 15 May 2013 and 13 April 2015. The study was conducted at 23 academic centres in nine European countries. Of 577 participants screened, 511 were eligible and were randomised (258 to placebo, 253 to nilvadipine). Participants took a trial treatment capsule once a day after breakfast for 78 weeks. Participants were aged >50 years, meeting National Institute of Neurological and Communicative Disorders and Stroke\/Alzheimer's disease Criteria (NINCDS-ADRDA) for diagnosis of probable Alzheimer disease, with a Standardised Mini-Mental State Examination (SMMSE) score of \u226512 and <27. Participants were randomly assigned to 8 mg sustained-release nilvadipine or matched placebo. The a priori defined primary outcome was progression on the Alzheimer's Disease Assessment Scale Cognitive Subscale-12 (ADAS-Cog 12) in the modified intention-to-treat (mITT) population (n = 498), with the Clinical Dementia Rating Scale sum of boxes (CDR-sb) as a gated co-primary outcome, eligible to be promoted to primary end point conditional on a significant effect on the ADAS-Cog 12. The analysis set had a mean age of 73 years and was 62% female. Baseline demographic and Alzheimer disease-specific characteristics were similar between treatment groups, with reported mean of 1.7 years since diagnosis and mean SMMSE of 20.4. The prespecified primary analyses failed to show any treatment benefit for nilvadipine on the co-primary outcome (p = 0.465). Decline from baseline in ADAS-Cog 12 on placebo was 0.79 (95% CI, -0.07-1.64) at 13 weeks, 6.41 (5.33-7.49) at 52 weeks, and 9.63 (8.33-10.93) at 78 weeks and on nilvadipine was 0.88 (0.02-1.74) at 13 weeks, 5.75 (4.66-6.85) at 52 weeks, and 9.41 (8.09-10.73) at 78 weeks. Exploratory analyses of the planned secondary outcomes showed no substantial effects, including on the CDR-sb or the Disability Assessment for Dementia. Nilvadipine appeared to be safe and well tolerated. Mortality was similar between groups (3 on nilvadipine, 4 on placebo); higher counts of adverse events (AEs) on nilvadipine (1,129 versus 1,030), and serious adverse events (SAEs; 146 versus 101), were observed. There were 14 withdrawals because of AEs. Major limitations of this study were that subjects had established dementia and the likelihood that non-Alzheimer subjects were included because of the lack of biomarker confirmation of the presence of brain amyloid.","The results do not suggest benefit of nilvadipine as a treatment in a population spanning mild to moderate Alzheimer disease.","Clinicaltrials.gov NCT02017340, EudraCT number 2012-002764-27."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Lawlor","ForeName":"Brian","Initials":"B","Identifier":"0000-0002-5012-2116","AffiliationInfo":[{"Affiliation":"Mercer's Institute for Research on Ageing, St. James's Hospital, Dublin, Ireland."},{"Affiliation":"Department of Medical Gerontology, Trinity College Dublin (TCD), Dublin, Ireland."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Segurado","ForeName":"Ricardo","Initials":"R","Identifier":"0000-0002-3547-6733","AffiliationInfo":[{"Affiliation":"Centre for Support and Training in Analysis and Research (CSTAR), University College Dublin (UCD), Dublin, Ireland."},{"Affiliation":"School of Public Health, Physiotherapy and Sport Science, University College Dublin (UCD), Dublin, Ireland."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Kennelly","ForeName":"Sean","Initials":"S","AffiliationInfo":[{"Affiliation":"Department of Age Related Healthcare, Tallaght Hospital, Dublin, Ireland."},{"Affiliation":"Department of Medical Gerontology, Trinity College Dublin, Dublin, Ireland."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Olde Rikkert","ForeName":"Marcel G M","Initials":"MGM","Identifier":"0000-0003-1397-1677","AffiliationInfo":{"Affiliation":"Department of Geriatric Medicine, Radboudumc Alzheimer Center, Donders Institute of Medical Neurosciences, Radboudumc, Nijmegen, the Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Howard","ForeName":"Robert","Initials":"R","Identifier":"0000-0002-3071-2338","AffiliationInfo":{"Affiliation":"Division of Psychiatry, University College London and King's College London, London, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Pasquier","ForeName":"Florence","Initials":"F","Identifier":"0000-0001-9880-9788","AffiliationInfo":{"Affiliation":"CHU Lille, Univ. Lille, DISTALZ Laboratory of Excellence, F-59000 Lille, France."}},{"@attributes":{"ValidYN":"Y"},"LastName":"B\u00f6rjesson-Hanson","ForeName":"Anne","Initials":"A","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Tsolaki","ForeName":"Magda","Initials":"M","Identifier":"0000-0002-2072-8010","AffiliationInfo":{"Affiliation":"Papanikolaou General Hospital of Thessaloniki, Thessaloniki, Greece."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lucca","ForeName":"Ugo","Initials":"U","AffiliationInfo":{"Affiliation":"Laboratory of Geriatric Neuropsychiatry, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Molloy","ForeName":"D William","Initials":"DW","Identifier":"0000-0001-7370-8630","AffiliationInfo":{"Affiliation":"University College Cork Centre for Gerontology and Rehabilitation, Cork, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Coen","ForeName":"Robert","Initials":"R","AffiliationInfo":{"Affiliation":"Mercer's Institute for Research on Ageing, St. James's Hospital, Dublin, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Riepe","ForeName":"Matthias W","Initials":"MW","AffiliationInfo":{"Affiliation":"Department of Geriatrics and Old Age Psychiatry, Psychiatry II, Ulm University at BKH G\u00fcnzburg, G\u00fcnzburg, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"K\u00e1lm\u00e1n","ForeName":"J\u00e1nos","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Psychiatry, University of Szeged, Szeged, Hungary."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Kenny","ForeName":"Rose Anne","Initials":"RA","AffiliationInfo":{"Affiliation":"Department of Medical Gerontology, Trinity College Dublin (TCD), Dublin, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Cregg","ForeName":"Fiona","Initials":"F","AffiliationInfo":{"Affiliation":"Department of Medical Gerontology, Trinity College Dublin (TCD), Dublin, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"O'Dwyer","ForeName":"Sarah","Initials":"S","AffiliationInfo":{"Affiliation":"Mercer's Institute for Research on Ageing, St. James's Hospital, Dublin, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Walsh","ForeName":"Cathal","Initials":"C","AffiliationInfo":[{"Affiliation":"Health Research Institute, University of Limerick, Limerick, Ireland."},{"Affiliation":"Mathematics Applications Consortium for Science and Industry (MACSI), Department of Mathematics and Statistics, University of Limerick, Limerick, Ireland."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Adams","ForeName":"Jessica","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Old Age Psychiatry, King's College London, London, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Banzi","ForeName":"Rita","Initials":"R","AffiliationInfo":{"Affiliation":"IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Breuilh","ForeName":"Laetitia","Initials":"L","AffiliationInfo":{"Affiliation":"CHU Lille, Univ. Lille, DISTALZ Laboratory of Excellence, F-59000 Lille, France."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Daly","ForeName":"Leslie","Initials":"L","Identifier":"0000-0001-8560-1195","AffiliationInfo":[{"Affiliation":"Centre for Support and Training in Analysis and Research (CSTAR), University College Dublin (UCD), Dublin, Ireland."},{"Affiliation":"School of Public Health, Physiotherapy and Sport Science, University College Dublin (UCD), Dublin, Ireland."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Hendrix","ForeName":"Suzanne","Initials":"S","AffiliationInfo":{"Affiliation":"Pentara Corporation, Salt Lake City, Utah, United States of America."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Aisen","ForeName":"Paul","Initials":"P","AffiliationInfo":{"Affiliation":"Department of Neurology, University of Southern California, Los Angeles, California, United States of America."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gaynor","ForeName":"Siobhan","Initials":"S","AffiliationInfo":{"Affiliation":"Molecular Medicine Ireland (MMI), Dublin, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Sheikhi","ForeName":"Ali","Initials":"A","AffiliationInfo":[{"Affiliation":"Health Research Institute, University of Limerick, Limerick, Ireland."},{"Affiliation":"Mathematics Applications Consortium for Science and Industry (MACSI), Department of Mathematics and Statistics, University of Limerick, Limerick, Ireland."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Taekema","ForeName":"Diana G","Initials":"DG","AffiliationInfo":{"Affiliation":"Department of Geriatric Medicine, Rijnstate Hospital, Arnhem, the Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Verhey","ForeName":"Frans R","Initials":"FR","AffiliationInfo":{"Affiliation":"Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, the Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Nemni","ForeName":"Raffaello","Initials":"R","AffiliationInfo":{"Affiliation":"IRCCS Don Gnocchi Foundation-University of Milan, Milan, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Nobili","ForeName":"Flavio","Initials":"F","Identifier":"0000-0001-9811-0897","AffiliationInfo":[{"Affiliation":"Department of Neuroscience (DINOGMI), University of Genoa, Genoa, Italy."},{"Affiliation":"IRCCS AOU Polyclinic, Hospital San Martino, Genoa, Italy."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Franceschi","ForeName":"Massimo","Initials":"M","AffiliationInfo":{"Affiliation":"Neurology Department, Multimedica, Castellanza, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni","Initials":"G","AffiliationInfo":{"Affiliation":"Centro San Giovanni di Dio-IRCCS Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"Centro San Giovanni di Dio-IRCCS Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Konsta","ForeName":"Anastasia","Initials":"A","AffiliationInfo":{"Affiliation":"Aristotle University of Thessaloniki (AUTH), First Psychiatric Department, Papageorgiou General Hospital, Thessaloniki, Greece."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Anastasios","ForeName":"Orologas","Initials":"O","AffiliationInfo":{"Affiliation":"Ahepa University General Hospital of Thessaloniki, Thessaloniki, Greece."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Nenopoulou","ForeName":"Styliani","Initials":"S","Identifier":"0000-0002-9386-3694","AffiliationInfo":{"Affiliation":"Papanikolaou General Hospital of Thessaloniki, Thessaloniki, Greece."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Tsolaki-Tagaraki","ForeName":"Fani","Initials":"F","Identifier":"0000-0003-2349-662X","AffiliationInfo":{"Affiliation":"Papanikolaou General Hospital of Thessaloniki, Thessaloniki, Greece."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Pakaski","ForeName":"Magdolna","Initials":"M","AffiliationInfo":{"Affiliation":"Department of Psychiatry, University of Szeged, Szeged, Hungary."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Dereeper","ForeName":"Olivier","Initials":"O","AffiliationInfo":{"Affiliation":"Centre Hospitalier de Calais, Calais, France."}},{"@attributes":{"ValidYN":"Y"},"LastName":"de la Sayette","ForeName":"Vincent","Initials":"V","AffiliationInfo":{"Affiliation":"Centre Hospitalier Universitaire de Caen, Caen, France."}},{"@attributes":{"ValidYN":"Y"},"LastName":"S\u00e9n\u00e9chal","ForeName":"Olivier","Initials":"O","AffiliationInfo":{"Affiliation":"Centre Hospitalier de Lens, Lens, France."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lavenu","ForeName":"Isabelle","Initials":"I","Identifier":"0000-0001-7345-3295","AffiliationInfo":{"Affiliation":"Centre Hospitalier de B\u00e9thune, B\u00e9thune, France."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Devendeville","ForeName":"Agn\u00e8s","Initials":"A","AffiliationInfo":{"Affiliation":"Centre Hospitalier Universitaire d'Amiens, Amien, France."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Calais","ForeName":"Gauthier","Initials":"G","AffiliationInfo":{"Affiliation":"Groupement des H\u00f4pitaux de l'Institut Catholique de Lille (GHICL), Lille, France."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Crawford","ForeName":"Fiona","Initials":"F","AffiliationInfo":[{"Affiliation":"Archer Pharmaceuticals, Sarasota, Florida, United States of America."},{"Affiliation":"Roskamp Institute, Sarasota, Florida, United States of America."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Mullan","ForeName":"Michael","Initials":"M","AffiliationInfo":[{"Affiliation":"Archer Pharmaceuticals, Sarasota, Florida, United States of America."},{"Affiliation":"Roskamp Institute, Sarasota, Florida, United States of America."}]},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"NILVAD Study Group"}]},"Language":"eng","DataBankList":{"@attributes":{"CompleteYN":"Y"},"DataBank":[{"DataBankName":"ClinicalTrials.gov","AccessionNumberList":{"AccessionNumber":"NCT02017340"}},{"DataBankName":"EudraCT","AccessionNumberList":{"AccessionNumber":"2012-002764-27"}}]},"PublicationTypeList":{"PublicationType":["Clinical Trial, Phase III","Journal Article","Multicenter Study","Randomized Controlled Trial","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2018","Month":"09","Day":"24"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"PLoS Med","NlmUniqueID":"101231360","ISSNLinking":"1549-1277"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Calcium Channel Blockers"},{"RegistryNumber":"0","NameOfSubstance":"Nootropic Agents"},{"RegistryNumber":"0214FUT37J","NameOfSubstance":"nilvadipine"},{"RegistryNumber":"I9ZF7L6G2L","NameOfSubstance":"Nifedipine"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":["drug therapy","psychology"]},{"DescriptorName":"Calcium Channel Blockers","QualifierName":"therapeutic use"},{"DescriptorName":"Cognitive Dysfunction","QualifierName":["drug therapy","psychology"]},{"DescriptorName":"Disease Progression"},{"DescriptorName":"Double-Blind Method"},{"DescriptorName":"Europe"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Nifedipine","QualifierName":["analogs & derivatives","therapeutic use"]},{"DescriptorName":"Nootropic Agents","QualifierName":"therapeutic use"},{"DescriptorName":"Treatment Outcome"}]},"CoiStatement":"I have read the journal's policy and the authors of this manuscript have the following competing interests: SH is a paid employee of Pentara Corporation, which received payment to verify the primary outcome analysis of this study, and is also a paid consultant for Acumen Pharmaceuticals, Affiris AG, Affirmativ Diagnostics PLLC, Alkahest, Allergan, Alzheon, Amylyx Pharmaceuticals, Apodemus, Avanir Pharmaceuticals, Banner Alzheimer's Institute, Biogen, Dr. Richard Isaacson, Gerson Lehrman Group, Grifols Shared Services North America, Ionis Pharmaceuticals, M3 Biotechnology, Neurotrope BioScience, Nutricia Research B.V., PhotoPharmics, Regenera Pharma, Roche (F. Hoffmann-La Roche--Switzerland), Toyama Chemical Co., and vTv Therapeutics; MM and FC are paid employees of Archer Pharmaceuticals, which owns patents for the use of nilvadipine in Alzheimer disease; MM, FC, SK, RS, and BL are named as inventors in a pending patent for the use of nilvadipine based on the results of this clinical trial. No other authors have declared competing interests."},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2018","Month":"02","Day":"23"},{"@attributes":{"PubStatus":"accepted"},"Year":"2018","Month":"08","Day":"24"},{"@attributes":{"PubStatus":"entrez"},"Year":"2018","Month":"9","Day":"25","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2018","Month":"9","Day":"25","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2019","Month":"4","Day":"10","Hour":"6","Minute":"0"}]},"PublicationStatus":"epublish","ArticleIdList":{"ArticleId":["30248105","10.1371\/journal.pmed.1002660","PMEDICINE-D-18-00761","PMC6152871"]},"ReferenceList":{"Reference":[{"Citation":"Am J Psychiatry. 1991 Jan;148(1):102-5","ArticleIdList":{"ArticleId":"1984692"}},{"Citation":"Int Psychogeriatr. 1997;9 Suppl 1:163-5","ArticleIdList":{"ArticleId":"9447439"}},{"Citation":"Arch Intern Med. 2002 Oct 14;162(18):2046-52","ArticleIdList":{"ArticleId":"12374512"}},{"Citation":"Clin Exp Hypertens. 1999 Oct;21(7):1177-88","ArticleIdList":{"ArticleId":"10513835"}},{"Citation":"BMJ Open. 2016 Jul 19;6(7):e011584","ArticleIdList":{"ArticleId":"27436668"}},{"Citation":"J Biol Chem. 2014 Dec 5;289(49):33927-44","ArticleIdList":{"ArticleId":"25331948"}},{"Citation":"Neurobiol Aging. 2005 Feb;26(2):157-63","ArticleIdList":{"ArticleId":"15582745"}},{"Citation":"BMJ Open. 2014 Oct 09;4(10):e006364","ArticleIdList":{"ArticleId":"25300460"}},{"Citation":"Clin Chim Acta. 2004 Dec;350(1-2):151-7","ArticleIdList":{"ArticleId":"15530472"}},{"Citation":"Lancet Neurol. 2010 Apr;9(4):363-72","ArticleIdList":{"ArticleId":"20189881"}},{"Citation":"Eur J Pharmacol. 2011 Jun 1;659(2-3):124-9","ArticleIdList":{"ArticleId":"21497592"}},{"Citation":"CNS Drugs. 2015 Feb;29(2):113-30","ArticleIdList":{"ArticleId":"25700645"}},{"Citation":"Neurology. 1993 Nov;43(11):2412-4","ArticleIdList":{"ArticleId":"8232972"}},{"Citation":"Neurology. 2009 May 19;72(20):1720-6","ArticleIdList":{"ArticleId":"19228583"}},{"Citation":"Brain Res. 2004 Feb 27;999(1):53-61","ArticleIdList":{"ArticleId":"14746921"}},{"Citation":"Int J Geriatr Psychiatry. 2011 Oct;26(10):1038-45","ArticleIdList":{"ArticleId":"21905098"}},{"Citation":"Sci Transl Med. 2011 Nov 30;3(111):111cm33","ArticleIdList":{"ArticleId":"22133718"}},{"Citation":"N Engl J Med. 2014 Jan 23;370(4):322-33","ArticleIdList":{"ArticleId":"24450891"}},{"Citation":"Can J Diabetes. 2017 Feb;41(1):114-119","ArticleIdList":{"ArticleId":"27614804"}},{"Citation":"Lancet. 1998 Oct 24;352(9137):1347-51","ArticleIdList":{"ArticleId":"9802273"}},{"Citation":"Arch Neurol. 2012 Dec;69(12):1632-8","ArticleIdList":{"ArticleId":"22964777"}},{"Citation":"Int J Geriatr Psychiatry. 2007 Dec;22(12):1264-6","ArticleIdList":{"ArticleId":"18033677"}},{"Citation":"Mol Med. 2011 Mar-Apr;17(3-4):149-62","ArticleIdList":{"ArticleId":"21170472"}},{"Citation":"Neurology. 1984 Jul;34(7):939-44","ArticleIdList":{"ArticleId":"6610841"}},{"Citation":"Am J Psychiatry. 1984 Nov;141(11):1356-64","ArticleIdList":{"ArticleId":"6496779"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","IndexingMethod":"Curated","Owner":"NLM"},"PMID":"29866102","DateCompleted":{"Year":"2019","Month":"03","Day":"11"},"DateRevised":{"Year":"2019","Month":"03","Day":"11"},"Article":{"@attributes":{"PubModel":"Electronic"},"Journal":{"ISSN":"1471-2318","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"18","Issue":"1","PubDate":{"Year":"2018","Month":"06","Day":"04"}},"Title":"BMC geriatrics","ISOAbbreviation":"BMC Geriatr"},"ArticleTitle":"Barriers and facilitators to the access to and use of formal dementia care: findings of a focus group study with people with dementia, informal carers and health and social care professionals in eight European countries.","Pagination":{"MedlinePgn":"131"},"ELocationID":"10.1186\/s12877-018-0816-1","Abstract":{"AbstractText":["People with dementia and informal carers often access formal care late in the process of dementia. The barriers and facilitators to service use from the perspectives of different stakeholders involved are not well understood. Thus, we aimed to explore the barriers and facilitators of access to and utilisation of formal care from the perspectives of people with dementia, their informal carers and health and social care professionals.","Focus groups with people with dementia, informal carers and professionals were conducted in eight European countries. Recruitment targeted people with dementia, informal carers with experience of formal care and professionals involved in providing (access to) formal care. Qualitative content analysis using open coding was used on a national level. Cross-national synthesis was based on the translated national reports.","Overall, 55 focus groups with 261 participants were conducted, involving 51 people with dementia, 96 informal carers and 114 professionals. Sixteen categories describing barriers and facilitators were identified, referring to three global themes: Aspects related to 1) individuals involved, 2) the system or 3) overarching aspects. The attitudes and beliefs of people with dementia and their carers may have a major impact, and they often serve as barriers. Formal care was perceived as a threat to the individual independence of people with dementia and was thus avoided as long as possible. A healthcare professional serving as a constant key contact person could be an essential facilitator to overcome these barriers. Contact should be initiated proactively, as early as possible, and a trusting and consistent relationship needs to be established. Beyond that, the findings largely confirm former research and show that barriers to accessing and using formal care still exist across Europe despite a number of national and European initiatives.","Further investigations are needed to elaborate how the concept of a key contact person could be integrated with existing case management approaches and how the independence and autonomy of people with dementia can be strengthened when formal care needs to be accessed and used. These may be meaningful facilitators regarding enhanced access to formal care for people with dementia and their families."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Stephan","ForeName":"Astrid","Initials":"A","AffiliationInfo":{"Affiliation":"Institute for Health and Nursing Science, Martin Luther University Halle-Wittenberg, Magdeburger Stra\u00dfe 8, 06112, Halle (Saale), Germany. astrid.stephan@medizin.uni-halle.de."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bieber","ForeName":"Anja","Initials":"A","AffiliationInfo":{"Affiliation":"Institute for Health and Nursing Science, Martin Luther University Halle-Wittenberg, Magdeburger Stra\u00dfe 8, 06112, Halle (Saale), Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hopper","ForeName":"Louise","Initials":"L","AffiliationInfo":{"Affiliation":"School of Nursing and Human Sciences, Dublin City University, Glasnevin, Dublin 9, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Joyce","ForeName":"Rachael","Initials":"R","AffiliationInfo":{"Affiliation":"School of Nursing and Human Sciences, Dublin City University, Glasnevin, Dublin 9, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Irving","ForeName":"Kate","Initials":"K","AffiliationInfo":{"Affiliation":"School of Nursing and Human Sciences, Dublin City University, Glasnevin, Dublin 9, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"Alzheimer Unit, IRCCS S. Centro Giovanni di Dio \"Fatebenefratelli\", Via Pilastroni 4, Brescia (BS), Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Portolani","ForeName":"Elisa","Initials":"E","AffiliationInfo":{"Affiliation":"Alzheimer Unit, IRCCS S. Centro Giovanni di Dio \"Fatebenefratelli\", Via Pilastroni 4, Brescia (BS), Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Kerpershoek","ForeName":"Liselot","Initials":"L","AffiliationInfo":{"Affiliation":"Alzheimer Center Limburg, Maastricht University, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Verhey","ForeName":"Frans","Initials":"F","AffiliationInfo":{"Affiliation":"Alzheimer Center Limburg, Maastricht University, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"de Vugt","ForeName":"Marjolein","Initials":"M","AffiliationInfo":{"Affiliation":"Alzheimer Center Limburg, Maastricht University, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Wolfs","ForeName":"Claire","Initials":"C","AffiliationInfo":{"Affiliation":"Alzheimer Center Limburg, Maastricht University, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Eriksen","ForeName":"Siren","Initials":"S","AffiliationInfo":{"Affiliation":"Norwegian National Advisory Unit on Ageing and Health, Vestfold Hospital Trust, T\u00f8nsberg, Norway."}},{"@attributes":{"ValidYN":"Y"},"LastName":"R\u00f8svik","ForeName":"Janne","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Geriatric Medicine, Oslo University Hospital, Aldring og Helse, Oslo, Norway."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Marques","ForeName":"Maria J","Initials":"MJ","AffiliationInfo":{"Affiliation":"Chronic Diseases Research Center, Nova Medical School | Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Campo M\u00e1rtires da P\u00e1tria, 130, 1169-056, Lisbon, Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gon\u00e7alves-Pereira","ForeName":"Manuel","Initials":"M","AffiliationInfo":{"Affiliation":"Chronic Diseases Research Center, Nova Medical School | Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Campo M\u00e1rtires da P\u00e1tria, 130, 1169-056, Lisbon, Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Sj\u00f6lund","ForeName":"Britt-Marie","Initials":"BM","AffiliationInfo":{"Affiliation":"Faculty of Health and Occupational Studies, Department of Health and Caring Sciences, University of G\u00e4vle, G\u00e4vle, Sweden."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Jelley","ForeName":"Hannah","Initials":"H","AffiliationInfo":{"Affiliation":"Dementia Services Development Centre Wales, Bangor University, Bangor, LL57 2PZ, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Woods","ForeName":"Bob","Initials":"B","AffiliationInfo":{"Affiliation":"Dementia Services Development Centre Wales, Bangor University, Bangor, LL57 2PZ, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Meyer","ForeName":"Gabriele","Initials":"G","AffiliationInfo":{"Affiliation":"Institute for Health and Nursing Science, Martin Luther University Halle-Wittenberg, Magdeburger Stra\u00dfe 8, 06112, Halle (Saale), Germany. gabriele.meyer@medizin.uni-halle.de."}},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"Actifcare Consortium"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2018","Month":"06","Day":"04"}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"BMC Geriatr","NlmUniqueID":"100968548","ISSNLinking":"1471-2318"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Caregivers","QualifierName":"psychology"},{"DescriptorName":"Dementia","QualifierName":["epidemiology","psychology","therapy"]},{"DescriptorName":"Europe","QualifierName":"epidemiology"},{"DescriptorName":"Female"},{"DescriptorName":"Focus Groups","QualifierName":"methods"},{"DescriptorName":"Health Personnel","QualifierName":"psychology"},{"DescriptorName":"Health Services Accessibility","QualifierName":"trends"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Social Workers","QualifierName":"psychology"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Dementia","Focus groups","Formal care","Informal carer","Person with dementia","Utilisation"]},"InvestigatorList":{"Investigator":[{"@attributes":{"ValidYN":"Y"},"LastName":"Verhey","ForeName":"Frans","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"de Vugt","ForeName":"Marjolein","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Wolfs","ForeName":"Claire","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Handels","ForeName":"Ron","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kerpershoek","ForeName":"Liselot","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Meyer","ForeName":"Gabriele","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Stephan","ForeName":"Astrid","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bieber","ForeName":"Anja","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Broda","ForeName":"Anja","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bartoszek","ForeName":"Gabriele","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Woods","ForeName":"Bob T","Initials":"BT"},{"@attributes":{"ValidYN":"Y"},"LastName":"Jelley","ForeName":"Hannah","Initials":"H"},{"@attributes":{"ValidYN":"Y"},"LastName":"Orrell","ForeName":"Martin","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Wimo","ForeName":"Anders","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sk\u00f6ldunger","ForeName":"Anders","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sj\u00f6lund","ForeName":"Britt-Marie","Initials":"BM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Engedal","ForeName":"Knut","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Selb\u00e6k","ForeName":"Geir","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Michelet","ForeName":"Mona","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"R\u00f8svik","ForeName":"Janne","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Eriksen","ForeName":"Siren","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Irving","ForeName":"Kate","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Hopper","ForeName":"Louise","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Joyce","ForeName":"Rachael","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Portolani","ForeName":"Elisa","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gon\u00e7alves-Pereira","ForeName":"Manuel","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Marques","ForeName":"Maria J","Initials":"MJ"},{"@attributes":{"ValidYN":"Y"},"LastName":"Concei\u00e7\u00e3o Balsinha","ForeName":"M","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"B\u00e1rrios","ForeName":"Helena","Initials":"H"},{"@attributes":{"ValidYN":"Y"},"LastName":"Machado","ForeName":"Ana","Initials":"A"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2017","Month":"03","Day":"19"},{"@attributes":{"PubStatus":"accepted"},"Year":"2018","Month":"05","Day":"14"},{"@attributes":{"PubStatus":"entrez"},"Year":"2018","Month":"6","Day":"6","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2018","Month":"6","Day":"6","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2019","Month":"3","Day":"12","Hour":"6","Minute":"0"}]},"PublicationStatus":"epublish","ArticleIdList":{"ArticleId":["29866102","10.1186\/s12877-018-0816-1","10.1186\/s12877-018-0816-1","PMC5987478"]},"ReferenceList":{"Reference":[{"Citation":"Int J Geriatr Psychiatry. 2005 Jun;20(6):537-46","ArticleIdList":{"ArticleId":"15920707"}},{"Citation":"Patient Educ Couns. 2012 Apr;87(1):43-8","ArticleIdList":{"ArticleId":"21889285"}},{"Citation":"BMC Health Serv Res. 2016 Aug 23;16(1):423","ArticleIdList":{"ArticleId":"27550084"}},{"Citation":"Health Policy. 2016 Mar;120(3):241-5","ArticleIdList":{"ArticleId":"26872702"}},{"Citation":"J Aging Res. 2014;2014:486521","ArticleIdList":{"ArticleId":"24701350"}},{"Citation":"Cochrane Database Syst Rev. 2015 Jan 05;1:CD008345","ArticleIdList":{"ArticleId":"25560977"}},{"Citation":"J Adv Nurs. 1997 Aug;26(2):418-23","ArticleIdList":{"ArticleId":"9292378"}},{"Citation":"Dementia (London). 2014 Sep;13(5):642-61","ArticleIdList":{"ArticleId":"24339077"}},{"Citation":"J Nurs Scholarsh. 2015 Sep;47(5):407-16","ArticleIdList":{"ArticleId":"26255994"}},{"Citation":"Gerontologist. 2005 Apr;45(2):177-85","ArticleIdList":{"ArticleId":"15799982"}},{"Citation":"Psychosoc Med. 2012;9:Doc11","ArticleIdList":{"ArticleId":"23133505"}},{"Citation":"Qual Health Res. 2012 Oct;22(10):1330-44","ArticleIdList":{"ArticleId":"22785626"}},{"Citation":"J Adv Nurs. 2008 Apr;62(1):107-15","ArticleIdList":{"ArticleId":"18352969"}},{"Citation":"Patient Educ Couns. 2011 Mar;82(3):420-8","ArticleIdList":{"ArticleId":"21292424"}},{"Citation":"Health Soc Care Community. 2016 May;24(3):321-33","ArticleIdList":{"ArticleId":"25754586"}},{"Citation":"Z Gerontol Geriatr. 2018 Jul;51(5):530-536","ArticleIdList":{"ArticleId":"28616816"}},{"Citation":"Int Psychogeriatr. 2015 Jun;27(6):927-36","ArticleIdList":{"ArticleId":"25566686"}},{"Citation":"J Eval Clin Pract. 2001 Aug;7(3):271-87","ArticleIdList":{"ArticleId":"11555086"}},{"Citation":"J Alzheimers Dis. 2014;40(3):743-57","ArticleIdList":{"ArticleId":"24531163"}},{"Citation":"Sociol Health Illn. 2011 Sep;33(6):899-913","ArticleIdList":{"ArticleId":"21371052"}},{"Citation":"Maturitas. 2015 Oct;82(2):162-9","ArticleIdList":{"ArticleId":"26271710"}},{"Citation":"Alzheimers Dement. 2010 Nov;6(6):482-93","ArticleIdList":{"ArticleId":"21044778"}},{"Citation":"Alzheimer Dis Assoc Disord. 2014 Oct-Dec;28(4):299-310","ArticleIdList":{"ArticleId":"25321607"}},{"Citation":"J Am Geriatr Soc. 2013 Dec;61(12):2087-95","ArticleIdList":{"ArticleId":"24479141"}},{"Citation":"Patient Educ Couns. 2007 Sep;68(1):33-42","ArticleIdList":{"ArticleId":"17544239"}},{"Citation":"BMC Psychiatry. 2017 Aug 30;17(1):316","ArticleIdList":{"ArticleId":"28854922"}},{"Citation":"Health Serv Res. 2002 Oct;37(5):1221-42","ArticleIdList":{"ArticleId":"12479494"}},{"Citation":"Int J Clin Pharm. 2017 Feb;39(1):104-112","ArticleIdList":{"ArticleId":"27933488"}},{"Citation":"Australas J Ageing. 2014 Sep;33(3):206-13","ArticleIdList":{"ArticleId":"24372663"}},{"Citation":"Nurse Educ Today. 2004 Feb;24(2):105-12","ArticleIdList":{"ArticleId":"14769454"}},{"Citation":"Int J Clin Pract Suppl. 2005 Mar;(146):8-14","ArticleIdList":{"ArticleId":"15801185"}},{"Citation":"Nurs Outlook. 2012 Nov-Dec;60(6):411-6","ArticleIdList":{"ArticleId":"22464693"}},{"Citation":"J Health Serv Res Policy. 2002 Jul;7(3):186-8","ArticleIdList":{"ArticleId":"12171751"}},{"Citation":"J Adv Nurs. 2006 Dec;56(5):491-7","ArticleIdList":{"ArticleId":"17078825"}},{"Citation":"Gerontologist. 2018 May 8;58(3):e180-e196","ArticleIdList":{"ArticleId":"28069886"}},{"Citation":"J Am Geriatr Soc. 2001 Dec;49(12):1714-21","ArticleIdList":{"ArticleId":"11844008"}},{"Citation":"Am J Alzheimers Dis Other Demen. 2011 May;26(3):195-204","ArticleIdList":{"ArticleId":"21273207"}},{"Citation":"Aging Ment Health. 2017 Jun 16;:1-9","ArticleIdList":{"ArticleId":"28621549"}},{"Citation":"J Clin Nurs. 2017 Aug 9;:null","ArticleIdList":{"ArticleId":"28793378"}},{"Citation":"Health Soc Care Community. 2008 Jan;16(1):42-53","ArticleIdList":{"ArticleId":"18181814"}},{"Citation":"Int J Geriatr Psychiatry. 2010 Oct;25(10):1006-12","ArticleIdList":{"ArticleId":"20872928"}},{"Citation":"Health Soc Care Community. 2015 Jan;23(1):51-53","ArticleIdList":{"ArticleId":"25602093"}},{"Citation":"Health Soc Care Community. 2014 Jan;22(1):1-12","ArticleIdList":{"ArticleId":"23530738"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"29226869","DateCompleted":{"Year":"2019","Month":"01","Day":"15"},"DateRevised":{"Year":"2019","Month":"12","Day":"10"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1875-8908","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"61","Issue":"2","PubDate":{"Year":"2018"}},"Title":"Journal of Alzheimer's disease : JAD","ISOAbbreviation":"J Alzheimers Dis"},"ArticleTitle":"The Heritability of Frontotemporal Lobar Degeneration: Validation of Pedigree Classification Criteria in a Northern Italy Cohort.","Pagination":{"MedlinePgn":"753-760"},"ELocationID":"10.3233\/JAD-170661","Abstract":{"AbstractText":"A large portion of frontotemporal lobar degeneration (FTLD) patients has a family history of disease and the presence of a pathogenic mutation confirms the clinical diagnosis. Recently, standardized criteria to evaluate FTLD pedigree, based on first- and second-degree affected relatives, their age at onset, and clinical phenotype, were proposed and validated in an American cohort. Herein we applied these criteria to 402 Italian FTLD pedigrees and assessed mutation frequencies in GRN, C9orf72, and MAPT genes with the aim of validating these criteria. Moreover, we evaluated whether genetic counseling requests reflect the estimated family risk. 12.4% of pedigrees had high family history, 6.5% medium, 15.4% low; 39% were apparent sporadic cases and 26.6% had family history of unknown significance. Mutations frequencies were in line with the categorization proposed: the highest rate was found in the most at-risk families (74%) and decreased in other categories (medium: 15.4%; low: 9.7%; sporadic: 1.3%). Mutation carriers with unknown family history (5.6%) were mostly early-onset patients. Detected mutation frequency was comparable with the US-cohort (13.7%), but mutations distribution among genes was different, with higher frequency of GRN mutations (9.4%) in our cohort. An elevated proportion of FTLD patients belonging to \"high risk\" pedigrees asked for genetic counseling (42%); requests decreased according to the estimated family risk (medium: 26.9%; low: 17.7%; sporadic: 5.1%). In conclusion, the proposed pedigree classification criteria, herein further validated, should be incorporated in the FTLD diagnostic work-up. Moreover, our data suggest to extend genetic screening to early-onset patients with unknown family history."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Fostinelli","ForeName":"Silvia","Initials":"S","AffiliationInfo":{"Affiliation":"Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ciani","ForeName":"Miriam","Initials":"M","AffiliationInfo":[{"Affiliation":"Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."},{"Affiliation":"Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanardini","ForeName":"Roberta","Initials":"R","AffiliationInfo":{"Affiliation":"Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"Alzheimer's Research Unit, MAC Memory Clinic, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Binetti","ForeName":"Giuliano","Initials":"G","AffiliationInfo":[{"Affiliation":"Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."},{"Affiliation":"Alzheimer's Research Unit, MAC Memory Clinic, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Ghidoni","ForeName":"Roberta","Initials":"R","AffiliationInfo":{"Affiliation":"Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Benussi","ForeName":"Luisa","Initials":"L","AffiliationInfo":{"Affiliation":"Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't","Validation Study"]}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"J Alzheimers Dis","NlmUniqueID":"9814863","ISSNLinking":"1387-2877"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"C9orf72 Protein"},{"RegistryNumber":"0","NameOfSubstance":"C9orf72 protein, human"},{"RegistryNumber":"0","NameOfSubstance":"GRN protein, human"},{"RegistryNumber":"0","NameOfSubstance":"MAPT protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Progranulins"},{"RegistryNumber":"0","NameOfSubstance":"tau Proteins"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Age of Onset"},{"DescriptorName":"Aged"},{"DescriptorName":"C9orf72 Protein","QualifierName":"genetics"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"Female"},{"DescriptorName":"Frontotemporal Lobar Degeneration","QualifierName":["classification","diagnosis","genetics"]},{"DescriptorName":"Genetic Counseling"},{"DescriptorName":"Genetic Testing","QualifierName":"standards"},{"DescriptorName":"Humans"},{"DescriptorName":"Italy"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Mutation"},{"DescriptorName":"Pedigree"},{"DescriptorName":"Progranulins","QualifierName":"genetics"},{"DescriptorName":"tau Proteins","QualifierName":"genetics"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["C9orf72","GRN","MAPT","frontotemporal lobar degeneration","genetic counseling","mutation","pedigree"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2017","Month":"12","Day":"12","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2019","Month":"1","Day":"16","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2017","Month":"12","Day":"12","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["29226869","JAD170661","10.3233\/JAD-170661"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"29068697","DateCompleted":{"Year":"2019","Month":"06","Day":"24"},"DateRevised":{"Year":"2019","Month":"06","Day":"24"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1364-6915","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"22","Issue":"7","PubDate":{"Year":"2018","Month":"07"}},"Title":"Aging & mental health","ISOAbbreviation":"Aging Ment Health"},"ArticleTitle":"Needs and quality of life of people with middle-stage dementia and their family carers from the European Actifcare study. When informal care alone may not suffice.","Pagination":{"MedlinePgn":"897-902"},"ELocationID":"10.1080\/13607863.2017.1390732","Abstract":{"AbstractText":["The Actifcare (Access to timely formal care) study investigated needs of people with dementia and their families during the phase in which formal care is being considered, and examined whether higher need levels are related to lower quality of life (QOL).","From eight European countries 451 people with dementia and their carers participated. Needs were measured with the Camberwell Assessment of Need for the Elderly. QOL was measured with the QOL-AD, and carer quality of life was measured with the CarerQol. The relationship between needs and QOL was analysed with multiple regression analyses.","Needs were expressed in the domains of psychological distress, daytime activities, company and information. People with dementia rated their unmet needs significantly lower than their carers: the mean number of self-rated unmet needs was 0.95, whereas the mean proxy ratings were 1.66. For met needs, the self-rated mean was 5.5 and was 8 when proxy-rated. The level of needs reported was negatively associated with QOL for both.","The study results show that informal carers reported almost twice as many needs as people with dementia. The domains in which needs are expressed should be the primary focus for interventions to support \u00a0 QOL.\u00a0The perspectives of people with dementia are informative when identifying needs."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Kerpershoek","ForeName":"Liselot","Initials":"L","AffiliationInfo":{"Affiliation":"a Alzheimer Centrum Limburg , Maastricht University , Maastricht , The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"de Vugt","ForeName":"Marjolein","Initials":"M","AffiliationInfo":{"Affiliation":"a Alzheimer Centrum Limburg , Maastricht University , Maastricht , The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Wolfs","ForeName":"Claire","Initials":"C","AffiliationInfo":{"Affiliation":"a Alzheimer Centrum Limburg , Maastricht University , Maastricht , The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Woods","ForeName":"Bob","Initials":"B","AffiliationInfo":{"Affiliation":"b Bangor University , Bangor , UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Jelley","ForeName":"Hannah","Initials":"H","AffiliationInfo":{"Affiliation":"b Bangor University , Bangor , UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Orrell","ForeName":"Martin","Initials":"M","AffiliationInfo":{"Affiliation":"b Bangor University , Bangor , UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stephan","ForeName":"Astrid","Initials":"A","AffiliationInfo":{"Affiliation":"c Martin Luther University Halle-Wittenberg (DE) , Institute of Health and Nursing sciences , Halle , Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bieber","ForeName":"Anja","Initials":"A","AffiliationInfo":{"Affiliation":"c Martin Luther University Halle-Wittenberg (DE) , Institute of Health and Nursing sciences , Halle , Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Meyer","ForeName":"Gabriele","Initials":"G","AffiliationInfo":{"Affiliation":"c Martin Luther University Halle-Wittenberg (DE) , Institute of Health and Nursing sciences , Halle , Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Selbaek","ForeName":"Geir","Initials":"G","AffiliationInfo":{"Affiliation":"d Department of Geriatric Medicine , Oslo University Hospital , Oslo , Norway."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Handels","ForeName":"Ron","Initials":"R","Identifier":"0000-0002-8663-0630","AffiliationInfo":[{"Affiliation":"a Alzheimer Centrum Limburg , Maastricht University , Maastricht , The Netherlands."},{"Affiliation":"e Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics , Karolinska Institutet , Stockholm , Sweden."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Wimo","ForeName":"Anders","Initials":"A","AffiliationInfo":[{"Affiliation":"e Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics , Karolinska Institutet , Stockholm , Sweden."},{"Affiliation":"f Centre for Research & Development Uppsala University \/ City Council of G\u00e4vleborg , G\u00e4vle , Sweden."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Hopper","ForeName":"Louise","Initials":"L","AffiliationInfo":{"Affiliation":"g School of Nursing and Human Sciences , Dublin City University , Dublin , Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Irving","ForeName":"Kate","Initials":"K","AffiliationInfo":{"Affiliation":"g School of Nursing and Human Sciences , Dublin City University , Dublin , Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Marques","ForeName":"Maria","Initials":"M","AffiliationInfo":{"Affiliation":"h CEDOC, Nova Medical School, Faculdade De Ci\u00eancias M\u00e9dicas , Universidade Nova De Lisboa , Lisbon , Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gon\u00e7alves-Pereira","ForeName":"Manuel","Initials":"M","AffiliationInfo":{"Affiliation":"h CEDOC, Nova Medical School, Faculdade De Ci\u00eancias M\u00e9dicas , Universidade Nova De Lisboa , Lisbon , Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Portolani","ForeName":"Elisa","Initials":"E","AffiliationInfo":{"Affiliation":"i Alzheimer's Research Unit-Memory Clinic , IRCCS Centro S. Giovanni di Dio , Milano , Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"i Alzheimer's Research Unit-Memory Clinic , IRCCS Centro S. Giovanni di Dio , Milano , Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Verhey","ForeName":"Frans","Initials":"F","AffiliationInfo":{"Affiliation":"a Alzheimer Centrum Limburg , Maastricht University , Maastricht , The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"Actifcare Consortium"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2017","Month":"10","Day":"25"}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"Aging Ment Health","NlmUniqueID":"9705773","ISSNLinking":"1360-7863"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Activities of Daily Living"},{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Caregivers","QualifierName":"psychology"},{"DescriptorName":"Dementia","QualifierName":["psychology","therapy"]},{"DescriptorName":"Female"},{"DescriptorName":"Health Services Needs and Demand"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Needs Assessment","QualifierName":"statistics & numerical data"},{"DescriptorName":"Patient Care"},{"DescriptorName":"Quality of Life","QualifierName":"psychology"},{"DescriptorName":"Severity of Illness Index"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["(un)met needs","Dementia","informal carer","quality of life"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2017","Month":"10","Day":"27","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2019","Month":"6","Day":"25","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2017","Month":"10","Day":"26","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["29068697","10.1080\/13607863.2017.1390732"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"28946566","DateCompleted":{"Year":"2018","Month":"04","Day":"09"},"DateRevised":{"Year":"2018","Month":"04","Day":"09"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1875-8908","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"60","Issue":"2","PubDate":{"Year":"2017"}},"Title":"Journal of Alzheimer's disease : JAD","ISOAbbreviation":"J Alzheimers Dis"},"ArticleTitle":"Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study.","Pagination":{"MedlinePgn":"335-340"},"ELocationID":"10.3233\/JAD-170260","Abstract":{"AbstractText":"Alcohol, coffee, and tobacco consumption was assessed on 151 FTD outpatients and 151 matched controls in a multicenter retrospective case-control design. No association was found for smoking and coffee intake. The risk of FTD was decreased by alcohol consumption (adj. OR 0.30, 95% CI 0.14-0.63); risk reduction was significant in current alcohol consumers (adj. OR 0.22, 95% CI 0.10-0.51). The risk of FTD inversely correlated with the duration of exposure (adj. OR 0.88, 95% CI 0.81-0.95, for every 5 years of exposure increase). Retrospective information and the unknown amount of consumed alcohol are limits of the present work."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Tremolizzo","ForeName":"Lucio","Initials":"L","AffiliationInfo":[{"Affiliation":"Neurology Unit, San Gerardo Hospital, Monza, Italy."},{"Affiliation":"School of Medicine and Surgery and Milan Center for Neuroscience (NeuroMI), University of Milano-Bicocca, Italy."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Bianchi","ForeName":"Elisa","Initials":"E","AffiliationInfo":{"Affiliation":"Laboratory of Neurological Disorders, IRCCS-Istituto di Ricerche Farmacologiche \"Mario Negri\", Milano, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Susani","ForeName":"Emanuela","Initials":"E","AffiliationInfo":{"Affiliation":"Neurology Unit, San Gerardo Hospital, Monza, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Pupillo","ForeName":"Elisabetta","Initials":"E","AffiliationInfo":{"Affiliation":"Laboratory of Neurological Disorders, IRCCS-Istituto di Ricerche Farmacologiche \"Mario Negri\", Milano, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Messina","ForeName":"Paolo","Initials":"P","AffiliationInfo":{"Affiliation":"Laboratory of Neurological Disorders, IRCCS-Istituto di Ricerche Farmacologiche \"Mario Negri\", Milano, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Aliprandi","ForeName":"Angelo","Initials":"A","AffiliationInfo":{"Affiliation":"Neurology Unit, Manzoni Hospital, Lecco, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Salmaggi","ForeName":"Andrea","Initials":"A","AffiliationInfo":{"Affiliation":"Neurology Unit, Manzoni Hospital, Lecco, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Cosseddu","ForeName":"Maura","Initials":"M","AffiliationInfo":{"Affiliation":"Neurology Unit, Spedali Civili and University of Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Pilotto","ForeName":"Andrea","Initials":"A","AffiliationInfo":{"Affiliation":"Neurology Unit, Spedali Civili and University of Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Borroni","ForeName":"Barbara","Initials":"B","AffiliationInfo":{"Affiliation":"Neurology Unit, Spedali Civili and University of Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Padovani","ForeName":"Alessandro","Initials":"A","AffiliationInfo":{"Affiliation":"Neurology Unit, Spedali Civili and University of Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonomini","ForeName":"Cristina","Initials":"C","AffiliationInfo":{"Affiliation":"Unit\u00e1 Operativa Alzheimer, IRCCS Centro S. Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"Unit\u00e1 Operativa Alzheimer, IRCCS Centro S. Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Appollonio","ForeName":"Ildebrando","Initials":"I","AffiliationInfo":[{"Affiliation":"Neurology Unit, San Gerardo Hospital, Monza, Italy."},{"Affiliation":"School of Medicine and Surgery and Milan Center for Neuroscience (NeuroMI), University of Milano-Bicocca, Italy."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Beghi","ForeName":"Ettore","Initials":"E","AffiliationInfo":{"Affiliation":"Laboratory of Neurological Disorders, IRCCS-Istituto di Ricerche Farmacologiche \"Mario Negri\", Milano, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ferrarese","ForeName":"Carlo","Initials":"C","AffiliationInfo":[{"Affiliation":"Neurology Unit, San Gerardo Hospital, Monza, Italy."},{"Affiliation":"School of Medicine and Surgery and Milan Center for Neuroscience (NeuroMI), University of Milano-Bicocca, Italy."}]}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Multicenter Study"]}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"J Alzheimers Dis","NlmUniqueID":"9814863","ISSNLinking":"1387-2877"},"ChemicalList":{"Chemical":{"RegistryNumber":"0","NameOfSubstance":"Coffee"}},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alcohol Drinking","QualifierName":"adverse effects"},{"DescriptorName":"Case-Control Studies"},{"DescriptorName":"Coffee","QualifierName":"adverse effects"},{"DescriptorName":"Female"},{"DescriptorName":"Frontotemporal Dementia","QualifierName":["epidemiology","psychology"]},{"DescriptorName":"Habits"},{"DescriptorName":"Humans"},{"DescriptorName":"Life Style"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Odds Ratio"},{"DescriptorName":"Retrospective Studies"},{"DescriptorName":"Risk Factors"},{"DescriptorName":"Smoking","QualifierName":"psychology"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Alcohol","coffee","frontotemporal dementia","risk factor","smoking","voluptuary habits"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2017","Month":"9","Day":"27","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2017","Month":"9","Day":"28","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2018","Month":"4","Day":"10","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["28946566","JAD170260","10.3233\/JAD-170260"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","IndexingMethod":"Curated","Owner":"NLM"},"PMID":"28774307","DateCompleted":{"Year":"2018","Month":"04","Day":"02"},"DateRevised":{"Year":"2018","Month":"12","Day":"02"},"Article":{"@attributes":{"PubModel":"Electronic"},"Journal":{"ISSN":"1472-6963","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"17","Issue":"1","PubDate":{"Year":"2017","Month":"Aug","Day":"03"}},"Title":"BMC health services research","ISOAbbreviation":"BMC Health Serv Res"},"ArticleTitle":"Perspectives of policy and political decision makers on access to formal dementia care: expert interviews in eight European countries.","Pagination":{"MedlinePgn":"518"},"ELocationID":"10.1186\/s12913-017-2456-0","Abstract":{"AbstractText":["As part of the ActifCare (ACcess to Timely Formal Care) project, we conducted expert interviews in eight European countries with policy and political decision makers, or representatives of relevant institutions, to determine their perspectives on access to formal care for people with dementia and their carers.","Each ActifCare country (Germany, Ireland, Italy, The Netherlands, Norway, Portugal, Sweden, United Kingdom) conducted semi-structured interviews with 4-7 experts (total N\u00a0=\u00a038). The interview guide addressed the topics \"Complexity and Continuity of Care\", \"Formal Services\", and \"Public Awareness\". Country-specific analysis of interview transcripts used an inductive qualitative content analysis. Cross-national synthesis focused on similarities in themes across the ActifCare countries.","The analysis revealed ten common themes and two additional sub-themes across countries. Among others, the experts highlighted the need for a coordinating role and the necessity of information to address issues of complexity and continuity of care, demanded person-centred, tailored, and multidisciplinary formal services, and referred to education, mass media and campaigns as means to raise public awareness.","Policy and political decision makers appear well acquainted with current discussions among both researchers and practitioners of possible approaches to improve access to dementia care. Experts described pragmatic, realistic strategies to influence dementia care. Suggested innovations concerned how to achieve improved dementia care, rather than transforming the nature of the services provided. Knowledge gained in these expert interviews may be useful to national decision makers when they consider reshaping the organisation of dementia care, and may thus help to develop best-practice strategies and recommendations."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Broda","ForeName":"Anja","Initials":"A","Identifier":"http:\/\/orcid.org\/0000-0003-2564-6521","AffiliationInfo":{"Affiliation":"Martin Luther University Halle-Wittenberg, Institute of Health and Nursing Sciences, Magdeburger Stra\u00dfe 8, D-06112, Halle (Saale), Germany. anja.broda@medizin.uni-halle.de."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bieber","ForeName":"Anja","Initials":"A","AffiliationInfo":{"Affiliation":"Martin Luther University Halle-Wittenberg, Institute of Health and Nursing Sciences, Magdeburger Stra\u00dfe 8, D-06112, Halle (Saale), Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Meyer","ForeName":"Gabriele","Initials":"G","AffiliationInfo":{"Affiliation":"Martin Luther University Halle-Wittenberg, Institute of Health and Nursing Sciences, Magdeburger Stra\u00dfe 8, D-06112, Halle (Saale), Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hopper","ForeName":"Louise","Initials":"L","AffiliationInfo":{"Affiliation":"Dublin City University, School of Nursing and Human Sciences, Dublin, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Joyce","ForeName":"Rachael","Initials":"R","AffiliationInfo":{"Affiliation":"Dublin City University, School of Nursing and Human Sciences, Dublin, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Irving","ForeName":"Kate","Initials":"K","AffiliationInfo":{"Affiliation":"Dublin City University, School of Nursing and Human Sciences, Dublin, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"IRCCS S. Giovanni di Dio \"Fatebenefratelli\", Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Portolani","ForeName":"Elisa","Initials":"E","AffiliationInfo":{"Affiliation":"IRCCS S. Giovanni di Dio \"Fatebenefratelli\", Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Kerpershoek","ForeName":"Liselot","Initials":"L","AffiliationInfo":{"Affiliation":"Alzheimer Center Limburg, Maastricht University, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Verhey","ForeName":"Frans","Initials":"F","AffiliationInfo":{"Affiliation":"Alzheimer Center Limburg, Maastricht University, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Vugt","ForeName":"Marjolein de","Initials":"M","AffiliationInfo":{"Affiliation":"Alzheimer Center Limburg, Maastricht University, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Wolfs","ForeName":"Claire","Initials":"C","AffiliationInfo":{"Affiliation":"Alzheimer Center Limburg, Maastricht University, Maastricht, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Eriksen","ForeName":"Siren","Initials":"S","AffiliationInfo":{"Affiliation":"Norwegian National Advisory Unit on Ageing and Health, Vestfold Hospital Trust, Oslo, Norway."}},{"@attributes":{"ValidYN":"Y"},"LastName":"R\u00f8svik","ForeName":"Janne","Initials":"J","AffiliationInfo":[{"Affiliation":"Norwegian National Advisory Unit on Ageing and Health, Vestfold Hospital Trust, Oslo, Norway."},{"Affiliation":"Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Marques","ForeName":"Maria J","Initials":"MJ","AffiliationInfo":{"Affiliation":"CEDOC, Chronic Diseases Research Center, Nova Medical School\/Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gon\u00e7alves-Pereira","ForeName":"Manuel","Initials":"M","AffiliationInfo":{"Affiliation":"CEDOC, Chronic Diseases Research Center, Nova Medical School\/Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Sj\u00f6lund","ForeName":"Britt-Marie","Initials":"BM","AffiliationInfo":[{"Affiliation":"Aging Research Center (ARC), Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet and Stockholm University, Stockholm, Sweden."},{"Affiliation":"Faculty of Health and Occupational Studies, Department of Health and Caring Sciences, University of G\u00e4vle, G\u00e4vle, Sweden."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Woods","ForeName":"Bob","Initials":"B","AffiliationInfo":{"Affiliation":"Bangor University, Dementia Services Development Centre, Bangor, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Jelley","ForeName":"Hannah","Initials":"H","AffiliationInfo":{"Affiliation":"Bangor University, Dementia Services Development Centre, Bangor, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Orrell","ForeName":"Martin","Initials":"M","AffiliationInfo":{"Affiliation":"Nottingham University, Institute of Mental Health, Nottingham, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stephan","ForeName":"Astrid","Initials":"A","AffiliationInfo":{"Affiliation":"Martin Luther University Halle-Wittenberg, Institute of Health and Nursing Sciences, Magdeburger Stra\u00dfe 8, D-06112, Halle (Saale), Germany."}},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"ActifCare Consortium"}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2017","Month":"08","Day":"03"}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"BMC Health Serv Res","NlmUniqueID":"101088677","ISSNLinking":"1472-6963"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Caregivers"},{"DescriptorName":"Decision Making"},{"DescriptorName":"Dementia","QualifierName":"therapy"},{"DescriptorName":"Europe"},{"DescriptorName":"Health Services Accessibility","QualifierName":"organization & administration"},{"DescriptorName":"Humans"},{"DescriptorName":"Interviews as Topic"},{"DescriptorName":"Politics"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Access to formal dementia care","Dementia","Expert interviews"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2017","Month":"03","Day":"08"},{"@attributes":{"PubStatus":"accepted"},"Year":"2017","Month":"07","Day":"18"},{"@attributes":{"PubStatus":"entrez"},"Year":"2017","Month":"8","Day":"5","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2017","Month":"8","Day":"5","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2018","Month":"4","Day":"3","Hour":"6","Minute":"0"}]},"PublicationStatus":"epublish","ArticleIdList":{"ArticleId":["28774307","10.1186\/s12913-017-2456-0","10.1186\/s12913-017-2456-0","PMC5543593"]},"ReferenceList":{"Reference":[{"Citation":"CMAJ. 2013 Oct 1;185(14):E669-80","ArticleIdList":{"ArticleId":"24003093"}},{"Citation":"Public Health. 2016 Feb;131:40-8","ArticleIdList":{"ArticleId":"26718421"}},{"Citation":"BMC Health Serv Res. 2016 Aug 23;16(1):423","ArticleIdList":{"ArticleId":"27550084"}},{"Citation":"J Adv Nurs. 2015 Jun;71(6):1405-16","ArticleIdList":{"ArticleId":"25430690"}},{"Citation":"Med Decis Making. 2011 Mar-Apr;31(2):292-8","ArticleIdList":{"ArticleId":"20671212"}},{"Citation":"Int J Geriatr Psychiatry. 2010 Jul;25(7):657-64","ArticleIdList":{"ArticleId":"19946862"}},{"Citation":"J Nurs Manag. 2014 May;22(4):410-22","ArticleIdList":{"ArticleId":"24809238"}},{"Citation":"Clin Interv Aging. 2014 Nov 27;9:2055-63","ArticleIdList":{"ArticleId":"25506210"}},{"Citation":"Acad Med. 2014 Sep;89(9):1245-51","ArticleIdList":{"ArticleId":"24979285"}},{"Citation":"Health Policy Plan. 2011 Jan;26(1):73-82","ArticleIdList":{"ArticleId":"20547652"}},{"Citation":"Patient Educ Couns. 2011 Mar;82(3):420-8","ArticleIdList":{"ArticleId":"21292424"}},{"Citation":"Dementia (London). 2015 Nov;14 (6):769-87","ArticleIdList":{"ArticleId":"24381211"}},{"Citation":"BMC Health Serv Res. 2015 May 28;15:208","ArticleIdList":{"ArticleId":"26017697"}},{"Citation":"Patient Educ Couns. 2007 Sep;68(1):33-42","ArticleIdList":{"ArticleId":"17544239"}},{"Citation":"Nurse Educ Today. 2004 Feb;24(2):105-12","ArticleIdList":{"ArticleId":"14769454"}},{"Citation":"BMC Palliat Care. 2015 Jul 25;14:32","ArticleIdList":{"ArticleId":"26208849"}},{"Citation":"Lancet Neurol. 2016 Nov;15(12 ):1285-1294","ArticleIdList":{"ArticleId":"27751558"}},{"Citation":"Health Soc Care Community. 2014 Jan;22(1):1-12","ArticleIdList":{"ArticleId":"23530738"}},{"Citation":"BMC Health Serv Res. 2012 Nov 14;12:395","ArticleIdList":{"ArticleId":"23151143"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"27869480","DateCompleted":{"Year":"2018","Month":"02","Day":"09"},"DateRevised":{"Year":"2018","Month":"06","Day":"18"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1364-6915","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"21","Issue":"1","PubDate":{"Year":"2017","Month":"01"}},"Title":"Aging & mental health","ISOAbbreviation":"Aging Ment Health"},"ArticleTitle":"Caregiver profiles in dementia related to quality of life, depression and perseverance time in the European Actifcare study: the importance of social health.","Pagination":{"MedlinePgn":"49-57"},"ELocationID":"10.1080\/13607863.2016.1255716","Abstract":{"AbstractText":["To identify caregiver profiles of persons with mild to moderate dementia and to investigate differences between identified caregiver profiles, using baseline data of the international prospective cohort study Actifcare.","A latent class analysis was used to discover different caregiver profiles based on disease related characteristics of 453 persons with dementia and their 453 informal caregivers. These profiles were compared with regard to quality of life (CarerQoL score), depressive symptoms (HADS-D score) and perseverance time.","A 5-class model was identified, with the best Bayesian Information Criterion value, significant likelihood ratio test (p < 0.001), high entropy score (0.88) and substantive interpretability. The classes could be differentiated on two axes: (i) caregivers' age, relationship with persons with dementia, severity of dementia, and (ii) tendency towards stress and difficulty adapting to stress. Classes showed significant differences with all dependent variables, and were labelled 'older low strain', 'older intermediate strain', 'older high strain', 'younger low strain' and 'younger high strain'.","Differences exist between types of caregivers that explain variability in quality of life, depressive symptoms and perseverance time. Our findings may give direction for tailored interventions for caregivers of persons with dementia, which may improve social health and reduce health care costs."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Janssen","ForeName":"Eveline P C J","Initials":"EP","AffiliationInfo":[{"Affiliation":"a Department of Psychiatry and Neuropsychology , School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University Medical Center , Maastricht , The Netherlands."},{"Affiliation":"b Department of Old Age Psychiatry , Mondriaan , Heerlen , The Netherlands."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"de Vugt","ForeName":"Marjolein","Initials":"M","AffiliationInfo":{"Affiliation":"a Department of Psychiatry and Neuropsychology , School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University Medical Center , Maastricht , The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"K\u00f6hler","ForeName":"Sebastian","Initials":"S","AffiliationInfo":{"Affiliation":"a Department of Psychiatry and Neuropsychology , School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University Medical Center , Maastricht , The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Wolfs","ForeName":"Claire","Initials":"C","AffiliationInfo":{"Affiliation":"a Department of Psychiatry and Neuropsychology , School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University Medical Center , Maastricht , The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Kerpershoek","ForeName":"Liselot","Initials":"L","AffiliationInfo":{"Affiliation":"a Department of Psychiatry and Neuropsychology , School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University Medical Center , Maastricht , The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Handels","ForeName":"Ron L H","Initials":"RL","AffiliationInfo":{"Affiliation":"a Department of Psychiatry and Neuropsychology , School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University Medical Center , Maastricht , The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Orrell","ForeName":"Martin","Initials":"M","AffiliationInfo":{"Affiliation":"c Department of Psychiatry and Applied Psychology, Faculty of Medicine & Health Sciences , Institute of Mental Health, University of Nottingham , Nottingham , United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Woods","ForeName":"Bob","Initials":"B","AffiliationInfo":{"Affiliation":"d Dementia Services Development Centre Wales , Bangor University , Bango , United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Jelley","ForeName":"Hannah","Initials":"H","AffiliationInfo":{"Affiliation":"d Dementia Services Development Centre Wales , Bangor University , Bango , United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stephan","ForeName":"Astrid","Initials":"A","AffiliationInfo":{"Affiliation":"e Medical Faculty , Institute for Health and Nursing Science , Halle-Wittenberg , Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bieber","ForeName":"Anja","Initials":"A","AffiliationInfo":{"Affiliation":"e Medical Faculty , Institute for Health and Nursing Science , Halle-Wittenberg , Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Meyer","ForeName":"Gabriele","Initials":"G","AffiliationInfo":{"Affiliation":"e Medical Faculty , Institute for Health and Nursing Science , Halle-Wittenberg , Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Engedal","ForeName":"Knut","Initials":"K","AffiliationInfo":{"Affiliation":"f Norwegian National Advisory Unit on Ageing and Health , Vestfold Hospital Trust , T\u00f8nsberg , Norway."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Selbaek","ForeName":"Geir","Initials":"G","AffiliationInfo":{"Affiliation":"f Norwegian National Advisory Unit on Ageing and Health , Vestfold Hospital Trust , T\u00f8nsberg , Norway."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Wimo","ForeName":"Anders","Initials":"A","AffiliationInfo":{"Affiliation":"g Department of Neurobiology, Care sciences and Society , Karolinska Institut , Stockholm , Sweden."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Irving","ForeName":"Kate","Initials":"K","AffiliationInfo":{"Affiliation":"h School of Nursing and Human Sciences, Dublin City University , Dublin , Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hopper","ForeName":"Louise","Initials":"L","AffiliationInfo":{"Affiliation":"h School of Nursing and Human Sciences, Dublin City University , Dublin , Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gon\u00e7alves-Pereira","ForeName":"Manuel","Initials":"M","AffiliationInfo":{"Affiliation":"i CEDOC - Chronic Diseases Research Center , Nova Medical School, Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa , Lisbon , Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Portolani","ForeName":"Elisa","Initials":"E","AffiliationInfo":{"Affiliation":"j Alzheimer Unit , IRCCS Centro San Giovanni di Dio, Fatebenefratelli , Brescia , Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"j Alzheimer Unit , IRCCS Centro San Giovanni di Dio, Fatebenefratelli , Brescia , Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Verhey","ForeName":"Frans R","Initials":"FR","AffiliationInfo":{"Affiliation":"a Department of Psychiatry and Neuropsychology , School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University Medical Center , Maastricht , The Netherlands."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Multicenter Study","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2016","Month":"11","Day":"21"}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"Aging Ment Health","NlmUniqueID":"9705773","ISSNLinking":"1360-7863"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Age Factors"},{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Caregivers","QualifierName":["psychology","statistics & numerical data"]},{"DescriptorName":"Cross-Sectional Studies"},{"DescriptorName":"Dementia","QualifierName":["classification","therapy"]},{"DescriptorName":"Depression","QualifierName":"psychology"},{"DescriptorName":"Europe"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Psychiatric Status Rating Scales"},{"DescriptorName":"Quality of Life","QualifierName":"psychology"},{"DescriptorName":"Severity of Illness Index"},{"DescriptorName":"Social Support"},{"DescriptorName":"Stress, Physiological"},{"DescriptorName":"Time Factors"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Dementia","caregivers","quality of life","social health","well-being"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2016","Month":"11","Day":"22","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2018","Month":"2","Day":"10","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2016","Month":"11","Day":"22","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["27869480","10.1080\/13607863.2016.1255716"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"27802513","DateCompleted":{"Year":"2017","Month":"05","Day":"29"},"DateRevised":{"Year":"2017","Month":"05","Day":"29"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"2168-6157","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"73","Issue":"12","PubDate":{"Year":"2016","Month":"Dec","Day":"01"}},"Title":"JAMA neurology","ISOAbbreviation":"JAMA Neurol"},"ArticleTitle":"Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study.","Pagination":{"MedlinePgn":"1417-1424"},"ELocationID":"10.1001\/jamaneurol.2016.3751","Abstract":{"AbstractText":["Cerebral amyloidosis is a key abnormality in Alzheimer disease (AD) and can be detected in vivo with positron emission tomography (PET) ligands. Although amyloid PET has clearly demonstrated analytical validity, its clinical utility is debated.","To evaluate the incremental diagnostic value of amyloid PET with florbetapir F 18 in addition to the routine clinical diagnostic assessment of patients evaluated for cognitive impairment.","The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study is a multicenter study involving 18 AD evaluation units from eastern Lombardy, Northern Italy, 228 consecutive adults with cognitive impairment were evaluated for AD and other causes of cognitive decline, with a prescan diagnostic confidence of AD between 15% and 85%. Participants underwent routine clinical and instrumental diagnostic assessment. A prescan diagnosis was made, diagnostic confidence was estimated, and drug treatment was provided. At the time of this workup, an amyloid PET\/computed tomographic scan was performed, and the result was communicated to physicians after workup completion. Physicians were asked to review the diagnosis, diagnostic confidence, and treatment after the scan. The study was conducted from August 5, 2013, to December 31, 2014.","Primary outcomes were prescan to postscan changes of diagnosis, diagnostic confidence, and treatment.","Of the 228 participants, 107 (46%) were male; mean (SD) age was 70.5 (7) years. Diagnostic change occurred in 46 patients (79%) having both a previous diagnosis of AD and an amyloid-negative scan (P\u2009<\u2009.001) and in 16 (53%) of those with non-AD diagnoses and an amyloid-positive scan (P\u2009<\u2009.001). Diagnostic confidence in AD diagnosis increased by 15.2% in amyloid-positive (P\u2009<\u2009.001; effect size Cohen d\u2009=\u20091.04) and decreased by 29.9% in amyloid-negative (P\u2009<\u2009.001; d\u2009=\u2009-1.19) scans. Acetylcholinesterase inhibitors and memantine hydrochloride were introduced in 61 (65.6%) patients with positive scan results who had not previously received those drugs, and the use of the drugs was discontinued in 6 (33.3%) patients with negative scan results who were receiving those drugs (P\u2009<\u2009.001).","Amyloid PET in addition to routine assessment in patients with cognitive impairment has a significant effect on diagnosis, diagnostic confidence, and drug treatment. The effect on health outcomes, such as morbidity and mortality, remains to be assessed."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Boccardi","ForeName":"Marina","Initials":"M","AffiliationInfo":{"Affiliation":"LANVIE-Laboratory of Neuroimaging of Aging, University of Geneva, Geneva, Switzerland2Laboratory of Alzheimer's Neuroimaging and Epidemiology, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Altomare","ForeName":"Daniele","Initials":"D","AffiliationInfo":{"Affiliation":"Laboratory of Alzheimer's Neuroimaging and Epidemiology, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy3Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ferrari","ForeName":"Clarissa","Initials":"C","AffiliationInfo":{"Affiliation":"Unit of Statistics, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Festari","ForeName":"Cristina","Initials":"C","AffiliationInfo":{"Affiliation":"Laboratory of Alzheimer's Neuroimaging and Epidemiology, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy3Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Guerra","ForeName":"Ugo Paolo","Initials":"UP","AffiliationInfo":{"Affiliation":"Department of Nuclear Medicine, Poliambulanza Foundation, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Paghera","ForeName":"Barbara","Initials":"B","AffiliationInfo":{"Affiliation":"Department of Nuclear Medicine, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Pizzocaro","ForeName":"Claudio","Initials":"C","AffiliationInfo":{"Affiliation":"Department of Nuclear Medicine, Poliambulanza Foundation, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lussignoli","ForeName":"Giulia","Initials":"G","AffiliationInfo":{"Affiliation":"Alzheimer's Unit, Memory Clinic, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Geroldi","ForeName":"Cristina","Initials":"C","AffiliationInfo":{"Affiliation":"Alzheimer's Unit, Memory Clinic, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"Alzheimer's Unit, Memory Clinic, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Cotelli","ForeName":"Maria Sofia","Initials":"MS","AffiliationInfo":{"Affiliation":"Neurology Unit, Ospedale di Vallecamonica Esine, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Turla","ForeName":"Marinella","Initials":"M","AffiliationInfo":{"Affiliation":"Neurology Unit, Ospedale di Vallecamonica Esine, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Borroni","ForeName":"Barbara","Initials":"B","AffiliationInfo":{"Affiliation":"Centre for Aging Brain and Neurodegenerative Disorders, Neurology Unit, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Rozzini","ForeName":"Luca","Initials":"L","AffiliationInfo":{"Affiliation":"Centre for Aging Brain and Neurodegenerative Disorders, Neurology Unit, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Mirabile","ForeName":"Dario","Initials":"D","AffiliationInfo":{"Affiliation":"European Foundation Biomedical Research, Center of Excellence Alzheimer, Ospedale Briolini, Gazzaniga, Bergamo, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Defanti","ForeName":"Carlo","Initials":"C","AffiliationInfo":{"Affiliation":"European Foundation Biomedical Research, Center of Excellence Alzheimer, Ospedale Briolini, Gazzaniga, Bergamo, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gennuso","ForeName":"Michele","Initials":"M","AffiliationInfo":{"Affiliation":"Neurology Unit, Ospedale Maggiore di Crema, Cremona, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Prelle","ForeName":"Alessandro","Initials":"A","AffiliationInfo":{"Affiliation":"Neurology Unit, Ospedale Maggiore di Crema, Cremona, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gentile","ForeName":"Simona","Initials":"S","AffiliationInfo":{"Affiliation":"Department of Rehabilitation, Fondazione Teresa Camplani, Casa di cura Ancelle della Carit\u00e0, Cremona, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Morandi","ForeName":"Alessandro","Initials":"A","AffiliationInfo":{"Affiliation":"Department of Rehabilitation, Fondazione Teresa Camplani, Casa di cura Ancelle della Carit\u00e0, Cremona, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Vollaro","ForeName":"Stefano","Initials":"S","AffiliationInfo":{"Affiliation":"Neurology Unit, Istituto Clinico Citt\u00e0 di Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Volta","ForeName":"Giorgio Dalla","Initials":"GD","AffiliationInfo":{"Affiliation":"Neurology Unit, Istituto Clinico Citt\u00e0 di Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bianchetti","ForeName":"Angelo","Initials":"A","AffiliationInfo":{"Affiliation":"Department of Medicine and Rehabilitation, Istituto Clinico Sant'Anna, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Conti","ForeName":"Marta Zaffira","Initials":"MZ","AffiliationInfo":{"Affiliation":"Hospice, Istituto Polifunzionale Sociosanitario Foundation Cardinal Giorgio Gusmini, Vertova, Bergamo, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Cappuccio","ForeName":"Melania","Initials":"M","AffiliationInfo":{"Affiliation":"Hospice, Istituto Polifunzionale Sociosanitario Foundation Cardinal Giorgio Gusmini, Vertova, Bergamo, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Carbone","ForeName":"Pasqualina","Initials":"P","AffiliationInfo":{"Affiliation":"Alzheimer Evaluation Unit, Istituto Ospedaliero di Sospiro Non-Profit Organization of Social Utility Foundation, Sospiro, Cremona, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bellandi","ForeName":"Daniele","Initials":"D","AffiliationInfo":{"Affiliation":"Alzheimer Evaluation Unit, Istituto Ospedaliero di Sospiro Non-Profit Organization of Social Utility Foundation, Sospiro, Cremona, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Abruzzi","ForeName":"Luciano","Initials":"L","AffiliationInfo":{"Affiliation":"Neurology Unit, Istituti Ospedalieri di Cremona, Cremona, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bettoni","ForeName":"Luigi","Initials":"L","AffiliationInfo":{"Affiliation":"Neurology Unit, Istituti Ospedalieri di Cremona, Cremona, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Villani","ForeName":"Daniele","Initials":"D","AffiliationInfo":{"Affiliation":"Alzheimer Evaluation Unit, Casa di Cura Figlie di S. Camillo, Cremona, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Raimondi","ForeName":"Maria Clara","Initials":"MC","AffiliationInfo":{"Affiliation":"Alzheimer Evaluation Unit, Casa di Cura Figlie di S. Camillo, Cremona, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lanari","ForeName":"Alessia","Initials":"A","AffiliationInfo":{"Affiliation":"Neurology Unit, Carlo Poma, Mantova, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ciccone","ForeName":"Alfonso","Initials":"A","AffiliationInfo":{"Affiliation":"Neurology Unit, Carlo Poma, Mantova, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Facchi","ForeName":"Emanuela","Initials":"E","AffiliationInfo":{"Affiliation":"Geriatric General Rehabilitation, Fondazione Richiedei, Palazzolo sull'Oglio, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Di Fazio","ForeName":"Ignazio","Initials":"I","AffiliationInfo":{"Affiliation":"Geriatric General Rehabilitation, Fondazione Richiedei, Palazzolo sull'Oglio, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Rozzini","ForeName":"Renzo","Initials":"R","AffiliationInfo":{"Affiliation":"Neurology Unit, Poliambulanza Foundation, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Boffelli","ForeName":"Stefano","Initials":"S","AffiliationInfo":{"Affiliation":"Neurology Unit, Poliambulanza Foundation, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Manzoni","ForeName":"Laura","Initials":"L","AffiliationInfo":{"Affiliation":"Neuromotor and Cognitive Rehabilitation Center, Clinic Quarenghi, San Pellegrino Terme, Bergamo, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Salvi","ForeName":"Giovanni Pietro","Initials":"GP","AffiliationInfo":{"Affiliation":"Neuromotor and Cognitive Rehabilitation Center, Clinic Quarenghi, San Pellegrino Terme, Bergamo, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Cavaliere","ForeName":"Sabina","Initials":"S","AffiliationInfo":{"Affiliation":"Alzheimer Evaluation Unit, Hospice Santa Maria Ausiliatrice Onlus Foundation, Bergamo, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Belotti","ForeName":"Gloria","Initials":"G","AffiliationInfo":{"Affiliation":"Alzheimer Evaluation Unit, Hospice Santa Maria Ausiliatrice Onlus Foundation, Bergamo, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Avanzi","ForeName":"Stefano","Initials":"S","AffiliationInfo":{"Affiliation":"Neuromotor Rehabilitation Medicine, Salvatore Maugeri Foundation Clinic of Work and Rehabilitation, Istituto di Ricovero e Cura a Carattere Scientifico, Castel Goffredo, Mantova, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Pasqualetti","ForeName":"Patrizio","Initials":"P","AffiliationInfo":{"Affiliation":"Service of Medical Statistics and Information Technology, Fatebenefratelli Foundation for Health Research and Education, Rome, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Muscio","ForeName":"Cristina","Initials":"C","AffiliationInfo":{"Affiliation":"Laboratory of Alzheimer's Neuroimaging and Epidemiology, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy26Division of Neurology V-Neuropathology, Fondazione, Istituto di Ricovero e Cura a Carattere Scientifico Istituto Neurologico Carlo Besta, Milan, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Padovani","ForeName":"Alessandro","Initials":"A","AffiliationInfo":{"Affiliation":"Centre for Aging Brain and Neurodegenerative Disorders, Neurology Unit, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB","AffiliationInfo":{"Affiliation":"LANVIE-Laboratory of Neuroimaging of Aging, University of Geneva, Geneva, Switzerland2Laboratory of Alzheimer's Neuroimaging and Epidemiology, Istituto di Ricovero e Cura a Carattere Scientifico Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy27Memory Clinic, University Hospital of Geneva, Geneva, Switzerland."}},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Working Group"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Multicenter Study"]}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"JAMA Neurol","NlmUniqueID":"101589536","ISSNLinking":"2168-6149"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Aniline Compounds"},{"RegistryNumber":"0","NameOfSubstance":"Ethylene Glycols"},{"RegistryNumber":"6867Q6IKOD","NameOfSubstance":"florbetapir"}]},"CitationSubset":["AIM","IM"],"CommentsCorrectionsList":{"CommentsCorrections":{"@attributes":{"RefType":"CommentIn"},"RefSource":"JAMA Neurol. 2016 Dec 1;73(12):1396-1398","PMID":"27802483"}},"MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":["diagnosis","diagnostic imaging","metabolism"]},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":"metabolism"},{"DescriptorName":"Aniline Compounds"},{"DescriptorName":"Cognitive Dysfunction","QualifierName":["diagnosis","diagnostic imaging","metabolism"]},{"DescriptorName":"Ethylene Glycols"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Positron-Emission Tomography","QualifierName":["methods","standards"]},{"DescriptorName":"Predictive Value of Tests"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2016","Month":"11","Day":"2","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2017","Month":"5","Day":"30","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2016","Month":"11","Day":"2","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["27802513","2578330","10.1001\/jamaneurol.2016.3751"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"27776263","DateCompleted":{"Year":"2017","Month":"11","Day":"16"},"DateRevised":{"Year":"2018","Month":"03","Day":"16"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1558-1497","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"49","PubDate":{"Year":"2017","Month":"01"}},"Title":"Neurobiology of aging","ISOAbbreviation":"Neurobiol Aging"},"ArticleTitle":"Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly.","Pagination":{"MedlinePgn":"60-68"},"ELocationID":["S0197-4580(16)30197-X","10.1016\/j.neurobiolaging.2016.08.019"],"Abstract":{"AbstractText":"The pathway leading from amyloid-\u03b2 deposition to cognitive impairment is believed to be a cornerstone of the pathogenesis of Alzheimer's disease (AD). However, what drives amyloid buildup in sporadic nongenetic cases of AD is still unknown. AD brains feature an inflammatory reaction around amyloid plaques, and a specific subset of the gut microbiota (GMB) may promote brain inflammation. We investigated the possible role of the GMB in AD pathogenesis by studying the association of brain amyloidosis with (1) GMB taxa with pro- and anti-inflammatory activity; and (2) peripheral inflammation in cognitively impaired patients. We measured the stool abundance of selected bacterial GMB taxa (Escherichia\/Shigella, Pseudomonas aeruginosa, Eubacterium rectale, Eubacterium hallii, Faecalibacterium prausnitzii, and Bacteroides fragilis) and the blood expression levels of cytokines (pro-inflammatory cytokines: CXCL2, CXCL10, interleukin [IL]-1\u03b2, IL-6, IL-18, IL-8, inflammasome complex (NLRP3), tumor necrosis factor-alpha [TNF-\u03b1]; anti-inflammatory cytokines: IL-4, IL-10, IL-13) in cognitively impaired patients with (n\u00a0= 40, Amy+) and with no brain amyloidosis (n\u00a0= 33, Amy-) and also in a group of controls (n\u00a0= 10, no brain amyloidosis and no cognitive impairment). Amy+ patients showed higher levels of pro-inflammatory cytokines (IL-6, CXCL2, NLRP3, and IL-1\u03b2) compared with both controls and with Amy- patients. A reduction of the anti-inflammatory cytokine IL-10 was observed in Amy+ versus Amy-. Amy+ showed lower abundance of E.\u00a0rectale and higher abundance of Escherichia\/Shigella compared with both healthy controls (fold change, FC\u00a0=\u00a0-9.6, p < 0.001 and FC\u00a0=\u00a0+12.8, p < 0.001, respectively) and to Amy- (FC\u00a0=\u00a0-7.7, p < 0.001 and FC\u00a0=\u00a0+7.4, p\u00a0= 0.003). A positive correlation was observed between pro-inflammatory cytokines IL-1\u03b2, NLRP3, and CXCL2 with abundance of the inflammatory bacteria taxon Escherichia\/Shigella (rho\u00a0= 0.60, p < 0.001; rho\u00a0= 0.57, p < 0.001; and rho\u00a0= 0.30, p\u00a0= 0.007, respectively) and a negative correlation with the anti-inflammatory E.\u00a0rectale (rho\u00a0=\u00a0-0.48, p < 0.001; rho\u00a0=\u00a0-0.25, p\u00a0= 0.024; rho\u00a0=\u00a0-0.49, p < 0.001). Our data indicate that an increase in the abundance of a pro-inflammatory GMB taxon, Escherichia\/Shigella, and a reduction in the abundance of an anti-inflammatory taxon, E.\u00a0rectale, are possibly associated with a peripheral inflammatory state in patients with cognitive impairment and brain amyloidosis. A possible causal relation between GMB-related inflammation and amyloidosis deserves further investigation.","CopyrightInformation":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Cattaneo","ForeName":"Annamaria","Initials":"A","AffiliationInfo":{"Affiliation":"Biological Psychiatry Laboratory, IRCCS Fatebenefratelli, Brescia, Italy; King's College London, Institute of Psychiatry, London, UK. Electronic address: acattaneo@fatebenefratelli.eu."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Cattane","ForeName":"Nadia","Initials":"N","AffiliationInfo":{"Affiliation":"Biological Psychiatry Laboratory, IRCCS Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Galluzzi","ForeName":"Samantha","Initials":"S","AffiliationInfo":{"Affiliation":"Laboratory of Neuroimaging and Alzheimer's Epidemiology, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Provasi","ForeName":"Stefania","Initials":"S","AffiliationInfo":{"Affiliation":"Biological Psychiatry Laboratory, IRCCS Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lopizzo","ForeName":"Nicola","Initials":"N","AffiliationInfo":{"Affiliation":"Biological Psychiatry Laboratory, IRCCS Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Festari","ForeName":"Cristina","Initials":"C","AffiliationInfo":{"Affiliation":"Laboratory of Neuroimaging and Alzheimer's Epidemiology, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ferrari","ForeName":"Clarissa","Initials":"C","AffiliationInfo":{"Affiliation":"Biological Psychiatry Laboratory, IRCCS Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Guerra","ForeName":"Ugo Paolo","Initials":"UP","AffiliationInfo":{"Affiliation":"Nuclear Medicine, Poliambulanza Foundation, Istituto Ospedaliero, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Paghera","ForeName":"Barbara","Initials":"B","AffiliationInfo":{"Affiliation":"Nuclear Medicine, University of Brescia and Spedali Civili di Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Muscio","ForeName":"Cristina","Initials":"C","AffiliationInfo":{"Affiliation":"Biological Psychiatry Laboratory, IRCCS Fatebenefratelli, Brescia, Italy; European Foundation Biomedical Research (FERB), Center of Excellence Alzheimer, Ospedale Briolini, Gazzaniga, Bergamo, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bianchetti","ForeName":"Angelo","Initials":"A","AffiliationInfo":{"Affiliation":"Department of Medicine and Rehabilitation, Istituto Clinico Sant'Anna, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Volta","ForeName":"Giorgio Dalla","Initials":"GD","AffiliationInfo":{"Affiliation":"Neurology Unit, Istituto Clinico Citt\u00e0 di Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Turla","ForeName":"Marinella","Initials":"M","AffiliationInfo":{"Affiliation":"Neurology Unit, Ospedale di Vallecamonica Esine, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Cotelli","ForeName":"Maria Sofia","Initials":"MS","AffiliationInfo":{"Affiliation":"Neurology Unit, Ospedale di Vallecamonica Esine, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gennuso","ForeName":"Michele","Initials":"M","AffiliationInfo":{"Affiliation":"Neurology Unit, Ospedale Maggiore di Crema, Cremona, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Prelle","ForeName":"Alessandro","Initials":"A","AffiliationInfo":{"Affiliation":"Neurology Unit, Ospedale Maggiore di Crema, Cremona, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"Biological Psychiatry Laboratory, IRCCS Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lussignoli","ForeName":"Giulia","Initials":"G","AffiliationInfo":{"Affiliation":"Biological Psychiatry Laboratory, IRCCS Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Mirabile","ForeName":"Dario","Initials":"D","AffiliationInfo":{"Affiliation":"European Foundation Biomedical Research (FERB), Center of Excellence Alzheimer, Ospedale Briolini, Gazzaniga, Bergamo, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bellandi","ForeName":"Daniele","Initials":"D","AffiliationInfo":{"Affiliation":"Alzheimer Evaluation Unit, Istituto Ospedaliero di Sospiro ONLUS Foundation, Cremona, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gentile","ForeName":"Simona","Initials":"S","AffiliationInfo":{"Affiliation":"Department of Rehabilitation, Casa di Cura Ancelle della Carit\u00e0, Cremona, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Belotti","ForeName":"Gloria","Initials":"G","AffiliationInfo":{"Affiliation":"Alzheimer Evaluation Unit, Hospice Santa Maria Ausiliatrice ONLUS Foundation, Bergamo, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Villani","ForeName":"Daniele","Initials":"D","AffiliationInfo":{"Affiliation":"Alzheimer Evaluation Unit, Casa di Cura Figlie di S. Camillo, Cremona, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Harach","ForeName":"Taoufiq","Initials":"T","AffiliationInfo":{"Affiliation":"Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bolmont","ForeName":"Tristan","Initials":"T","AffiliationInfo":{"Affiliation":"Stemedica International SA, Lausanne, Switzerland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Padovani","ForeName":"Alessandro","Initials":"A","AffiliationInfo":{"Affiliation":"Neurology Unit, Department of Medical and Experimental Sciences, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Boccardi","ForeName":"Marina","Initials":"M","AffiliationInfo":{"Affiliation":"Laboratory of Neuroimaging and Alzheimer's Epidemiology, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB","AffiliationInfo":{"Affiliation":"Laboratory of Neuroimaging and Alzheimer's Epidemiology, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy; LANVIE-Laboratory of Neuroimaging of Aging, University Hospitals, Geneva, Switzerland; Memory Clinic, University Hospitals and University of Geneva, Geneva, Switzerland."}},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"INDIA-FBP Group"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2016","Month":"08","Day":"31"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Neurobiol Aging","NlmUniqueID":"8100437","ISSNLinking":"0197-4580"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Cytokines"},{"RegistryNumber":"0","NameOfSubstance":"Inflammation Mediators"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":["etiology","metabolism"]},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":"metabolism"},{"DescriptorName":"Brain","QualifierName":"metabolism"},{"DescriptorName":"Cognition Disorders","QualifierName":["etiology","metabolism"]},{"DescriptorName":"Cytokines","QualifierName":"metabolism"},{"DescriptorName":"Female"},{"DescriptorName":"Gastrointestinal Microbiome","QualifierName":"physiology"},{"DescriptorName":"Humans"},{"DescriptorName":"Inflammation","QualifierName":["etiology","metabolism"]},{"DescriptorName":"Inflammation Mediators","QualifierName":"metabolism"},{"DescriptorName":"Intestines","QualifierName":"microbiology"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Plaque, Amyloid","QualifierName":["etiology","metabolism"]}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Brain amyloidosis","Cognitive impairment","Gut microbiota","Inflammation","Neurodegeneration"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2015","Month":"12","Day":"28"},{"@attributes":{"PubStatus":"revised"},"Year":"2016","Month":"08","Day":"23"},{"@attributes":{"PubStatus":"accepted"},"Year":"2016","Month":"08","Day":"24"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2016","Month":"10","Day":"25","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2017","Month":"11","Day":"29","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2016","Month":"10","Day":"25","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["27776263","S0197-4580(16)30197-X","10.1016\/j.neurobiolaging.2016.08.019"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","IndexingMethod":"Curated","Owner":"NLM"},"PMID":"27550084","DateCompleted":{"Year":"2017","Month":"10","Day":"02"},"DateRevised":{"Year":"2018","Month":"12","Day":"02"},"Article":{"@attributes":{"PubModel":"Electronic"},"Journal":{"ISSN":"1472-6963","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"16","Issue":"1","PubDate":{"Year":"2016","Month":"08","Day":"23"}},"Title":"BMC health services research","ISOAbbreviation":"BMC Health Serv Res"},"ArticleTitle":"Access to timely formal dementia care in Europe: protocol of the Actifcare (ACcess to Timely Formal Care) study.","Pagination":{"MedlinePgn":"423"},"ELocationID":"10.1186\/s12913-016-1672-3","Abstract":{"AbstractText":["Previous findings indicate that people with dementia and their informal carers experience difficulties accessing and using formal care services due to a mismatch between needs and service use. This mismatch causes overall dissatisfaction and is a waste of the scarce financial care resources. This article presents the background and methods of the Actifcare (ACcess to Timely Formal Care) project. This is a European study aiming at best-practice development in finding timely access to formal care for community-dwelling people with dementia and their informal carers. There are five main objectives: 1) Explore predisposing and enabling factors associated with the use of formal care, 2) Explore the association between the use of formal care, needs and quality of life and 3) Compare these across European countries, 4) Understand the costs and consequences of formal care services utilization in people with unmet needs, 5) Determine the major costs and quality of life drivers and their relationship with formal care services across European countries.","In a longitudinal cohort study conducted in eight European countries approximately 450 people with dementia and informal carers will be assessed three times in 1\u00a0year (baseline, 6 and 12\u00a0months). In this year we will closely monitor the process of finding access to formal care. Data on service use, quality of life and needs will be collected.","The results of Actifcare are expected to reveal best-practices in organizing formal care. Knowledge about enabling and predisposing factors regarding access to care services, as well as its costs and consequences, can advance the state of the art in health systems research into pathways to dementia care, in order to benefit people with dementia and their informal carers."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Kerpershoek","ForeName":"Liselot","Initials":"L","AffiliationInfo":{"Affiliation":"Maastricht University, Maastricht, Netherlands. liselot.kerpershoek@maastrichtuniversity.nl."}},{"@attributes":{"ValidYN":"Y"},"LastName":"de Vugt","ForeName":"Marjolein","Initials":"M","AffiliationInfo":{"Affiliation":"Maastricht University, Maastricht, Netherlands. m.devugt@maastrichtuniversity.nl."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Wolfs","ForeName":"Claire","Initials":"C","AffiliationInfo":{"Affiliation":"Maastricht University, Maastricht, Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Jelley","ForeName":"Hannah","Initials":"H","AffiliationInfo":{"Affiliation":"Bangor University, Bangor, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Orrell","ForeName":"Martin","Initials":"M","AffiliationInfo":{"Affiliation":"UCL, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Woods","ForeName":"Bob","Initials":"B","AffiliationInfo":{"Affiliation":"Bangor University, Bangor, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stephan","ForeName":"Astrid","Initials":"A","AffiliationInfo":{"Affiliation":"Martin-Luther University Halle-Wittenberg, Halle, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bieber","ForeName":"Anja","Initials":"A","AffiliationInfo":{"Affiliation":"Martin-Luther University Halle-Wittenberg, Halle, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Meyer","ForeName":"Gabriele","Initials":"G","AffiliationInfo":{"Affiliation":"Martin-Luther University Halle-Wittenberg, Halle, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Engedal","ForeName":"Knut","Initials":"K","AffiliationInfo":{"Affiliation":"Oslo University Hospital, Oslo, Norway."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Selbaek","ForeName":"Geir","Initials":"G","AffiliationInfo":{"Affiliation":"Oslo University Hospital, Oslo, Norway."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Handels","ForeName":"Ron","Initials":"R","AffiliationInfo":[{"Affiliation":"Maastricht University, Maastricht, Netherlands."},{"Affiliation":"Karolinska Institutet, Solna, Sweden."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Wimo","ForeName":"Anders","Initials":"A","AffiliationInfo":{"Affiliation":"Karolinska Institutet, Solna, Sweden."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hopper","ForeName":"Louise","Initials":"L","AffiliationInfo":{"Affiliation":"Dublin City University, Dublin, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Irving","ForeName":"Kate","Initials":"K","AffiliationInfo":{"Affiliation":"Dublin City University, Dublin, Ireland."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Marques","ForeName":"Maria","Initials":"M","AffiliationInfo":{"Affiliation":"CEDOC, Nova Medical School | Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gon\u00e7alves-Pereira","ForeName":"Manuel","Initials":"M","AffiliationInfo":{"Affiliation":"CEDOC, Nova Medical School | Faculdade de Ci\u00eancias M\u00e9dicas, Universidade Nova de Lisboa, Lisbon, Portugal."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Portolani","ForeName":"Elisa","Initials":"E","AffiliationInfo":{"Affiliation":"Alzheimer's Research Unit-Memory Clinic, IRCCS \"Centro S.Giovanni di Dio, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"Alzheimer's Research Unit-Memory Clinic, IRCCS \"Centro S.Giovanni di Dio, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Verhey","ForeName":"Frans","Initials":"F","AffiliationInfo":{"Affiliation":"Maastricht University, Maastricht, Netherlands."}},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"Actifcare Consortium"}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2016","Month":"08","Day":"23"}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"BMC Health Serv Res","NlmUniqueID":"101088677","ISSNLinking":"1472-6963"},"CitationSubset":"IM","CommentsCorrectionsList":{"CommentsCorrections":{"@attributes":{"RefType":"ErratumIn"},"RefSource":"BMC Health Serv Res. 2016 Oct 28;16(1):620","PMID":"27793151"}},"MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Caregivers"},{"DescriptorName":"Dementia","QualifierName":"therapy"},{"DescriptorName":"Europe"},{"DescriptorName":"Health Services Accessibility","QualifierName":"statistics & numerical data"},{"DescriptorName":"Humans"},{"DescriptorName":"Independent Living"},{"DescriptorName":"Longitudinal Studies"},{"DescriptorName":"Needs Assessment"},{"DescriptorName":"Quality of Life"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Dementia","Formal care","Needs","Service use"]},"InvestigatorList":{"Investigator":[{"@attributes":{"ValidYN":"Y"},"LastName":"Verhey","ForeName":"Frans","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"de Vugt","ForeName":"Marjolein","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Wolfs","ForeName":"Claire","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Handels","ForeName":"Ron","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kerpershoek","ForeName":"Liselot","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Meyer","ForeName":"Gabriele","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Stephan","ForeName":"Astrid","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bieber","ForeName":"Anja","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Broda","ForeName":"Anja","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bartoszek","ForeName":"Gabriele","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Woods","ForeName":"Bob","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Orrell","ForeName":"Martin","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Jelley","ForeName":"Hannah","Initials":"H"},{"@attributes":{"ValidYN":"Y"},"LastName":"Wimo","ForeName":"Anders","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sk\u00f6ldunger","ForeName":"Anders","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sj\u00f6lund","ForeName":"Britt-Marie","Initials":"BM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Engedal","ForeName":"Knut","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Selbaek","ForeName":"Geir","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Michelet","ForeName":"Mona","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Rosvik","ForeName":"Janne","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Eriksen","ForeName":"Siren","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Irving","ForeName":"Kate","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Hopper","ForeName":"Louise","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Joyce","ForeName":"Rachael","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gon\u00e7alves-Pereira","ForeName":"Manuel","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Marques","ForeName":"MariaJ","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Balsinha","ForeName":"MConcei\u00e7\u00e3o","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Machado","ForeName":"Ana","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Portolani","ForeName":"Elisa","Initials":"E"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2016","Month":"01","Day":"29"},{"@attributes":{"PubStatus":"accepted"},"Year":"2016","Month":"08","Day":"15"},{"@attributes":{"PubStatus":"entrez"},"Year":"2016","Month":"8","Day":"24","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2016","Month":"8","Day":"24","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2017","Month":"10","Day":"3","Hour":"6","Minute":"0"}]},"PublicationStatus":"epublish","ArticleIdList":{"ArticleId":["27550084","10.1186\/s12913-016-1672-3","10.1186\/s12913-016-1672-3","PMC4994155"]},"ReferenceList":{"Reference":[{"Citation":"Int J Geriatr Psychiatry. 2005 Jun;20(6):537-46","ArticleIdList":{"ArticleId":"15920707"}},{"Citation":"Patient Educ Couns. 2012 Apr;87(1):43-8","ArticleIdList":{"ArticleId":"21889285"}},{"Citation":"Qual Life Res. 2011 Aug;20(6):875-87","ArticleIdList":{"ArticleId":"21197582"}},{"Citation":"Neurology. 1994 Dec;44(12):2308-14","ArticleIdList":{"ArticleId":"7991117"}},{"Citation":"J Clin Epidemiol. 1994 Nov;47(11):1245-51","ArticleIdList":{"ArticleId":"7722560"}},{"Citation":"J Health Soc Behav. 1995 Mar;36(1):1-10","ArticleIdList":{"ArticleId":"7738325"}},{"Citation":"Arch Gerontol Geriatr. 1999 May-Jun;28(3):227-37","ArticleIdList":{"ArticleId":"15374084"}},{"Citation":"BMC Public Health. 2012 Jan 23;12:68","ArticleIdList":{"ArticleId":"22269343"}},{"Citation":"Age Ageing. 1982 May;11(2):121-6","ArticleIdList":{"ArticleId":"7102472"}},{"Citation":"Psychosom Med. 2002 May-Jun;64(3):510-9","ArticleIdList":{"ArticleId":"12021425"}},{"Citation":"Neurology. 1993 Nov;43(11):2412-4","ArticleIdList":{"ArticleId":"8232972"}},{"Citation":"Acta Psychiatr Scand. 1983 Jun;67(6):361-70","ArticleIdList":{"ArticleId":"6880820"}},{"Citation":"Health Technol Assess. 2005 Mar;9(10 ):1-93, iii-iv","ArticleIdList":{"ArticleId":"15774233"}},{"Citation":"Soc Sci Med. 1993 Mar;36(6):725-33","ArticleIdList":{"ArticleId":"8480217"}},{"Citation":"Soc Sci Med. 2008 Sep;67(5):874-82","ArticleIdList":{"ArticleId":"18572295"}},{"Citation":"J Psychiatr Res. 1975 Nov;12(3):189-98","ArticleIdList":{"ArticleId":"1202204"}},{"Citation":"Alzheimers Dement. 2013 Jul;9(4):429-435.e17","ArticleIdList":{"ArticleId":"23142433"}},{"Citation":"Gerontologist. 1969 Autumn;9(3):179-86","ArticleIdList":{"ArticleId":"5349366"}},{"Citation":"BMC Health Serv Res. 2013 Jan 03;13:2","ArticleIdList":{"ArticleId":"23286826"}},{"Citation":"Qual Life Res. 2006 Aug;15(6):1005-21","ArticleIdList":{"ArticleId":"16900281"}},{"Citation":"Br J Med Psychol. 1984 Jun;57 ( Pt 2):173-80","ArticleIdList":{"ArticleId":"6743598"}},{"Citation":"Int J Geriatr Psychiatry. 2010 Oct;25(10):1006-12","ArticleIdList":{"ArticleId":"20872928"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","IndexingMethod":"Curated","Owner":"NLM"},"PMID":"27194245","DateCompleted":{"Year":"2018","Month":"02","Day":"15"},"DateRevised":{"Year":"2018","Month":"12","Day":"02"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1573-6792","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"29","Issue":"5","PubDate":{"Year":"2016","Month":"09"}},"Title":"Brain topography","ISOAbbreviation":"Brain Topogr"},"ArticleTitle":"Grey Matter Density Predicts the Improvement of Naming Abilities After tDCS Intervention in Agrammatic Variant of Primary Progressive Aphasia.","Pagination":{"MedlinePgn":"738-51"},"ELocationID":"10.1007\/s10548-016-0494-2","Abstract":{"AbstractText":"Agrammatic variant primary progressive aphasia is a neurodegenerative disorder specifically characterized by language deficits. A recent study has demonstrated a beneficial effect of transcranial direct current stimulation (tDCS) in combination with language training on naming accuracy in these patients. The aim of the study was to evaluate whether the improvement of naming accuracy after tDCS during language training was related to regional grey matter (GM) density. Eighteen avPPA patients underwent a brain magnetic resonance imaging before receiving a treatment that consisted of tDCS over the left dorsolateral prefrontal cortex during individualized language training (10 daily therapy sessions, 5\u00a0days per week from Monday to Friday). Performances on neuropsychological tests and naming of objects (treated and untreated) and actions were assessed at baseline, post-treatment \u00a0and 3\u00a0months after treatment. Correlations between individual changes after treatment on neuropsychological tests and on picture naming task and voxel-based GM volume at baseline were performed. We found that the improvement in the naming of treated objects was positively correlated with GM volume in the left fusiform, left middle temporal, and right inferior temporal gyri whereas action naming change was related to GM density in the left middle temporal gyrus. In conclusion baseline density of GM in these brain regions was associated with greater treatment response on naming performances, suggesting that intervention in early disease stages might be most successful. These findings have implication for designing future rehabilitation protocols in language variants of frontotemporal dementia."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Cotelli","ForeName":"Maria","Initials":"M","AffiliationInfo":{"Affiliation":"Neuropsychology Unit, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Via Pilastroni 4, 25125, Brescia, Italy. mcotelli@fatebenefratelli.eu."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Manenti","ForeName":"Rosa","Initials":"R","AffiliationInfo":{"Affiliation":"Neuropsychology Unit, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Via Pilastroni 4, 25125, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Paternic\u00f2","ForeName":"Donata","Initials":"D","AffiliationInfo":{"Affiliation":"Centre for Neurodegenerative Disorders, University of Brescia, Piazza Spedali Civili 1, 25100, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Cosseddu","ForeName":"Maura","Initials":"M","AffiliationInfo":{"Affiliation":"Centre for Neurodegenerative Disorders, University of Brescia, Piazza Spedali Civili 1, 25100, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Brambilla","ForeName":"Michela","Initials":"M","AffiliationInfo":{"Affiliation":"Neuropsychology Unit, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Via Pilastroni 4, 25125, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Petesi","ForeName":"Michela","Initials":"M","AffiliationInfo":{"Affiliation":"Neuropsychology Unit, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Via Pilastroni 4, 25125, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Premi","ForeName":"Enrico","Initials":"E","AffiliationInfo":{"Affiliation":"Stroke Unit, Spedali Civili Hospital, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasparotti","ForeName":"Roberto","Initials":"R","AffiliationInfo":{"Affiliation":"Neuroradiology Unit, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"Alzheimer's Unit - Memory Clinic, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Padovani","ForeName":"Alessandro","Initials":"A","AffiliationInfo":{"Affiliation":"Centre for Neurodegenerative Disorders, University of Brescia, Piazza Spedali Civili 1, 25100, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Borroni","ForeName":"Barbara","Initials":"B","AffiliationInfo":{"Affiliation":"Centre for Neurodegenerative Disorders, University of Brescia, Piazza Spedali Civili 1, 25100, Brescia, Italy. bborroni@inwind.it."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2016","Month":"05","Day":"19"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Brain Topogr","NlmUniqueID":"8903034","ISSNLinking":"0896-0267"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aphasia, Primary Progressive","QualifierName":["diagnostic imaging","therapy"]},{"DescriptorName":"Brain","QualifierName":["diagnostic imaging","physiology"]},{"DescriptorName":"Brain Mapping"},{"DescriptorName":"Female"},{"DescriptorName":"Gray Matter","QualifierName":["diagnostic imaging","pathology"]},{"DescriptorName":"Humans"},{"DescriptorName":"Language"},{"DescriptorName":"Language Therapy","QualifierName":"methods"},{"DescriptorName":"Magnetic Resonance Imaging"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Organ Size"},{"DescriptorName":"Prognosis"},{"DescriptorName":"Temporal Lobe","QualifierName":["diagnostic imaging","pathology"]},{"DescriptorName":"Transcranial Direct Current Stimulation","QualifierName":"methods"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Frontotemporal dementia","MRI","Primary progressive aphasia","Treatment","Voxel-based morphometry","tDCS"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2015","Month":"12","Day":"01"},{"@attributes":{"PubStatus":"accepted"},"Year":"2016","Month":"05","Day":"07"},{"@attributes":{"PubStatus":"entrez"},"Year":"2016","Month":"5","Day":"20","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2016","Month":"5","Day":"20","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2018","Month":"2","Day":"16","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["27194245","10.1007\/s10548-016-0494-2","10.1007\/s10548-016-0494-2"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"26758278","DateCompleted":{"Year":"2018","Month":"02","Day":"08"},"DateRevised":{"Year":"2019","Month":"12","Day":"10"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1559-1182","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"54","Issue":"1","PubDate":{"Year":"2017","Month":"01"}},"Title":"Molecular neurobiology","ISOAbbreviation":"Mol Neurobiol"},"ArticleTitle":"Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer's Disease: a Genetic Study of ATP7B Frequency.","Pagination":{"MedlinePgn":"671-681"},"ELocationID":"10.1007\/s12035-015-9664-6","Abstract":{"AbstractText":"Meta-analyses show that serum copper non-bound-to-ceruloplasmin (non-Cp-Cu) is higher in patients with Alzheimer's disease (AD). ATP7B gene variants associate with AD, modulating the size of non-Cp-Cu pool. However, a dedicated genetic study comparing AD patients after stratification for a copper biomarker to demonstrate the existence of a copper subtype of AD has not yet been carried out. An independent patient sample of 287 AD patients was assessed for non-Cp-Cu serum concentrations, rs1801243, rs1061472, and rs732774 ATP7B genetic variants and the APOE4 genotype. Patients were stratified into two groups based on a non-Cp-Cu cutoff (1.9\u00a0\u03bcM). Single-locus and haplotype-group analyses were performed to define their frequencies in dependence of the non-Cp-Cu group. The two AD subgroups did not differ regarding age, sex, MMSE score, or APOE4 frequency allele, while they did differ regarding non-Cp-Cu concentrations in serum, allele, genotype, and haplotype frequencies of rs1061472 A\u2009>\u2009G and rs732774 C\u2009>\u2009T after multiple testing corrections. AD patients with a GG genotype had a 1.76-fold higher risk of having a non-Cp-Cu higher than 1.9\u00a0\u03bcmol\/L (p\u2009=\u20090.029), and those with a TT genotype for rs732774 C\u2009>\u2009T of 1.8-fold (p\u2009=\u20090.018). After 100,000 permutations for multiple testing corrections, the haplotype containing the AC alleles appeared more frequently in AD patients with normal non-Cp-Cu [43 vs. 33\u00a0%; Pm\u2009=\u20090.03], while the haplotype containing the GT risk alleles appeared more frequently in the higher non-Cp-Cu AD (66 vs. 55\u00a0%; Pm\u2009=\u20090.01). Genetic heterogeneity sustains a copper AD metabolic subtype; non-Cp-Cu is a marker of this copper AD."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Squitti","ForeName":"Rosanna","Initials":"R","AffiliationInfo":[{"Affiliation":"Fatebenefratelli Foundation, AFaR Division, Fatebenefratelli Hospital, Isola Tiberina, Rome, Italy. rosanna.squitti@afar.it."},{"Affiliation":"Institute of Cognition Sciences and Technologies (CNR), Fatebenefratelli Hospital, Isola Tiberina, Rome, Italy. rosanna.squitti@afar.it."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Ventriglia","ForeName":"Mariacarla","Initials":"M","AffiliationInfo":{"Affiliation":"Fatebenefratelli Foundation, AFaR Division, Fatebenefratelli Hospital, Isola Tiberina, Rome, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gennarelli","ForeName":"Massimo","Initials":"M","AffiliationInfo":[{"Affiliation":"Genetic Unit, IRCCS Centro San Giovanni di Dio, Fatebenefratelli, Brescia, Italy."},{"Affiliation":"Departement of Molecular and Translational Medicine, University of Brescia, Brescia, Italy."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Colabufo","ForeName":"Nicola A","Initials":"NA","AffiliationInfo":{"Affiliation":"Dipartimento di Farmacia-Scienze del Farmaco, Universit\u00e0 degli Studi di Bari \"A. Moro\", via Orabona 4, 70125, Bari, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"El Idrissi","ForeName":"Imane Ghafir","Initials":"IG","AffiliationInfo":{"Affiliation":"Biofordrug srl, Spin-off, Universit\u00e0 degli studi di Bari \"A. Moro\", via Orabona 4, 70125, Bari, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bucossi","ForeName":"Serena","Initials":"S","AffiliationInfo":{"Affiliation":"Institute of Cognition Sciences and Technologies (CNR), Fatebenefratelli Hospital, Isola Tiberina, Rome, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Mariani","ForeName":"Stefania","Initials":"S","AffiliationInfo":{"Affiliation":"Fatebenefratelli Foundation, AFaR Division, Fatebenefratelli Hospital, Isola Tiberina, Rome, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Rongioletti","ForeName":"Mauro","Initials":"M","AffiliationInfo":{"Affiliation":"Unit\u00e0 Biomolecolare - Fatebenefratelli Hospital, Isola Tiberina, Rome, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"Alzheimer Unit, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Congiu","ForeName":"Chiara","Initials":"C","AffiliationInfo":{"Affiliation":"Alzheimer Unit, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Rossini","ForeName":"Paolo M","Initials":"PM","AffiliationInfo":{"Affiliation":"Institute of Neurology, Department of Geriatrics, Neuroscience and Orthopedics, Catholic University, Policlinic A. Gemelli, Rome, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonvicini","ForeName":"Cristian","Initials":"C","AffiliationInfo":{"Affiliation":"Genetic Unit, IRCCS Centro San Giovanni di Dio, Fatebenefratelli, Brescia, Italy."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2016","Month":"01","Day":"12"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Mol Neurobiol","NlmUniqueID":"8900963","ISSNLinking":"0893-7648"},"ChemicalList":{"Chemical":[{"RegistryNumber":"789U1901C5","NameOfSubstance":"Copper"},{"RegistryNumber":"EC 1.16.3.1","NameOfSubstance":"Ceruloplasmin"},{"RegistryNumber":"EC 7.2.2.8","NameOfSubstance":"ATP7B protein, human"},{"RegistryNumber":"EC 7.2.2.8","NameOfSubstance":"Copper-Transporting ATPases"}]},"CitationSubset":"IM","CommentsCorrectionsList":{"CommentsCorrections":{"@attributes":{"RefType":"ErratumIn"},"RefSource":"Mol Neurobiol. 2017 Jan;54(1):682-683","PMID":"26819212"}},"MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":["diagnosis","epidemiology","genetics"]},{"DescriptorName":"Ceruloplasmin"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"Copper"},{"DescriptorName":"Copper-Transporting ATPases","QualifierName":"genetics"},{"DescriptorName":"Female"},{"DescriptorName":"Gene Frequency","QualifierName":"genetics"},{"DescriptorName":"Haplotypes","QualifierName":"genetics"},{"DescriptorName":"Humans"},{"DescriptorName":"Italy","QualifierName":"epidemiology"},{"DescriptorName":"Male"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["ATP7B","Alzheimer\u2019s disease","Ceruloplasmin","Copper","Free copper","Non-ceruloplasmin-copper"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2015","Month":"09","Day":"09"},{"@attributes":{"PubStatus":"accepted"},"Year":"2015","Month":"12","Day":"17"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2016","Month":"1","Day":"14","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2018","Month":"2","Day":"9","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2016","Month":"1","Day":"14","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["26758278","10.1007\/s12035-015-9664-6","10.1007\/s12035-015-9664-6"]},"ReferenceList":{"Reference":[{"Citation":"J Alzheimers Dis. 2013;33(3):823-9","ArticleIdList":{"ArticleId":"23076075"}},{"Citation":"Arch Intern Med. 2011 Oct 10;171(18):1625-33","ArticleIdList":{"ArticleId":"21987192"}},{"Citation":"Biochem Biophys Res Commun. 2006 Oct 27;349(3):1079-86","ArticleIdList":{"ArticleId":"16970921"}},{"Citation":"J Biol Chem. 1999 Dec 24;274(52):37111-6","ArticleIdList":{"ArticleId":"10601271"}},{"Citation":"Lancet Neurol. 2008 Sep;7(9):779-86","ArticleIdList":{"ArticleId":"18672400"}},{"Citation":"Biofactors. 2012 Mar-Apr;38(2):107-13","ArticleIdList":{"ArticleId":"22438177"}},{"Citation":"Am J Clin Nutr. 1996 May;63(5):842S-5S","ArticleIdList":{"ArticleId":"8615372"}},{"Citation":"Clin Neurophysiol. 2010 Apr;121(4):502-7","ArticleIdList":{"ArticleId":"20097602"}},{"Citation":"J Biol Regul Homeost Agents. 2013 Apr-Jun;27(2):319-27","ArticleIdList":{"ArticleId":"23830383"}},{"Citation":"Chem Rev. 2006 Jun;106(6):1995-2044","ArticleIdList":{"ArticleId":"16771441"}},{"Citation":"Prog Neurobiol. 2011 Aug;94(3):296-306","ArticleIdList":{"ArticleId":"21600264"}},{"Citation":"J Alzheimers Dis. 2011;24(1):175-85","ArticleIdList":{"ArticleId":"21187586"}},{"Citation":"Nucleic Acids Res. 1988 Feb 11;16(3):1215","ArticleIdList":{"ArticleId":"3344216"}},{"Citation":"Curr Alzheimer Res. 2013 Feb;10(2):191-8","ArticleIdList":{"ArticleId":"23036026"}},{"Citation":"Neurology. 2006 Jul 11;67(1):76-82","ArticleIdList":{"ArticleId":"16832081"}},{"Citation":"J Alzheimers Dis. 2015;44(2):343-54","ArticleIdList":{"ArticleId":"25261447"}},{"Citation":"Clin Chem. 2007 Sep;53(9):1601-8","ArticleIdList":{"ArticleId":"17634212"}},{"Citation":"Free Radic Biol Med. 2012 Jan 15;52(2):298-302","ArticleIdList":{"ArticleId":"22080049"}},{"Citation":"J Alzheimers Dis. 2012;29(4):913-9","ArticleIdList":{"ArticleId":"22356903"}},{"Citation":"Brain Res. 2010 Mar 10;1319:118-30","ArticleIdList":{"ArticleId":"20026314"}},{"Citation":"Arch Neurol. 2006 Aug;63(8):1085-8","ArticleIdList":{"ArticleId":"16908733"}},{"Citation":"World J Gastroenterol. 2008 Apr 21;14(15):2383-7","ArticleIdList":{"ArticleId":"18416466"}},{"Citation":"Lancet Neurol. 2014 Aug;13(8):788-94","ArticleIdList":{"ArticleId":"25030513"}},{"Citation":"Behav Brain Funct. 2010 Jun 15;6:33","ArticleIdList":{"ArticleId":"20550661"}},{"Citation":"J Psychiatr Res. 1975 Nov;12(3):189-98","ArticleIdList":{"ArticleId":"1202204"}},{"Citation":"Bioinformatics. 2005 Jan 15;21(2):263-5","ArticleIdList":{"ArticleId":"15297300"}},{"Citation":"Lancet Neurol. 2007 Aug;6(8):734-46","ArticleIdList":{"ArticleId":"17616482"}},{"Citation":"Neurobiol Aging. 2014 Sep;35 Suppl 2:S40-50","ArticleIdList":{"ArticleId":"24913894"}},{"Citation":"Ann Neurol. 2014 Apr;75(4):574-80","ArticleIdList":{"ArticleId":"24623259"}},{"Citation":"J Alzheimers Dis. 2015;46(1):75-87","ArticleIdList":{"ArticleId":"25697706"}},{"Citation":"Rejuvenation Res. 2013 Feb;16(1):3-10","ArticleIdList":{"ArticleId":"22950421"}},{"Citation":"Am J Physiol. 1994 May;266(5 Pt 1):G907-13","ArticleIdList":{"ArticleId":"8203535"}},{"Citation":"Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14771-6","ArticleIdList":{"ArticleId":"23959870"}},{"Citation":"Neurobiol Dis. 2013 Nov;59:100-10","ArticleIdList":{"ArticleId":"23867235"}},{"Citation":"J Alzheimers Dis. 2011;23(2):239-48","ArticleIdList":{"ArticleId":"20930297"}},{"Citation":"Neurotherapeutics. 2008 Jul;5(3):421-32","ArticleIdList":{"ArticleId":"18625454"}},{"Citation":"J Alzheimers Dis. 2014;42(3):893-900","ArticleIdList":{"ArticleId":"25024310"}},{"Citation":"J Alzheimers Dis. 2014;38(4):809-22","ArticleIdList":{"ArticleId":"24072069"}},{"Citation":"Lancet Neurol. 2015 Jan;14(1):103-13","ArticleIdList":{"ArticleId":"25496901"}},{"Citation":"Am J Hum Genet. 2007 Sep;81(3):559-75","ArticleIdList":{"ArticleId":"17701901"}},{"Citation":"Int J Alzheimers Dis. 2011;2011:973692","ArticleIdList":{"ArticleId":"21760992"}},{"Citation":"J Hepatol. 2012 Mar;56(3):671-85","ArticleIdList":{"ArticleId":"22340672"}},{"Citation":"Am J Hum Genet. 2004 Apr;74(4):765-9","ArticleIdList":{"ArticleId":"14997420"}},{"Citation":"Neurobiol Aging. 2014 Sep;35 Suppl 2:S74-8","ArticleIdList":{"ArticleId":"24913896"}},{"Citation":"J Alzheimers Dis. 2012;29(3):493-501","ArticleIdList":{"ArticleId":"22258517"}},{"Citation":"Neurology. 2005 Mar 22;64(6):1040-6","ArticleIdList":{"ArticleId":"15781823"}},{"Citation":"Ann Clin Biochem. 2003 Mar;40(Pt 2):115-21","ArticleIdList":{"ArticleId":"12662398"}},{"Citation":"Neuromolecular Med. 2013 Sep;15(3):515-22","ArticleIdList":{"ArticleId":"23760784"}},{"Citation":"Neurology. 1984 Jul;34(7):939-44","ArticleIdList":{"ArticleId":"6610841"}},{"Citation":"Neurology. 2009 Jan 6;72(1):50-5","ArticleIdList":{"ArticleId":"19122030"}},{"Citation":"J Alzheimers Dis. 2015;46(3):593-604","ArticleIdList":{"ArticleId":"25854930"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"25757651","DateCompleted":{"Year":"2016","Month":"06","Day":"27"},"DateRevised":{"Year":"2015","Month":"09","Day":"25"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1875-8908","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"46","Issue":"1","PubDate":{"Year":"2015"}},"Title":"Journal of Alzheimer's disease : JAD","ISOAbbreviation":"J Alzheimers Dis"},"ArticleTitle":"Understanding Emotions in Frontotemporal Dementia: The Explicit and Implicit Emotional Cue Mismatch.","Pagination":{"MedlinePgn":"211-25"},"ELocationID":"10.3233\/JAD-142826","Abstract":{"AbstractText":["Previous studies have reported significant deficits in emotion recognition among individuals along the frontotemporal dementia (FTD) spectrum. The basis of emotional impairment is still poorly understood and explicit (emotion appraisal) and implicit (autonomic system activity) responses have not been carefully evaluated.","We investigated explicit evaluation of emotions by testing valence and arousal using self-report measures and we also assessed automatic responses to emotional cues, using autonomic measures (skin conductance response and heart rate).","16 behavioral variant FTD and 12 agrammatic variants of primary progressive aphasia patients were included. The performance of these patients was compared to a group of 14 patients with Alzheimer's disease and 20 healthy controls. Each subject was required to observe and evaluate affective pictures while autonomic parameters were recorded.","FTD patients preserved a functional general competency in terms of valence (correct positive versus negative attribution) and arousal (correct dichotomy between high versus low arousal category) distinction. These patients showed significant changes in autonomic implicit response compared to the other groups. The mismatch between explicit and implicit responsiveness to emotional cues was found both in behavioral variant FTD and in agrammatic variants of primary progressive aphasia. Emotional responsiveness was related to the severity of behavioral abnormalities as measured by the Frontal Behavioral Inventory and associated with atrophy of the left putamen.","The present findings indicate that FTD patients are able to explicitly \"appraise\" the emotion, but they cannot implicitly \"feel\" the emotion. This mismatch between the two levels may help explain the general emotional behavior impairment found in these patients."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Balconi","ForeName":"Michela","Initials":"M","AffiliationInfo":{"Affiliation":"Research Unit in Affective and Social Neuroscience, Department of Psychology, Catholic University, Milan, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Cotelli","ForeName":"Maria","Initials":"M","AffiliationInfo":{"Affiliation":"Neuropsychology Unit, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Brambilla","ForeName":"Michela","Initials":"M","AffiliationInfo":{"Affiliation":"Neuropsychology Unit, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Manenti","ForeName":"Rosa","Initials":"R","AffiliationInfo":{"Affiliation":"Neuropsychology Unit, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Cosseddu","ForeName":"Maura","Initials":"M","AffiliationInfo":{"Affiliation":"Centre for Aging Brain and Neurodegenerative Disorders, Neurology unit, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Premi","ForeName":"Enrico","Initials":"E","AffiliationInfo":{"Affiliation":"Centre for Aging Brain and Neurodegenerative Disorders, Neurology unit, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasparotti","ForeName":"Roberto","Initials":"R","AffiliationInfo":{"Affiliation":"Neuroradiology Unit, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"Alzheimer Unit, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Padovani","ForeName":"Alessandro","Initials":"A","AffiliationInfo":{"Affiliation":"Centre for Aging Brain and Neurodegenerative Disorders, Neurology unit, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Borroni","ForeName":"Barbara","Initials":"B","AffiliationInfo":{"Affiliation":"Centre for Aging Brain and Neurodegenerative Disorders, Neurology unit, University of Brescia, Brescia, Italy."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"J Alzheimers Dis","NlmUniqueID":"9814863","ISSNLinking":"1387-2877"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Analysis of Variance"},{"DescriptorName":"Aphasia","QualifierName":"complications"},{"DescriptorName":"Cues"},{"DescriptorName":"Diagnosis, Computer-Assisted"},{"DescriptorName":"Female"},{"DescriptorName":"Frontotemporal Dementia","QualifierName":"complications"},{"DescriptorName":"Galvanic Skin Response","QualifierName":"physiology"},{"DescriptorName":"Heart Rate","QualifierName":"physiology"},{"DescriptorName":"Humans"},{"DescriptorName":"Magnetic Resonance Imaging"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Mood Disorders","QualifierName":"etiology"},{"DescriptorName":"Neurologic Examination"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Photic Stimulation"},{"DescriptorName":"Psychiatric Status Rating Scales"},{"DescriptorName":"Psychophysics"},{"DescriptorName":"Statistics as Topic"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Basal ganglia","dementia","emotional disturbances","putamen"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2015","Month":"3","Day":"12","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2015","Month":"3","Day":"12","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2016","Month":"6","Day":"28","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["25757651","T443374T4R676H24","10.3233\/JAD-142826"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"24296814","DateCompleted":{"Year":"2014","Month":"10","Day":"30"},"DateRevised":{"Year":"2014","Month":"02","Day":"17"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1875-8908","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"39","Issue":"4","PubDate":{"Year":"2014"}},"Title":"Journal of Alzheimer's disease : JAD","ISOAbbreviation":"J Alzheimers Dis"},"ArticleTitle":"Treatment of primary progressive aphasias by transcranial direct current stimulation combined with language training.","Pagination":{"MedlinePgn":"799-808"},"ELocationID":"10.3233\/JAD-131427","Abstract":{"AbstractText":["Primary progressive aphasia (PPA) is an untreatable neurodegenerative disorder that disrupts language functions. Previous studies have demonstrated transcranial direct current stimulation (tDCS) may improve language symptoms in patients with post stroke aphasia or neurodegenerative diseases.","The present study investigated whether the application of anodal tDCS (AtDCS) to the scalp overlying the left dorsolateral prefrontal cortex (DLPFC), which may increase cortical excitability, in combination with individualized speech therapy would improve naming accuracy in the agrammatic variant of PPA (avPPA).","Sixteen avPPA patients were randomly allocated into two subgroups: AtDCS (n = 8) or placebo tDCS (PtDCS). tDCS was applied over the left DLPFC (BA 8\/9) 25 minutes per day for two weeks (10 days). Each patient underwent 25 minutes of individualized speech therapy with either AtDCS or PtDCS during each treatment session. Neuropsychological assessment, experimental naming, and linguistic abilities in daily living were assessed at baseline (T0), after two weeks of intervention (T1) and at a 12-week follow-up (T2).","Significant improvement in experimental naming was observed in both groups at T1 and T2, but this effect was significantly greater in AtDCS than PtDCS patients. Naming correctness, as assessed using the Aachener Aphasie Test, increased selectively in the AtDCS group from T0 to T1, and this effect remained significant at T2. The analysis of daily living language abilities improved selectively in AtDCS group.","Our results support the beneficial effect of targeted language training in combination with brain stimulation in avPPA patients. tDCS should be considered a useful tool for the improvement of language functions in patients with neurodegenerative diseases in future trials."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Cotelli","ForeName":"Maria","Initials":"M","AffiliationInfo":{"Affiliation":"IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Manenti","ForeName":"Rosa","Initials":"R","AffiliationInfo":{"Affiliation":"IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Petesi","ForeName":"Michela","Initials":"M","AffiliationInfo":{"Affiliation":"IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Brambilla","ForeName":"Michela","Initials":"M","AffiliationInfo":{"Affiliation":"IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Cosseddu","ForeName":"Maura","Initials":"M","AffiliationInfo":{"Affiliation":"Centre for Aging Brain and Neurodegenerative Disorders, Neurology unit, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Miniussi","ForeName":"Carlo","Initials":"C","AffiliationInfo":{"Affiliation":"IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy Department of Clinical and Experimental Sciences, National Institute of Neuroscience, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Padovani","ForeName":"Alessandro","Initials":"A","AffiliationInfo":{"Affiliation":"Centre for Aging Brain and Neurodegenerative Disorders, Neurology unit, University of Brescia, Brescia, Italy E.U.L.O Ente Universitario Lombardia Orientale, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Borroni","ForeName":"Barbara","Initials":"B","AffiliationInfo":{"Affiliation":"Centre for Aging Brain and Neurodegenerative Disorders, Neurology unit, University of Brescia, Brescia, Italy."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Randomized Controlled Trial"]}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"J Alzheimers Dis","NlmUniqueID":"9814863","ISSNLinking":"1387-2877"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aphasia, Primary Progressive","QualifierName":["diagnosis","therapy"]},{"DescriptorName":"Combined Modality Therapy","QualifierName":"methods"},{"DescriptorName":"Female"},{"DescriptorName":"Follow-Up Studies"},{"DescriptorName":"Humans"},{"DescriptorName":"Language Therapy","QualifierName":"methods"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Transcranial Magnetic Stimulation","QualifierName":"methods"},{"DescriptorName":"Treatment Outcome"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Aphasia","frontotemporal dementia","non-invasive brain stimulation","rehabilitation"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2013","Month":"12","Day":"4","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2013","Month":"12","Day":"4","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2014","Month":"10","Day":"31","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["24296814","52G5233255M2783Q","10.3233\/JAD-131427"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"24024214","DateCompleted":{"Year":"2014","Month":"04","Day":"07"},"DateRevised":{"Year":"2018","Month":"11","Day":"13"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"2314-6141","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"2013","PubDate":{"Year":"2013"}},"Title":"BioMed research international","ISOAbbreviation":"Biomed Res Int"},"ArticleTitle":"Serum brain-derived neurotrophic factor levels in different neurological diseases.","Pagination":{"MedlinePgn":"901082"},"ELocationID":"10.1155\/2013\/901082","Abstract":{"AbstractText":"Consistent evidence indicates the involvement of the brain-derived neurotrophic factor (BDNF) in neurodegenerative disorders such as Alzheimer's disease (AD) and Parkinson's disease (PD). In the present study, we compared serum BDNF in 624 subjects: 266 patients affected by AD, 28 by frontotemporal dementia (FTD), 40 by Lewy body dementia (LBD), 91 by vascular dementia (VAD), 30 by PD, and 169 controls. Our results evidenced lower BDNF serum levels in AD, FTD, LBD, and VAD patients (P < 0.001) and a higher BDNF concentration in patients affected by PD (P = 0.045). Analyses of effects of pharmacological treatments suggested significantly higher BDNF serum levels in patients taking mood stabilizers\/antiepileptics (P = 0.009) and L-DOPA (P < 0.001) and significant reductions in patients taking benzodiazepines (P = 0.020). In conclusion, our results support the role of BDNF alterations in neurodegenerative mechanisms common to different forms of neurological disorders and underline the importance of including drug treatment in the analyses to avoid confounding effects. "},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Ventriglia","ForeName":"Mariacarla","Initials":"M","AffiliationInfo":{"Affiliation":"Department of Neuroscience, AFaR-Fatebenefratelli Hospital, Isola Tiberina 39, 00186 Rome, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanardini","ForeName":"Roberta","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonomini","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Volpe","ForeName":"Daniele","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Pasqualetti","ForeName":"Patrizio","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gennarelli","ForeName":"Massimo","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bocchio-Chiavetto","ForeName":"Luisella","Initials":"L"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2013","Month":"08","Day":"19"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Biomed Res Int","NlmUniqueID":"101600173"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Anticonvulsants"},{"RegistryNumber":"0","NameOfSubstance":"Brain-Derived Neurotrophic Factor"},{"RegistryNumber":"12794-10-4","NameOfSubstance":"Benzodiazepines"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":["blood","drug therapy"]},{"DescriptorName":"Anticonvulsants","QualifierName":"administration & dosage"},{"DescriptorName":"Benzodiazepines","QualifierName":"administration & dosage"},{"DescriptorName":"Brain-Derived Neurotrophic Factor","QualifierName":"blood"},{"DescriptorName":"Dementia, Vascular","QualifierName":"blood"},{"DescriptorName":"Female"},{"DescriptorName":"Frontotemporal Dementia","QualifierName":"blood"},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":"blood"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Parkinson Disease","QualifierName":["blood","drug therapy"]}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2013","Month":"04","Day":"30"},{"@attributes":{"PubStatus":"revised"},"Year":"2013","Month":"07","Day":"17"},{"@attributes":{"PubStatus":"accepted"},"Year":"2013","Month":"07","Day":"21"},{"@attributes":{"PubStatus":"entrez"},"Year":"2013","Month":"9","Day":"12","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2013","Month":"9","Day":"12","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2014","Month":"4","Day":"8","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["24024214","10.1155\/2013\/901082","PMC3760208"]},"ReferenceList":{"Reference":[{"Citation":"J Psychiatr Res. 2010 Jun;44(8):506-10","ArticleIdList":{"ArticleId":"19954800"}},{"Citation":"J Alzheimers Dis. 2009;16(3):649-56","ArticleIdList":{"ArticleId":"19276559"}},{"Citation":"Neurology. 1967 May;17(5):427-42","ArticleIdList":{"ArticleId":"6067254"}},{"Citation":"J Neurochem. 2004 Mar;88(5):1059-67","ArticleIdList":{"ArticleId":"15009662"}},{"Citation":"Neuromolecular Med. 2011 Dec;13(4):217-22","ArticleIdList":{"ArticleId":"21898045"}},{"Citation":"Pharmacol Ther. 2012 Apr;134(1):116-24","ArticleIdList":{"ArticleId":"22281237"}},{"Citation":"Dev Neurobiol. 2010 Apr;70(5):289-97","ArticleIdList":{"ArticleId":"20186711"}},{"Citation":"Psychiatry Investig. 2009 Dec;6(4):299-305","ArticleIdList":{"ArticleId":"20140129"}},{"Citation":"Acta Neuropathol. 2001 Mar;101(3):229-38","ArticleIdList":{"ArticleId":"11307622"}},{"Citation":"Biochem Biophys Res Commun. 2004 May 21;318(1):113-8","ArticleIdList":{"ArticleId":"15110760"}},{"Citation":"World J Biol Psychiatry. 2010 Sep;11(6):763-73","ArticleIdList":{"ArticleId":"20334574"}},{"Citation":"Biol Psychiatry. 2003 Jul 1;54(1):70-5","ArticleIdList":{"ArticleId":"12842310"}},{"Citation":"Neurology. 1993 Feb;43(2):250-60","ArticleIdList":{"ArticleId":"8094895"}},{"Citation":"J Neurosci. 2009 Dec 9;29(49):15472-8","ArticleIdList":{"ArticleId":"20007471"}},{"Citation":"Eur J Neurosci. 2005 Sep;22(5):1081-9","ArticleIdList":{"ArticleId":"16176349"}},{"Citation":"Scand J Immunol. 2003 May;57(5):493-7","ArticleIdList":{"ArticleId":"12753507"}},{"Citation":"Neuropharmacology. 1998 Dec;37(12):1553-61","ArticleIdList":{"ArticleId":"9886678"}},{"Citation":"Amino Acids. 2005 Mar;28(2):157-64","ArticleIdList":{"ArticleId":"15750845"}},{"Citation":"Mov Disord. 2007 Sep 15;22(12):1689-707; quiz 1837","ArticleIdList":{"ArticleId":"17542011"}},{"Citation":"Brain Res. 2006 Jun 20;1095(1):207-10","ArticleIdList":{"ArticleId":"16725125"}},{"Citation":"Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):158-9","ArticleIdList":{"ArticleId":"19013208"}},{"Citation":"J Geriatr Psychiatry Neurol. 2008 Sep;21(3):166-70","ArticleIdList":{"ArticleId":"18503034"}},{"Citation":"J Psychiatr Res. 2007 Aug;41(5):387-94","ArticleIdList":{"ArticleId":"16554070"}},{"Citation":"Alzheimer Dis Assoc Disord. 2011 Apr-Jun;25(2):144-8","ArticleIdList":{"ArticleId":"20975515"}},{"Citation":"Thromb Haemost. 2006 Jul;96(1):102-3","ArticleIdList":{"ArticleId":"16807663"}},{"Citation":"Eur Arch Psychiatry Clin Neurosci. 2012 Nov;262 Suppl 2:S71-7","ArticleIdList":{"ArticleId":"22986448"}},{"Citation":"Curr Opin Neurobiol. 2007 Jun;17(3):325-30","ArticleIdList":{"ArticleId":"17419049"}},{"Citation":"J Neurol. 2010 Apr;257(4):540-5","ArticleIdList":{"ArticleId":"19847468"}},{"Citation":"World J Biol Psychiatry. 2010 Sep;11(6):774-80","ArticleIdList":{"ArticleId":"20491609"}},{"Citation":"Eur Arch Psychiatry Clin Neurosci. 2006 Oct;256(7):402-6","ArticleIdList":{"ArticleId":"16783499"}},{"Citation":"Neuroscience. 1999;88(4):1015-32","ArticleIdList":{"ArticleId":"10336117"}},{"Citation":"Neuroreport. 2004 Mar 22;15(4):717-20","ArticleIdList":{"ArticleId":"15094483"}},{"Citation":"J Psychiatr Res. 1975 Nov;12(3):189-98","ArticleIdList":{"ArticleId":"1202204"}},{"Citation":"Biol Psychiatry. 2007 Sep 1;62(5):530-5","ArticleIdList":{"ArticleId":"17560556"}},{"Citation":"Brain Res Mol Brain Res. 1996 Mar;36(2):280-6","ArticleIdList":{"ArticleId":"8965648"}},{"Citation":"Biomark Med. 2010 Dec;4(6):871-87","ArticleIdList":{"ArticleId":"21133708"}},{"Citation":"Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):17-22","ArticleIdList":{"ArticleId":"21803112"}},{"Citation":"Neurology. 1998 Dec;51(6):1546-54","ArticleIdList":{"ArticleId":"9855500"}},{"Citation":"Ther Drug Monit. 2010 Feb;32(1):19-29","ArticleIdList":{"ArticleId":"19901867"}},{"Citation":"Biol Psychiatry. 2008 Sep 15;64(6):527-32","ArticleIdList":{"ArticleId":"18571629"}},{"Citation":"Int J Neuropsychopharmacol. 2010 Feb;13(1):103-8","ArticleIdList":{"ArticleId":"19835669"}},{"Citation":"Biol Psychiatry. 2001 Aug 15;50(4):260-5","ArticleIdList":{"ArticleId":"11522260"}},{"Citation":"FEBS Lett. 2000 Mar 24;470(2):113-7","ArticleIdList":{"ArticleId":"10734218"}},{"Citation":"Nat Rev Neurol. 2009 Jun;5(6):311-22","ArticleIdList":{"ArticleId":"19498435"}},{"Citation":"Prog Neurobiol. 2001 Jan;63(1):71-124","ArticleIdList":{"ArticleId":"11040419"}},{"Citation":"Thromb Haemost. 2002 Apr;87(4):728-34","ArticleIdList":{"ArticleId":"12008958"}},{"Citation":"Mol Cell Neurosci. 2006 Jan;31(1):70-84","ArticleIdList":{"ArticleId":"16214365"}},{"Citation":"Ann N Y Acad Sci. 2008 Nov;1144:97-112","ArticleIdList":{"ArticleId":"19076369"}},{"Citation":"Dement Geriatr Cogn Disord. 2011;31(1):31-6","ArticleIdList":{"ArticleId":"21135555"}},{"Citation":"Brain Res. 2004 Jul 30;1016(1):72-8","ArticleIdList":{"ArticleId":"15234254"}},{"Citation":"J Clin Psychopharmacol. 2010 Dec;30(6):751-3","ArticleIdList":{"ArticleId":"21057246"}},{"Citation":"Acta Neuropathol. 2005 Feb;109(2):141-50","ArticleIdList":{"ArticleId":"15619128"}},{"Citation":"J Psychiatr Res. 2009 Jan;43(3):247-54","ArticleIdList":{"ArticleId":"18511076"}},{"Citation":"Nat Rev Drug Discov. 2011 Mar;10(3):209-19","ArticleIdList":{"ArticleId":"21358740"}},{"Citation":"Neurology. 1984 Jul;34(7):939-44","ArticleIdList":{"ArticleId":"6610841"}},{"Citation":"Neurosci Lett. 2000 Jan 21;279(1):33-6","ArticleIdList":{"ArticleId":"10670781"}},{"Citation":"Neurology. 2005 Dec 27;65(12):1863-72","ArticleIdList":{"ArticleId":"16237129"}},{"Citation":"J Neurosci. 2006 Jul 5;26(27):7189-200","ArticleIdList":{"ArticleId":"16822976"}},{"Citation":"J Neurochem. 2005 Jun;93(6):1412-21","ArticleIdList":{"ArticleId":"15935057"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"23719513","DateCompleted":{"Year":"2015","Month":"02","Day":"09"},"DateRevised":{"Year":"2014","Month":"07","Day":"15"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1875-8908","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"41","Issue":"2","PubDate":{"Year":"2014"}},"Title":"Journal of Alzheimer's disease : JAD","ISOAbbreviation":"J Alzheimers Dis"},"ArticleTitle":"Estimating the inheritance of frontotemporal lobar degeneration in the Italian population.","Pagination":{"MedlinePgn":"371-6"},"ELocationID":"10.3233\/JAD-130128","Abstract":{"AbstractText":"Frontotemporal dementia (FTD) has a strong genetic basis, with familial forms occurring in 30-50% of cases. Causative genes have been identified, with an autosomal dominant pattern of inheritance. Notwithstanding, in a number of cases with positive family history no pathogenetic mutation has been reported, and the role of genetics in sporadic cases is still unclear. In the present study, we aim to estimate the genetic contribution to FTD using concordance among parent-offspring pairs. Heritability of early-onset (EO, <65 years) and late-onset (LO, \u226565 years) FTD was estimated by examining the concordance between parents and offspring. Probands with at least one parent whose dementia status was known were recruited from 15 Italian centers, and the presence or absence of dementia was considered in siblings. Different prevalence estimates, as available by literature data, were tested. A total of 260 probands and 1619 family members were considered in this study. We found that parent-offspring concordance in FTD was 6.25%, resulting in hereditability of 98.5% (95% confidence interval (CI): 85.0%-100.0%). Equal heritability for both sexes regardless of parental gender was reported. EO-FTD showed hereditability of 86.3% (95% CI: 77.0%-95.0%) and LO-FTD of 75.7% (95% CI: 65.0%-86.0%). Estimating the contribution of genetics in FTD may help in driving future genetic studies to identify new pathogenetic determinants. We suggest that in most of the cases FTD is a genetic-based disease, even in the elderly. Different inheritance modality might be considered in future work, beyond autosomal dominant disease. "},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Borroni","ForeName":"Barbara","Initials":"B","AffiliationInfo":{"Affiliation":"Neurology Unit, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Grassi","ForeName":"Mario","Initials":"M","AffiliationInfo":{"Affiliation":"Department of Statistics and Epidemiology, University of Pavia, Pavia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bianchi","ForeName":"Marta","Initials":"M","AffiliationInfo":{"Affiliation":"Neurology Unit, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bruni","ForeName":"Amalia Cecilia","Initials":"AC","AffiliationInfo":{"Affiliation":"Neurogenetic Research Centre, Lamezia Terme, Azienda Sanitaria Provinciale Catanzaro, Catanzaro, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maletta","ForeName":"Raffaele Giovanni","Initials":"RG","AffiliationInfo":{"Affiliation":"Neurogenetic Research Centre, Lamezia Terme, Azienda Sanitaria Provinciale Catanzaro, Catanzaro, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Anfossi","ForeName":"Maria","Initials":"M","AffiliationInfo":{"Affiliation":"Neurogenetic Research Centre, Lamezia Terme, Azienda Sanitaria Provinciale Catanzaro, Catanzaro, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Pepe","ForeName":"Daniele","Initials":"D","AffiliationInfo":{"Affiliation":"Department of Statistics and Epidemiology, University of Pavia, Pavia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Cagnin","ForeName":"Annachiara","Initials":"A","AffiliationInfo":{"Affiliation":"Department of Neurosciences, University of Padova, Padova, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Caffarra","ForeName":"Paolo","Initials":"P","AffiliationInfo":{"Affiliation":"Department of Neuroscience, University of Parma, Parma, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Cappa","ForeName":"Stefano","Initials":"S","AffiliationInfo":{"Affiliation":"IRCCS San Raffaele, Universit\u00e1 Vita e Salute, Milan, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Clerici","ForeName":"Francesca","Initials":"F","AffiliationInfo":{"Affiliation":"Center for Research and Treatment of Cognitive Dysfunctions, Institute of Clinical Neurology, Department of Biomedical and Clinical Sciences, \"Luigi Sacco\" Hospital, University of Milan, Milan, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Daniele","ForeName":"Antonio","Initials":"A","AffiliationInfo":{"Affiliation":"Neurology Unit, Universit\u00e1 Cattolica, Rome, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB","AffiliationInfo":{"Affiliation":"IRCCS Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Galimberti","ForeName":"Daniela","Initials":"D","AffiliationInfo":{"Affiliation":"University of Milan, Fondazione C\u00e1Granda, IRCCS Ospedale Policlinico, Milan, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Parnetti","ForeName":"Lucilla","Initials":"L","AffiliationInfo":{"Affiliation":"Section of Neurology, Centre for Memory Disturbances, University of Perugia, Perugia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Perri","ForeName":"Roberta","Initials":"R","AffiliationInfo":{"Affiliation":"IRCCS Santa Lucia, Rome, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Rainero","ForeName":"Innocenzo","Initials":"I","AffiliationInfo":{"Affiliation":"Neurology Unit, University of Torino, Torino, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Tremolizzo","ForeName":"Lucio","Initials":"L","AffiliationInfo":{"Affiliation":"Department of Neurology, San Gerardo Hospital, Monza and University of Milano-Bicocca, Milano, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Turla","ForeName":"Marinella","Initials":"M","AffiliationInfo":{"Affiliation":"Neurology Unit, ValleCamonica Hospital, Esine, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"IRCCS Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Padovani","ForeName":"Alessandro","Initials":"A","AffiliationInfo":{"Affiliation":"Neurology Unit, University of Brescia, Brescia, Italy."}}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Multicenter Study"]}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"J Alzheimers Dis","NlmUniqueID":"9814863","ISSNLinking":"1387-2877"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Age of Onset"},{"DescriptorName":"Aged"},{"DescriptorName":"Female"},{"DescriptorName":"Frontotemporal Lobar Degeneration","QualifierName":["epidemiology","genetics"]},{"DescriptorName":"Humans"},{"DescriptorName":"Inheritance Patterns"},{"DescriptorName":"Italy","QualifierName":"epidemiology"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Parents"},{"DescriptorName":"Registries"},{"DescriptorName":"Sex Factors"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Frontotemporal dementia","frontotemporal lobar degeneration","genetics","heritability","inheritance"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2013","Month":"5","Day":"31","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2013","Month":"5","Day":"31","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2015","Month":"2","Day":"11","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["23719513","53L2032600H65KW1","10.3233\/JAD-130128"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"23126239","DateCompleted":{"Year":"2013","Month":"05","Day":"24"},"DateRevised":{"Year":"2018","Month":"11","Day":"13"},"Article":{"@attributes":{"PubModel":"Electronic"},"Journal":{"ISSN":"1759-0914","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"4","Issue":"7","PubDate":{"Year":"2012","Month":"Dec","Day":"14"}},"Title":"ASN neuro","ISOAbbreviation":"ASN Neuro"},"ArticleTitle":"Analysis of grey matter in thalamus and basal ganglia based on EEG \u03b13\/\u03b12 frequency ratio reveals specific changes in subjects with mild cognitive impairment.","Pagination":{"MedlinePgn":"e00103"},"ELocationID":["10.1042\/AN20120058","e00103"],"Abstract":{"AbstractText":"GM (grey matter) changes of thalamus and basal ganglia have been demonstrated to be involved in AD (Alzheimer's disease). Moreover, the increase of a specific EEG (electroencephalogram) marker, \u03b13\/\u03b12, have been associated with AD-converters subjects with MCI (mild cognitive impairment). To study the association of prognostic EEG markers with specific GM changes of thalamus and basal ganglia in subjects with MCI to detect biomarkers (morpho-physiological) early predictive of AD and non-AD dementia. Seventy-four adult subjects with MCI underwent EEG recording and high-resolution 3D MRI (three-dimensional magnetic resonance imaging). The \u03b13\/\u03b12 ratio was computed for each subject. Three groups were obtained according to increasing tertile values of \u03b13\/\u03b12 ratio. GM density differences between groups were investigated using a VBM (voxel-based morphometry) technique. Subjects with higher \u03b13\/\u03b12 ratios when compared with subjects with lower and middle \u03b13\/\u03b12 ratios showed minor atrophy in the ventral stream of basal ganglia (head of caudate nuclei and accumbens nuclei bilaterally) and of the pulvinar nuclei in the thalamus; The integrated analysis of EEG and morpho-structural markers could be useful in the comprehension of anatomo-physiological underpinning of the MCI entity."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Moretti","ForeName":"Davide V","Initials":"DV","AffiliationInfo":{"Affiliation":"IRCCSS Centro Giovanni di Dio Fatebenefratelli, Brescia, Italy. davide.moretti@afar.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Paternic\u00f2","ForeName":"Donata","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Binetti","ForeName":"Giuliano","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2012","Month":"12","Day":"14"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"ASN Neuro","NlmUniqueID":"101507115","ISSNLinking":"1759-0914"},"ChemicalList":{"Chemical":{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"}},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Alzheimer Disease","QualifierName":["diagnosis","physiopathology"]},{"DescriptorName":"Basal Ganglia","QualifierName":["pathology","physiopathology"]},{"DescriptorName":"Biomarkers","QualifierName":"analysis"},{"DescriptorName":"Cognitive Dysfunction","QualifierName":["diagnosis","physiopathology"]},{"DescriptorName":"Disease Progression"},{"DescriptorName":"Electroencephalography"},{"DescriptorName":"Humans"},{"DescriptorName":"Image Interpretation, Computer-Assisted"},{"DescriptorName":"Magnetic Resonance Imaging"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Thalamus","QualifierName":["pathology","physiopathology"]}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2012","Month":"11","Day":"7","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2012","Month":"11","Day":"7","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2013","Month":"5","Day":"28","Hour":"6","Minute":"0"}]},"PublicationStatus":"epublish","ArticleIdList":{"ArticleId":["23126239","AN20120058","10.1042\/AN20120058","PMC3522208"]},"ReferenceList":{"Reference":[{"Citation":"Neuroimage. 2009 Jul 15;46(4):938-48","ArticleIdList":{"ArticleId":"19303446"}},{"Citation":"Clin Neurophysiol. 2006 Feb;117(2):252-68","ArticleIdList":{"ArticleId":"16377238"}},{"Citation":"Neurobiol Aging. 2011 Apr;32(4):563-71","ArticleIdList":{"ArticleId":"20022139"}},{"Citation":"Neuroimage. 2006 Aug 1;32(1):104-10","ArticleIdList":{"ArticleId":"16631382"}},{"Citation":"Int J Psychophysiol. 1997 Jun;26(1-3):319-40","ArticleIdList":{"ArticleId":"9203012"}},{"Citation":"J Neurosci. 2006 Oct 4;26(40):10222-31","ArticleIdList":{"ArticleId":"17021177"}},{"Citation":"J Alzheimers Dis. 2010;19(4):1273-82","ArticleIdList":{"ArticleId":"20308792"}},{"Citation":"Clin Neurophysiol. 2004 Feb;115(2):299-308","ArticleIdList":{"ArticleId":"14744569"}},{"Citation":"Am J Geriatr Psychiatry. 2010 Nov;18(11):1026-35","ArticleIdList":{"ArticleId":"20808086"}},{"Citation":"Brain. 2007 Mar;130(Pt 3):720-30","ArticleIdList":{"ArticleId":"17293358"}},{"Citation":"Brain. 2001 Apr;124(Pt 4):739-56","ArticleIdList":{"ArticleId":"11287374"}},{"Citation":"Int J Alzheimers Dis. 2012;2012:253153","ArticleIdList":{"ArticleId":"22506130"}},{"Citation":"Brain. 1998 Apr;121 ( Pt 4):611-31","ArticleIdList":{"ArticleId":"9577389"}},{"Citation":"J Alzheimers Dis. 2008 Jul;14(3):285-99","ArticleIdList":{"ArticleId":"18599955"}},{"Citation":"Psychiatry Res. 2008 Aug 30;163(3):248-59","ArticleIdList":{"ArticleId":"18672352"}},{"Citation":"Neuroscience. 2006;137(4):1087-106","ArticleIdList":{"ArticleId":"16343791"}},{"Citation":"Neuropsychopharmacology. 2010 Jan;35(1):4-26","ArticleIdList":{"ArticleId":"19812543"}},{"Citation":"Brain. 2008 Dec;131(Pt 12):3277-85","ArticleIdList":{"ArticleId":"19022861"}},{"Citation":"J Cogn Neurosci. 2003 Nov 15;15(8):1122-34","ArticleIdList":{"ArticleId":"14709231"}},{"Citation":"Brain Res Rev. 2007 Jan;53(1):63-88","ArticleIdList":{"ArticleId":"16887192"}},{"Citation":"Clin Neurophysiol. 2009 Feb;120(2):295-303","ArticleIdList":{"ArticleId":"19121602"}},{"Citation":"J Neurosci. 2010 May 5;30(18):6342-54","ArticleIdList":{"ArticleId":"20445060"}},{"Citation":"Ann Neurol. 1980 May;7(5):486-8","ArticleIdList":{"ArticleId":"7396427"}},{"Citation":"Brain. 2007 Mar;130(Pt 3):740-52","ArticleIdList":{"ArticleId":"17293359"}},{"Citation":"Cereb Cortex. 2004 Apr;14(4):364-75","ArticleIdList":{"ArticleId":"15028641"}},{"Citation":"Prog Neurobiol. 2009 Oct;89(2):125-33","ArticleIdList":{"ArticleId":"19560509"}},{"Citation":"J Alzheimers Dis. 2008 Nov;15(3):357-72","ArticleIdList":{"ArticleId":"18997289"}},{"Citation":"Philos Trans R Soc Lond B Biol Sci. 2003 Oct 29;358(1438):1605-24","ArticleIdList":{"ArticleId":"14561322"}},{"Citation":"Nat Rev Neurosci. 2009 Apr;10(4):272-82","ArticleIdList":{"ArticleId":"19300446"}},{"Citation":"J Neurosci. 2007 Feb 28;27(9):2230-40","ArticleIdList":{"ArticleId":"17329420"}},{"Citation":"Ann Neurol. 2004 Jul;56(1):27-35","ArticleIdList":{"ArticleId":"15236399"}},{"Citation":"Clin Neurophysiol. 2004 Jul;115(7):1490-505","ArticleIdList":{"ArticleId":"15203050"}},{"Citation":"Clin Neurophysiol. 2007 Aug;118(8):1866-76","ArticleIdList":{"ArticleId":"17576096"}},{"Citation":"J Neurosci. 2003 Feb 1;23(3):986-93","ArticleIdList":{"ArticleId":"12574428"}},{"Citation":"J Neurol. 2009 Jun;256(6):916-24","ArticleIdList":{"ArticleId":"19252794"}},{"Citation":"Clin Neurophysiol. 2007 Dec;118(12):2716-29","ArticleIdList":{"ArticleId":"17977786"}},{"Citation":"Neuroimage. 2007 Oct 15;38(1):95-113","ArticleIdList":{"ArticleId":"17761438"}},{"Citation":"Hum Brain Mapp. 1997;5(2):110-8","ArticleIdList":{"ArticleId":"10096415"}},{"Citation":"J Alzheimers Dis. 2010;19(3):963-76","ArticleIdList":{"ArticleId":"20157252"}},{"Citation":"Arch Neurol. 2001 Dec;58(12):1985-92","ArticleIdList":{"ArticleId":"11735772"}},{"Citation":"Neuron. 2002 Feb 28;33(5):827-40","ArticleIdList":{"ArticleId":"11879658"}},{"Citation":"Acta Neurol Scand. 2003 Aug;108(2):90-6","ArticleIdList":{"ArticleId":"12859284"}},{"Citation":"Cortex. 2003 Sep-Dec;39(4-5):993-1008","ArticleIdList":{"ArticleId":"14584563"}},{"Citation":"Int J Psychophysiol. 2003 Mar;47(3):199-216","ArticleIdList":{"ArticleId":"12663065"}},{"Citation":"J Psychiatr Res. 1975 Nov;12(3):189-98","ArticleIdList":{"ArticleId":"1202204"}},{"Citation":"Lancet Neurol. 2007 Aug;6(8):734-46","ArticleIdList":{"ArticleId":"17616482"}},{"Citation":"Neuroimage. 2010 Jan 1;49(1):1-8","ArticleIdList":{"ArticleId":"19744568"}},{"Citation":"Int J Alzheimers Dis. 2011 Apr 13;2011:539621","ArticleIdList":{"ArticleId":"21584257"}},{"Citation":"J Alzheimers Dis. 2009;17(2):349-57","ArticleIdList":{"ArticleId":"19363263"}},{"Citation":"Neurosci Biobehav Rev. 2008;32(3):408-22","ArticleIdList":{"ArticleId":"17854894"}},{"Citation":"Philos Trans R Soc Lond B Biol Sci. 2002 Dec 29;357(1428):1695-708","ArticleIdList":{"ArticleId":"12626004"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2006 Nov;77(11):1219-22","ArticleIdList":{"ArticleId":"16891386"}},{"Citation":"Neuroimage. 2008 Feb 15;39(4):2002-9","ArticleIdList":{"ArticleId":"18061483"}},{"Citation":"Brain Res Cogn Brain Res. 2005 Dec;25(3):936-47","ArticleIdList":{"ArticleId":"16289526"}},{"Citation":"Biol Cybern. 2011 Oct;105(3-4):183-95","ArticleIdList":{"ArticleId":"22095173"}},{"Citation":"IEEE Trans Biomed Eng. 1975 Sep;22(5):361-9","ArticleIdList":{"ArticleId":"1193622"}},{"Citation":"J Int Neuropsychol Soc. 2003 Nov;9(7):1061-77","ArticleIdList":{"ArticleId":"14738287"}},{"Citation":"Neuroreport. 1999 Nov 26;10(17):3589-94","ArticleIdList":{"ArticleId":"10619649"}},{"Citation":"Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):323-32","ArticleIdList":{"ArticleId":"19561442"}},{"Citation":"Curr Alzheimer Res. 2010 Sep;7(6):487-505","ArticleIdList":{"ArticleId":"20455865"}},{"Citation":"Brain Res Brain Res Rev. 1999 Apr;29(2-3):169-95","ArticleIdList":{"ArticleId":"10209231"}},{"Citation":"J Cogn Neurosci. 2006 Feb;18(2):227-41","ArticleIdList":{"ArticleId":"16494683"}},{"Citation":"Gerontologist. 1969 Autumn;9(3):179-86","ArticleIdList":{"ArticleId":"5349366"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2006 Jun;77(6):714-8","ArticleIdList":{"ArticleId":"16549412"}},{"Citation":"Neurology. 2005 Aug 9;65(3):404-11","ArticleIdList":{"ArticleId":"16087905"}},{"Citation":"Biol Cybern. 1976 May 17;22(4):235-8","ArticleIdList":{"ArticleId":"953081"}},{"Citation":"Clin Neurophysiol. 2008 Jul;119(7):1534-45","ArticleIdList":{"ArticleId":"18485814"}},{"Citation":"Conf Proc IEEE Eng Med Biol Soc. 2009;2009:2224-7","ArticleIdList":{"ArticleId":"19964954"}},{"Citation":"Brain. 2008 Dec;131(Pt 12):3266-76","ArticleIdList":{"ArticleId":"18988639"}},{"Citation":"Prog Neurobiol. 2010 Dec;92(4):533-57","ArticleIdList":{"ArticleId":"20831892"}},{"Citation":"Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15222-7","ArticleIdList":{"ArticleId":"10611366"}},{"Citation":"Brain Lang. 2013 Jul;126(1):89-98","ArticleIdList":{"ArticleId":"22964132"}},{"Citation":"Med Biol Eng Comput. 1977 Sep;15(5):513-8","ArticleIdList":{"ArticleId":"199805"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"23111906","DateCompleted":{"Year":"2013","Month":"07","Day":"26"},"DateRevised":{"Year":"2018","Month":"11","Day":"13"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1098-1004","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"34","Issue":"2","PubDate":{"Year":"2013","Month":"Feb"}},"Title":"Human mutation","ISOAbbreviation":"Hum Mutat"},"ArticleTitle":"A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats.","Pagination":{"MedlinePgn":"363-73"},"ELocationID":"10.1002\/humu.22244","Abstract":{"AbstractText":"We assessed the geographical distribution of C9orf72 G(4) C(2) expansions in a pan-European frontotemporal lobar degeneration (FTLD) cohort (n = 1,205), ascertained by the European Early-Onset Dementia (EOD) consortium. Next, we performed a meta-analysis of our data and that of other European studies, together 2,668 patients from 15 Western European countries. The frequency of the C9orf72 expansions in Western Europe was 9.98% in overall FTLD, with 18.52% in familial, and 6.26% in sporadic FTLD patients. Outliers were Finland and Sweden with overall frequencies of respectively 29.33% and 20.73%, but also Spain with 25.49%. In contrast, prevalence in Germany was limited to 4.82%. In addition, we studied the role of intermediate repeats (7-24 repeat units), which are strongly correlated with the risk haplotype, on disease and C9orf72 expression. In vitro reporter gene expression studies demonstrated significantly decreased transcriptional activity of C9orf72 with increasing number of normal repeat units, indicating that intermediate repeats might act as predisposing alleles and in favor of the loss-of-function disease mechanism. Further, we observed a significantly increased frequency of short indels in the GC-rich low complexity sequence adjacent to the G(4) C(2) repeat in C9orf72 expansion carriers (P < 0.001) with the most common indel creating one long contiguous imperfect G(4) C(2) repeat, which is likely more prone to replication slippage and pathological expansion.","CopyrightInformation":"\u00a9 2012 Wiley Periodicals, Inc."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"van der Zee","ForeName":"Julie","Initials":"J","AffiliationInfo":{"Affiliation":"Department of Molecular Genetics, VIB, Antwerp, Belgium."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gijselinck","ForeName":"Ilse","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Dillen","ForeName":"Lubina","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Langenhove","ForeName":"Tim","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Theuns","ForeName":"Jessie","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Engelborghs","ForeName":"Sebastiaan","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Philtjens","ForeName":"St\u00e9phanie","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Vandenbulcke","ForeName":"Mathieu","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sleegers","ForeName":"Kristel","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sieben","ForeName":"Anne","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"B\u00e4umer","ForeName":"Veerle","Initials":"V"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maes","ForeName":"Githa","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Corsmit","ForeName":"Ellen","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Borroni","ForeName":"Barbara","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Padovani","ForeName":"Alessandro","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Archetti","ForeName":"Silvana","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Perneczky","ForeName":"Robert","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Diehl-Schmid","ForeName":"Janine","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"de Mendon\u00e7a","ForeName":"Alexandre","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Miltenberger-Miltenyi","ForeName":"Gabriel","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Pereira","ForeName":"S\u00f3nia","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Pimentel","ForeName":"Jos\u00e9","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Nacmias","ForeName":"Benedetta","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bagnoli","ForeName":"Silvia","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sorbi","ForeName":"Sandro","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Graff","ForeName":"Caroline","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Chiang","ForeName":"Huei-Hsin","Initials":"HH"},{"@attributes":{"ValidYN":"Y"},"LastName":"Westerlund","ForeName":"Marie","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sanchez-Valle","ForeName":"Raquel","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Llado","ForeName":"Albert","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gelpi","ForeName":"Ellen","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Santana","ForeName":"Isabel","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Almeida","ForeName":"Maria Ros\u00e1rio","Initials":"MR"},{"@attributes":{"ValidYN":"Y"},"LastName":"Santiago","ForeName":"Beatriz","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonvicini","ForeName":"Cristian","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Synofzik","ForeName":"Matthis","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"Vom Hagen","ForeName":"Jennifer M\u00fcller","Initials":"JM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sch\u00f6ls","ForeName":"Ludger","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Heneka","ForeName":"Michael T","Initials":"MT"},{"@attributes":{"ValidYN":"Y"},"LastName":"Jessen","ForeName":"Frank","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Matej","ForeName":"Radoslav","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Parobkova","ForeName":"Eva","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kovacs","ForeName":"Gabor G","Initials":"GG"},{"@attributes":{"ValidYN":"Y"},"LastName":"Str\u00f6bel","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sarafov","ForeName":"Stayko","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Tournev","ForeName":"Ivailo","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Jordanova","ForeName":"Albena","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Danek","ForeName":"Adrian","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Arzberger","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Fabrizi","ForeName":"Gian Maria","Initials":"GM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Testi","ForeName":"Silvia","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Salmon","ForeName":"Eric","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Santens","ForeName":"Patrick","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Martin","ForeName":"Jean-Jacques","Initials":"JJ"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cras","ForeName":"Patrick","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Vandenberghe","ForeName":"Rik","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"De Deyn","ForeName":"Peter Paul","Initials":"PP"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cruts","ForeName":"Marc","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Broeckhoven","ForeName":"Christine","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"van der Zee","ForeName":"Julie","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gijselinck","ForeName":"Ilse","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Dillen","ForeName":"Lubina","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Langenhove","ForeName":"Tim","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Theuns","ForeName":"Jessie","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Philtjens","ForeName":"St\u00e9phanie","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sleegers","ForeName":"Kristel","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"B\u00e4umer","ForeName":"Veerle","Initials":"V"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maes","ForeName":"Githa","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Corsmit","ForeName":"Ellen","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cruts","ForeName":"Marc","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Broeckhoven","ForeName":"Christine","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"van der Zee","ForeName":"Julie","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gijselinck","ForeName":"Ilse","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Dillen","ForeName":"Lubina","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Langenhove","ForeName":"Tim","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Philtjens","ForeName":"St\u00e9phanie","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Theuns","ForeName":"Jessie","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sleegers","ForeName":"Kristel","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"B\u00e4umer","ForeName":"Veerle","Initials":"V"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maes","ForeName":"Githa","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cruts","ForeName":"Marc","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Broeckhoven","ForeName":"Christine","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Engelborghs","ForeName":"Sebastiaan","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"De Deyn","ForeName":"Peter P","Initials":"PP"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cras","ForeName":"Patrick","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Engelborghs","ForeName":"Sebastiaan","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"De Deyn","ForeName":"Peter P","Initials":"PP"},{"@attributes":{"ValidYN":"Y"},"LastName":"Vandenbulcke","ForeName":"Mathieu","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Vandenbulcke","ForeName":"Mathieu","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Borroni","ForeName":"Barbara","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Padovani","ForeName":"Alessandro","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Archetti","ForeName":"Silvana","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Perneczky","ForeName":"Robert","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Diehl-Schmid","ForeName":"Janine","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Synofzik","ForeName":"Matthis","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"M\u00fcller Vom Hagen","ForeName":"Jennifer","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sch\u00f6ls","ForeName":"Ludger","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Synofzik","ForeName":"Matthis","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maetzler","ForeName":"Walter","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"M\u00fcller Vom Hagen","ForeName":"Jennifer","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sch\u00f6ls","ForeName":"Ludger","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Heneka","ForeName":"Michael T","Initials":"MT"},{"@attributes":{"ValidYN":"Y"},"LastName":"Jessen","ForeName":"Frank","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ramirez","ForeName":"Alfredo","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kurzwelly","ForeName":"Delia","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sachtleben","ForeName":"Carmen","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Mairer","ForeName":"Wolfgang","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"de Mendon\u00e7a","ForeName":"Alexandre","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Miltenberger-Miltenyi","ForeName":"Gabriel","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Pereira","ForeName":"S\u00f3nia","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Firmo","ForeName":"Clara","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Pimentel","ForeName":"Jos\u00e9","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sanchez-Valle","ForeName":"Raquel","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Llado","ForeName":"Albert","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Antonell","ForeName":"Anna","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Molinuevo","ForeName":"Jose","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gelpi","ForeName":"Ellen","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Graff","ForeName":"Caroline","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Chiang","ForeName":"Huei-Hsin","Initials":"HH"},{"@attributes":{"ValidYN":"Y"},"LastName":"Westerlund","ForeName":"Marie","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Graff","ForeName":"Caroline","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kinhult St\u00e5hlbom","ForeName":"Anne","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Thonberg","ForeName":"H\u00e5kan","Initials":"H"},{"@attributes":{"ValidYN":"Y"},"LastName":"Nennesmo","ForeName":"Inger","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"B\u00f6rjesson-Hanson","ForeName":"Anne","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Nacmias","ForeName":"Benedetta","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bagnoli","ForeName":"Silvia","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sorbi","ForeName":"Sandro","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bessi","ForeName":"Valentina","Initials":"V"},{"@attributes":{"ValidYN":"Y"},"LastName":"Piaceri","ForeName":"Irene","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Santana","ForeName":"Isabel","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Santiago","ForeName":"Beatriz","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Santana","ForeName":"Isabel","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Helena Ribeiro","ForeName":"Maria","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ros\u00e1rio Almeida","ForeName":"Maria","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Oliveira","ForeName":"Catarina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Massano","ForeName":"Jo\u00e3o","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Garret","ForeName":"Carolina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Pires","ForeName":"Paula","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonvicini","ForeName":"Cristian","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sarafov","ForeName":"Stayko","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Tournev","ForeName":"Ivailo","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Jordanova","ForeName":"Albena","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Tournev","ForeName":"Ivailo","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kovacs","ForeName":"Gabor G","Initials":"GG"},{"@attributes":{"ValidYN":"Y"},"LastName":"Str\u00f6bel","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Heneka","ForeName":"Michael T","Initials":"MT"},{"@attributes":{"ValidYN":"Y"},"LastName":"Jessen","ForeName":"Frank","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ramirez","ForeName":"Alfredo","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kurzwelly","ForeName":"Delia","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sachtleben","ForeName":"Carmen","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Mairer","ForeName":"Wolfgang","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"Jessen","ForeName":"Frank","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Matej","ForeName":"Radoslav","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Parobkova","ForeName":"Eva","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Danel","ForeName":"Adrian","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Arzberger","ForeName":"Thomas","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Maria Fabrizi","ForeName":"Gian","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Testi","ForeName":"Silvia","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ferrari","ForeName":"Sergio","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cavallaro","ForeName":"Tiziana","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Salmon","ForeName":"Eric","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Santens","ForeName":"Patrick","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cras","ForeName":"Patrick","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"European Early-Onset Dementia Consortium"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Meta-Analysis","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2013","Month":"01","Day":"04"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Hum Mutat","NlmUniqueID":"9215429","ISSNLinking":"1059-7794"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"C9orf72 Protein"},{"RegistryNumber":"0","NameOfSubstance":"C9orf72 protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Proteins"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Adult"},{"DescriptorName":"Age of Onset"},{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alleles"},{"DescriptorName":"Alzheimer Disease","QualifierName":"genetics"},{"DescriptorName":"Base Sequence"},{"DescriptorName":"C9orf72 Protein"},{"DescriptorName":"Chromosomes, Human, Pair 9","QualifierName":"genetics"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"DNA Repeat Expansion"},{"DescriptorName":"Europe","QualifierName":"epidemiology"},{"DescriptorName":"Finland","QualifierName":"epidemiology"},{"DescriptorName":"Frontotemporal Lobar Degeneration","QualifierName":["epidemiology","genetics"]},{"DescriptorName":"Genome-Wide Association Study","QualifierName":"methods"},{"DescriptorName":"Genomic Instability"},{"DescriptorName":"Germany","QualifierName":"epidemiology"},{"DescriptorName":"Haplotypes"},{"DescriptorName":"Humans"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Molecular Sequence Data"},{"DescriptorName":"Prevalence"},{"DescriptorName":"Proteins","QualifierName":"genetics"},{"DescriptorName":"Spain","QualifierName":"epidemiology"},{"DescriptorName":"Sweden","QualifierName":"epidemiology"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2012","Month":"06","Day":"29"},{"@attributes":{"PubStatus":"accepted"},"Year":"2012","Month":"10","Day":"09"},{"@attributes":{"PubStatus":"entrez"},"Year":"2012","Month":"11","Day":"1","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2012","Month":"11","Day":"1","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2013","Month":"7","Day":"28","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["23111906","10.1002\/humu.22244","PMC3638346"]},"ReferenceList":{"Reference":[{"Citation":"Lancet Neurol. 2010 Oct;9(10):978-85","ArticleIdList":{"ArticleId":"20801718"}},{"Citation":"Clin Genet. 2013 Mar;83(3):279-83","ArticleIdList":{"ArticleId":"22650353"}},{"Citation":"J Neurol. 2011 Apr;258(4):647-55","ArticleIdList":{"ArticleId":"21072532"}},{"Citation":"Neuron. 2011 Oct 20;72(2):245-56","ArticleIdList":{"ArticleId":"21944778"}},{"Citation":"Neuron. 2011 Oct 20;72(2):257-68","ArticleIdList":{"ArticleId":"21944779"}},{"Citation":"Neurobiol Aging. 2012 Jan;33(1):209.e3-8","ArticleIdList":{"ArticleId":"21925771"}},{"Citation":"Acta Neuropathol. 2011 Dec;122(6):673-90","ArticleIdList":{"ArticleId":"22083254"}},{"Citation":"Acta Neuropathol. 2011 Dec;122(6):691-702","ArticleIdList":{"ArticleId":"22101323"}},{"Citation":"PLoS One. 2011;6(12):e28260","ArticleIdList":{"ArticleId":"22163004"}},{"Citation":"Methods Mol Biol. 2000;132:365-86","ArticleIdList":{"ArticleId":"10547847"}},{"Citation":"Am J Med Genet. 2000 Jul 17;93(2):99-106","ArticleIdList":{"ArticleId":"10869110"}},{"Citation":"Cell. 1994 Jun 17;77(6):853-61","ArticleIdList":{"ArticleId":"7911740"}},{"Citation":"Hum Mol Genet. 1998 Nov;7(12):1935-46","ArticleIdList":{"ArticleId":"9811938"}},{"Citation":"Neurology. 1998 Dec;51(6):1546-54","ArticleIdList":{"ArticleId":"9855500"}},{"Citation":"Hum Mol Genet. 1999 Jun;8(6):1061-7","ArticleIdList":{"ArticleId":"10332038"}},{"Citation":"Genome Res. 2005 Mar;15(3):436-42","ArticleIdList":{"ArticleId":"15741513"}},{"Citation":"Brain. 2006 Apr;129(Pt 4):868-76","ArticleIdList":{"ArticleId":"16495328"}},{"Citation":"Neurology. 2006 Mar 28;66(6):839-44","ArticleIdList":{"ArticleId":"16421333"}},{"Citation":"Eur J Hum Genet. 2008 Feb;16(2):140-2","ArticleIdList":{"ArticleId":"18043718"}},{"Citation":"PLoS Genet. 2008;4(9):e1000193","ArticleIdList":{"ArticleId":"18802454"}},{"Citation":"BMC Neurol. 2008;8:32","ArticleIdList":{"ArticleId":"18755042"}},{"Citation":"Neurology. 2009 May 12;72(19):1669-76","ArticleIdList":{"ArticleId":"19433740"}},{"Citation":"Nat Genet. 2009 Oct;41(10):1083-7","ArticleIdList":{"ArticleId":"19734901"}},{"Citation":"Neurology. 2009 Oct 20;73(16):1280-5","ArticleIdList":{"ArticleId":"19776381"}},{"Citation":"Acta Neuropathol. 2010 Jan;119(1):1-4","ArticleIdList":{"ArticleId":"19924424"}},{"Citation":"Nat Genet. 2010 Mar;42(3):234-9","ArticleIdList":{"ArticleId":"20154673"}},{"Citation":"Arch Neurol. 2010 May;67(5):606-16","ArticleIdList":{"ArticleId":"20457961"}},{"Citation":"BMC Genomics. 2010;11:298","ArticleIdList":{"ArticleId":"20459859"}},{"Citation":"Lancet Neurol. 2010 Oct;9(10):986-94","ArticleIdList":{"ArticleId":"20801717"}},{"Citation":"Lancet Neurol. 2012 Jan;11(1):54-65","ArticleIdList":{"ArticleId":"22154785"}},{"Citation":"Acta Neuropathol. 2012 Mar;123(3):409-17","ArticleIdList":{"ArticleId":"22228244"}},{"Citation":"Brain. 2012 Mar;135(Pt 3):693-708","ArticleIdList":{"ArticleId":"22300873"}},{"Citation":"Brain. 2012 Mar;135(Pt 3):723-35","ArticleIdList":{"ArticleId":"22300876"}},{"Citation":"Brain. 2012 Mar;135(Pt 3):709-22","ArticleIdList":{"ArticleId":"22344582"}},{"Citation":"Brain. 2012 Mar;135(Pt 3):736-50","ArticleIdList":{"ArticleId":"22366791"}},{"Citation":"Brain. 2012 Mar;135(Pt 3):765-83","ArticleIdList":{"ArticleId":"22366793"}},{"Citation":"Brain. 2012 Mar;135(Pt 3):784-93","ArticleIdList":{"ArticleId":"22366794"}},{"Citation":"Brain. 2012 Mar;135(Pt 3):794-806","ArticleIdList":{"ArticleId":"22366795"}},{"Citation":"Lancet Neurol. 2012 Apr;11(4):323-30","ArticleIdList":{"ArticleId":"22406228"}},{"Citation":"Nat Rev Neurol. 2012 May;8(5):249-50","ArticleIdList":{"ArticleId":"22487746"}},{"Citation":"Neuroreport. 2012 Jun 20;23(9):556-9","ArticleIdList":{"ArticleId":"22564974"}},{"Citation":"Neurobiol Aging. 2012 Aug;33(8):1850.e1-11","ArticleIdList":{"ArticleId":"22459598"}},{"Citation":"J Alzheimers Dis. 2012;31(2):447-52","ArticleIdList":{"ArticleId":"22571983"}},{"Citation":"Neuropathology. 2012 Oct;32(5):505-14","ArticleIdList":{"ArticleId":"22181065"}},{"Citation":"Ann Med. 2012 Dec;44(8):817-28","ArticleIdList":{"ArticleId":"22420316"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):196-203","ArticleIdList":{"ArticleId":"20562461"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"23070466","DateCompleted":{"Year":"2013","Month":"09","Day":"04"},"DateRevised":{"Year":"2018","Month":"11","Day":"13"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1432-1459","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"260","Issue":"2","PubDate":{"Year":"2013","Month":"Feb"}},"Title":"Journal of neurology","ISOAbbreviation":"J Neurol"},"ArticleTitle":"Supporting evidence for using biomarkers in the diagnosis of MCI due to AD.","Pagination":{"MedlinePgn":"640-50"},"ELocationID":"10.1007\/s00415-012-6694-0","Abstract":{"AbstractText":"The aim of this study is to support the use of biomarkers in the diagnosis of mild cognitive impairment (MCI) due to Alzheimer's disease (AD) according to the revised NIA-AA diagnostic criteria. We compared clinical features and conversion to AD and other dementias among groups of MCI patients with different abnormal biomarker profiles. In this study, we enrolled 58 patients with MCI, and for each of them AD biomarkers (CSF Abeta42 and tau, temporoparietal hypometabolism on 18F-FDG PET, and hippocampal volume) were collected. Patients were divided into three groups: (i) no abnormal biomarker, (ii) AD biomarker pattern (including three subgroups of early = only abnormal Abeta42, intermediate = abnormal Abeta42 and FDG PET or tau, and late = abnormal Abeta42, FDG PET or tau, and HV), and (iii) any other biomarker combination. MCI patients with AD biomarker pattern had lower behavioural disturbances than patients with any other biomarker combination (p < 0.0005). This group also showed lower performance on verbal and non-verbal memory than the other two groups (p = 0.07 and p = 0.004, respectively). Within the three subgroups with AD biomarker patterns we observed a significant trend toward a higher rate of conversion to dementia (p for trend = 0.006). With regard to dementia conversion, 100 % of patients with an AD biomarker pattern developed AD, but none of the patients with no abnormal biomarker and 27 % of patients with any other biomarker combination (p = 0.002) did so. We also described some clinical cases representative for each of these three groups. The results of this study provide evidence in favour of the use of biomarkers for the diagnosis of MCI due to AD, in line with recently published research criteria."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Galluzzi","ForeName":"Samantha","Initials":"S","AffiliationInfo":{"Affiliation":"Laboratory of Epidemiology, Neuroimaging and Telemedicine (LENITEM), IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, via Pilastroni 4, 25125 Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Geroldi","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Amicucci","ForeName":"Giovanni","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bocchio-Chiavetto","ForeName":"Luisella","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonetti","ForeName":"Matteo","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonvicini","ForeName":"Cristian","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cotelli","ForeName":"Maria","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ghidoni","ForeName":"Roberta","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Paghera","ForeName":"Barbara","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB"},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"Translational Outpatient Memory Clinic Working Group"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2012","Month":"10","Day":"16"}},"MedlineJournalInfo":{"Country":"Germany","MedlineTA":"J Neurol","NlmUniqueID":"0423161","ISSNLinking":"0340-5354"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Apolipoproteins E"},{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"},{"RegistryNumber":"0","NameOfSubstance":"Peptide Fragments"},{"RegistryNumber":"0","NameOfSubstance":"amyloid beta-protein (1-42)"},{"RegistryNumber":"0","NameOfSubstance":"tau Proteins"},{"RegistryNumber":"0Z5B2CJX4D","NameOfSubstance":"Fluorodeoxyglucose F18"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":["complications","genetics"]},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Analysis of Variance"},{"DescriptorName":"Apolipoproteins E","QualifierName":"genetics"},{"DescriptorName":"Biomarkers","QualifierName":"metabolism"},{"DescriptorName":"Cognitive Dysfunction","QualifierName":["diagnosis","diagnostic imaging","etiology","genetics"]},{"DescriptorName":"Female"},{"DescriptorName":"Fluorodeoxyglucose F18"},{"DescriptorName":"Genetic Testing"},{"DescriptorName":"Humans"},{"DescriptorName":"Magnetic Resonance Imaging"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Peptide Fragments","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Positron-Emission Tomography"},{"DescriptorName":"tau Proteins","QualifierName":"cerebrospinal fluid"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2012","Month":"06","Day":"07"},{"@attributes":{"PubStatus":"accepted"},"Year":"2012","Month":"09","Day":"26"},{"@attributes":{"PubStatus":"revised"},"Year":"2012","Month":"09","Day":"24"},{"@attributes":{"PubStatus":"entrez"},"Year":"2012","Month":"10","Day":"17","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2012","Month":"10","Day":"17","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2013","Month":"9","Day":"5","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["23070466","10.1007\/s00415-012-6694-0"]},"ReferenceList":{"Reference":[{"Citation":"J Nucl Med. 2012 Apr;53(4):592-600","ArticleIdList":{"ArticleId":"22343502"}},{"Citation":"Brain. 2007 Mar;130(Pt 3):720-30","ArticleIdList":{"ArticleId":"17293358"}},{"Citation":"J Nucl Med. 2000 Nov;41(11):1920-8","ArticleIdList":{"ArticleId":"11079505"}},{"Citation":"Neuroimage. 2002 Sep;17 (1):302-16","ArticleIdList":{"ArticleId":"12482085"}},{"Citation":"Neurology. 1994 Dec;44(12):2308-14","ArticleIdList":{"ArticleId":"7991117"}},{"Citation":"Alzheimers Dement. 2008 Jan;4(1):38-48","ArticleIdList":{"ArticleId":"18631949"}},{"Citation":"Dement Geriatr Cogn Disord. 2011;31(1):37-44","ArticleIdList":{"ArticleId":"21135556"}},{"Citation":"Neurology. 2008 May 6;70(19 Pt 2):1827-35","ArticleIdList":{"ArticleId":"18458217"}},{"Citation":"Br J Clin Psychol. 1993 May;32 ( Pt 2):209-13","ArticleIdList":{"ArticleId":"8318938"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2011 Mar;82(3):240-6","ArticleIdList":{"ArticleId":"20802215"}},{"Citation":"Stroke. 2001 Jun;32(6):1318-22","ArticleIdList":{"ArticleId":"11387493"}},{"Citation":"Lancet Neurol. 2010 Jan;9(1):119-28","ArticleIdList":{"ArticleId":"20083042"}},{"Citation":"Alzheimers Dement. 2009 Jul;5(4):307-17","ArticleIdList":{"ArticleId":"19560101"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2011 May;82(5):476-86","ArticleIdList":{"ArticleId":"20971753"}},{"Citation":"Alzheimers Dement. 2011 May;7(3):263-9","ArticleIdList":{"ArticleId":"21514250"}},{"Citation":"Arch Neurol. 2012 May;69(5):614-22","ArticleIdList":{"ArticleId":"22782510"}},{"Citation":"J Neurol. 2010 Dec;257(12 ):2004-14","ArticleIdList":{"ArticleId":"20632026"}},{"Citation":"J Psychiatr Res. 1975 Nov;12(3):189-98","ArticleIdList":{"ArticleId":"1202204"}},{"Citation":"Arch Neurol. 2003 Dec;60(12):1696-702","ArticleIdList":{"ArticleId":"14676043"}},{"Citation":"Neurobiol Aging. 2001 Jul-Aug;22(4):683-9","ArticleIdList":{"ArticleId":"11445269"}},{"Citation":"Neurobiol Aging. 1997 Jul-Aug;18(4):351-7","ArticleIdList":{"ArticleId":"9330961"}},{"Citation":"J Biomed Biotechnol. 2011;2011:697036","ArticleIdList":{"ArticleId":"21876644"}},{"Citation":"Ann Neurol. 1995 Oct;38(4):649-52","ArticleIdList":{"ArticleId":"7574462"}},{"Citation":"Neurology. 2003 Feb 25;60(4):652-6","ArticleIdList":{"ArticleId":"12601108"}},{"Citation":"Arch Neurol. 2011 Mar;68(3):329-37","ArticleIdList":{"ArticleId":"21059987"}},{"Citation":"Clin Chem. 2001 Oct;47(10):1776-81","ArticleIdList":{"ArticleId":"11568086"}},{"Citation":"Neurology. 2002 Jul 23;59(2):198-205","ArticleIdList":{"ArticleId":"12136057"}},{"Citation":"Gerontologist. 1969 Autumn;9(3):179-86","ArticleIdList":{"ArticleId":"5349366"}},{"Citation":"Alzheimers Dement. 2011 May;7(3):270-9","ArticleIdList":{"ArticleId":"21514249"}},{"Citation":"Neurodegener Dis. 2011;8(6):413-20","ArticleIdList":{"ArticleId":"21709402"}},{"Citation":"Acta Neuropathol. 2011 Feb;121(2):171-81","ArticleIdList":{"ArticleId":"21170538"}},{"Citation":"Aging Clin Exp Res. 2009 Aug-Oct;21(4-5):266-76","ArticleIdList":{"ArticleId":"19959914"}},{"Citation":"Neurology. 2000 Aug 22;55(4):484-89","ArticleIdList":{"ArticleId":"10953178"}},{"Citation":"Neurology. 1996 Nov;47(5):1113-24","ArticleIdList":{"ArticleId":"8909416"}},{"Citation":"Arch Neurol. 2001 Nov;58(11):1803-9","ArticleIdList":{"ArticleId":"11708987"}},{"Citation":"Brain. 2009 May;132(Pt 5):1355-65","ArticleIdList":{"ArticleId":"19339253"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2008 Dec;79(12):1331-8","ArticleIdList":{"ArticleId":"18653550"}},{"Citation":"Neurology. 1984 Jul;34(7):939-44","ArticleIdList":{"ArticleId":"6610841"}},{"Citation":"Neurology. 2004 Mar 23;62(6):925-31","ArticleIdList":{"ArticleId":"15037694"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","IndexingMethod":"Automated","Owner":"NLM"},"PMID":"22889034","DateCompleted":{"Year":"2012","Month":"10","Day":"24"},"DateRevised":{"Year":"2018","Month":"12","Day":"01"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1532-5415","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"60","Issue":"8","PubDate":{"Year":"2012","Month":"Aug"}},"Title":"Journal of the American Geriatrics Society","ISOAbbreviation":"J Am Geriatr Soc"},"ArticleTitle":"Too many hidden patients. The exclusion of individuals with Alzheimer's disease from Alzheimer's disease pharmacological clinical trials.","Pagination":{"MedlinePgn":"1596-7"},"ELocationID":"10.1111\/j.1532-5415.2012.04068.x","AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Almici","ForeName":"Monica","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sartori","ForeName":"Sara","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Lombardi","ForeName":"Francesca","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonomini","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Geroldi","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Letter","Comment"]}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"J Am Geriatr Soc","NlmUniqueID":"7503062","ISSNLinking":"0002-8614"},"CitationSubset":"IM","CommentsCorrectionsList":{"CommentsCorrections":{"@attributes":{"RefType":"CommentOn"},"RefSource":"J Am Geriatr Soc. 2012 Mar;60(3):413-9","PMID":"22288835"}},"MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Biomedical Research"},{"DescriptorName":"Cognition Disorders"},{"DescriptorName":"Dementia"},{"DescriptorName":"Female"},{"DescriptorName":"Geriatrics"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Patient Selection"},{"DescriptorName":"Periodicals as Topic"},{"DescriptorName":"Research Subjects"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2012","Month":"8","Day":"15","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2012","Month":"8","Day":"15","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2012","Month":"10","Day":"25","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["22889034","10.1111\/j.1532-5415.2012.04068.x"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"22607813","DateCompleted":{"Year":"2012","Month":"10","Day":"04"},"DateRevised":{"Year":"2012","Month":"06","Day":"04"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1873-4111","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"72","Issue":"3","PubDate":{"Year":"2012","Month":"Jul"}},"Title":"Maturitas","ISOAbbreviation":"Maturitas"},"ArticleTitle":"Reminiscence therapy in dementia: a review.","Pagination":{"MedlinePgn":"203-5"},"ELocationID":"10.1016\/j.maturitas.2012.04.008","Abstract":{"AbstractText":"Dementia is a progressive disorder that impacts several cognitive functions. However, some aspects of cognitive function are preserved until late in the disease and can therefore be the targets of specific interventions. The rehabilitation of cognitive function disorders represents an expanding area of neurological rehabilitation, and it has recently attracted growing political, social and ethical attention. Here, we review the efficacy of reminiscence therapy to improve cognitive functions and\/or mood. Available studies suggest that reminiscence therapy can improve mood and some cognitive abilities. Further studies, based on larger patient samples including placebo and control conditions, should be conducted to identify the optimal conditions for such treatment protocols.","CopyrightInformation":"Copyright \u00a9 2012. Published by Elsevier Ireland Ltd."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Cotelli","ForeName":"Maria","Initials":"M","AffiliationInfo":{"Affiliation":"IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. mcotelli@fatebenefratelli.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Manenti","ForeName":"Rosa","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Review"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2012","Month":"05","Day":"16"}},"MedlineJournalInfo":{"Country":"Ireland","MedlineTA":"Maturitas","NlmUniqueID":"7807333","ISSNLinking":"0378-5122"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Affect"},{"DescriptorName":"Cognition"},{"DescriptorName":"Cognition Disorders","QualifierName":"rehabilitation"},{"DescriptorName":"Dementia","QualifierName":["complications","therapy"]},{"DescriptorName":"Humans"},{"DescriptorName":"Memory"},{"DescriptorName":"Psychotherapy"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2012","Month":"04","Day":"16"},{"@attributes":{"PubStatus":"accepted"},"Year":"2012","Month":"04","Day":"21"},{"@attributes":{"PubStatus":"entrez"},"Year":"2012","Month":"5","Day":"22","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2012","Month":"5","Day":"23","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2012","Month":"10","Day":"5","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["22607813","S0378-5122(12)00154-5","10.1016\/j.maturitas.2012.04.008"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"22330829","DateCompleted":{"Year":"2012","Month":"08","Day":"09"},"DateRevised":{"Year":"2017","Month":"09","Day":"22"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1875-8908","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"29","Issue":"3","PubDate":{"Year":"2012"}},"Title":"Journal of Alzheimer's disease : JAD","ISOAbbreviation":"J Alzheimers Dis"},"ArticleTitle":"Possible influence of a non-synonymous polymorphism located in the NGF precursor on susceptibility to late-onset Alzheimer's disease and mild cognitive impairment.","Pagination":{"MedlinePgn":"699-705"},"ELocationID":"10.3233\/JAD-2012-112006","Abstract":{"AbstractText":"The complex network of neurotrophic factors is supposed to play a role in neurodegeneration, but the effect of variations in their coding genes on susceptibility to sporadic Alzheimer's disease is not established. The mature form of nerve growth factor (NGF) derives from a precursor, proNGF, which was recently discovered to exert crucial functions in brain. We designed a case-control association study to test the hypothesis as to whether polymorphisms located in the proNGF genomic region influence the liability to Alzheimer's disease and its prodromal form, mild cognitive impairment. Three independent case-control samples, with individuals aged >60 years, were collected in Italian Alzheimer Units. One polymorphism located in the proNGF region, rs6330, demonstrated a minor allele frequency >5% and was used in the association study. The minor allele of rs6330 was more frequent in patients from the three sample series as compared to respective normal controls. Multivariate logistic regression showed a significant association under the dominant model in one cohort (OR 1.83, 95% CI 1.00-3.54) and in the pooled case-control sample (OR 1.47, 95% CI 1.03-2.08). These findings further suggest that proNGF may play a role in Alzheimer-type neurodegeneration and that genetic variations in the NGF locus may influence the occurrence of sporadic, late-onset Alzheimer's disease."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Di Maria","ForeName":"Emilio","Initials":"E","AffiliationInfo":{"Affiliation":"Department of Health Sciences, University of Genova, Genova, Italy. emilio.dimaria@unige.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Giorgio","ForeName":"Elisa","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Uliana","ForeName":"Vera","Initials":"V"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonvicini","ForeName":"Cristian","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Faravelli","ForeName":"Francesca","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cammarata","ForeName":"Sergio","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Novello","ForeName":"Maria Cristina","Initials":"MC"},{"@attributes":{"ValidYN":"Y"},"LastName":"Galimberti","ForeName":"Daniela","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Scarpini","ForeName":"Elio","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gennarelli","ForeName":"Massimo","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Tabaton","ForeName":"Massimo","Initials":"M"}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":{"GrantID":"GTB07001","Agency":"Telethon","Country":"Italy"}},"PublicationTypeList":{"PublicationType":["Journal Article","Multicenter Study","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"J Alzheimers Dis","NlmUniqueID":"9814863","ISSNLinking":"1387-2877"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Protein Precursors"},{"RegistryNumber":"9061-61-4","NameOfSubstance":"Nerve Growth Factor"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":"genetics"},{"DescriptorName":"Case-Control Studies"},{"DescriptorName":"Cognitive Dysfunction","QualifierName":"genetics"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"Europe"},{"DescriptorName":"Female"},{"DescriptorName":"Gene Frequency"},{"DescriptorName":"Genetic Predisposition to Disease"},{"DescriptorName":"Genotype"},{"DescriptorName":"Humans"},{"DescriptorName":"Logistic Models"},{"DescriptorName":"Male"},{"DescriptorName":"Nerve Growth Factor","QualifierName":"genetics"},{"DescriptorName":"Polymorphism, Genetic","QualifierName":"genetics"},{"DescriptorName":"Protein Precursors","QualifierName":"genetics"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2012","Month":"2","Day":"15","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2012","Month":"2","Day":"15","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2012","Month":"8","Day":"10","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["22330829","E2M2838105552640","10.3233\/JAD-2012-112006"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"21399481","DateCompleted":{"Year":"2012","Month":"08","Day":"13"},"DateRevised":{"Year":"2013","Month":"08","Day":"16"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1546-4156","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"25","Issue":"4","PubDate":{"MedlineDate":"2011 Oct-Dec"}},"Title":"Alzheimer disease and associated disorders","ISOAbbreviation":"Alzheimer Dis Assoc Disord"},"ArticleTitle":"Prevalence and demographic features of early-onset neurodegenerative dementia in Brescia County, Italy.","Pagination":{"MedlinePgn":"341-4"},"ELocationID":"10.1097\/WAD.0b013e3182147f80","Abstract":{"AbstractText":"A few epidemiologic studies are available on the prevalence of early-onset Alzheimer disease (AD) and frontotemporal lobar degeneration (FTLD). The aim of this study was to establish in an Italian population, namely in Brescia County, the prevalence of early-onset neurodegenerative dementia, and how it is shared between AD and FTLD. A network among the participating centers has been established for 10 years. A standardized form was sent to be filled in for each patient. The census day was chosen as December 1, 2009. The prevalence of disease was calculated stratifying patients according to sex and diagnosis. On the census day, 175 patients in the whole population aged 45--65 years were enrolled into the study. The resulting overall prevalence of early-onset neurodegenerative dementia was found of 55.1 per 100,000 inhabitants (95%confidence interval, 47.0--63.4). A comparable prevalence between AD and FTLD was reported (25.5 and 29.6 per 100,000 inhabitants, respectively), and no differences in sex distribution were found both in AD and FTLD. The improvement of knowledge on early-onset neurodegenerative dementias allows us to reconsider its epidemiology and to rethink its impact on public polices. This would be crucial for defining the urgency of treatment approaches."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Borroni","ForeName":"Barbara","Initials":"B","AffiliationInfo":{"Affiliation":"Department of Neurology, University of Brescia, Italy. bborroni@inwind.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Alberici","ForeName":"Antonella","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Grassi","ForeName":"Mario","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Rozzini","ForeName":"Luca","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Turla","ForeName":"Marinella","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bianchetti","ForeName":"Angelo","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gilberti","ForeName":"Nicola","Initials":"N"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonvicini","ForeName":"Cristian","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Volta","ForeName":"Giorgio Dalla","Initials":"GD"},{"@attributes":{"ValidYN":"Y"},"LastName":"Rozzini","ForeName":"Renzo","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Padovani","ForeName":"Alessandro","Initials":"A"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Comparative Study","Journal Article","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Alzheimer Dis Assoc Disord","NlmUniqueID":"8704771","ISSNLinking":"0893-0341"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":["diagnosis","epidemiology","psychology"]},{"DescriptorName":"Female"},{"DescriptorName":"Frontotemporal Lobar Degeneration","QualifierName":["diagnosis","epidemiology","psychology"]},{"DescriptorName":"Humans"},{"DescriptorName":"Italy","QualifierName":"epidemiology"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Prevalence"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2011","Month":"3","Day":"15","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2011","Month":"3","Day":"15","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2012","Month":"8","Day":"14","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["21399481","10.1097\/WAD.0b013e3182147f80"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"20574108","DateCompleted":{"Year":"2011","Month":"08","Day":"19"},"DateRevised":{"Year":"2017","Month":"11","Day":"14"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1468-330X","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"82","Issue":"7","PubDate":{"Year":"2011","Month":"Jul"}},"Title":"Journal of neurology, neurosurgery, and psychiatry","ISOAbbreviation":"J Neurol Neurosurg Psychiatry"},"ArticleTitle":"Improved language performance in Alzheimer disease following brain stimulation.","Pagination":{"MedlinePgn":"794-7"},"ELocationID":"10.1136\/jnnp.2009.197848","Abstract":{"AbstractText":["Repetitive transcranial magnetic stimulation (rTMS) has been proposed as a possible treatment for the cognitive deficits associated with Alzheimer disease (AD). The aim of this study was to assess the long-term effects, on cognitive performance, of rTMS applied to the left dorsolateral prefrontal cortex (DLPFC) in AD patients.","Ten AD patients were randomly assigned to one of two study groups. Multiple-baseline design was used.The first group underwent a 4-week real rTMS stimulation protocol, while the second underwent a 2-week placebo treatment, followed by 2 weeks of real rTMS stimulation. Each session consisted of the application of rhythmic high-frequency rTMS over the DLPFC for 25 min. Sessions occurred once daily, 5 days\/week. The main analysed outcome was the change in cognitive test performance at 2 and 4 weeks after rTMS treatment initiation, with a follow-up performed 8 weeks after the end of rTMS, in comparison with baseline performance.","A significant difference was found between groups over sessions in terms of the percentage of correct responses of auditory sentence comprehension. Only real treatment induced an improvement in performance with respect to baseline or placebo. Moreover, both groups showed a lasting effect on the improved performance 8 weeks after the end of treatment.","The findings provide initial evidence for the persistent beneficial effects of rTMS on sentence comprehension in AD patients. Rhythmic rTMS, in conjunction with other therapeutic interventions, may represent a novel approach to the treatment of language dysfunction in AD patients."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Cotelli","ForeName":"Maria","Initials":"M","AffiliationInfo":{"Affiliation":"IRCCS Centro San Giovanni di Dio Fatebenefratelli, Via Pilastroni, 4, Brescia 25125, Italy. mcotelli@fatebenefratelli.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Calabria","ForeName":"Marco","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Manenti","ForeName":"Rosa","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Rosini","ForeName":"Sandra","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cappa","ForeName":"Stefano F","Initials":"SF"},{"@attributes":{"ValidYN":"Y"},"LastName":"Miniussi","ForeName":"Carlo","Initials":"C"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Randomized Controlled Trial","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2010","Month":"06","Day":"23"}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"J Neurol Neurosurg Psychiatry","NlmUniqueID":"2985191R","ISSNLinking":"0022-3050"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Activities of Daily Living"},{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":["psychology","therapy"]},{"DescriptorName":"Aphasia","QualifierName":"psychology"},{"DescriptorName":"Behavior"},{"DescriptorName":"Cognition","QualifierName":"physiology"},{"DescriptorName":"Female"},{"DescriptorName":"Functional Laterality","QualifierName":"physiology"},{"DescriptorName":"Humans"},{"DescriptorName":"Language"},{"DescriptorName":"Male"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Prefrontal Cortex","QualifierName":"physiopathology"},{"DescriptorName":"Psychomotor Performance","QualifierName":"physiology"},{"DescriptorName":"Socioeconomic Factors"},{"DescriptorName":"Transcranial Magnetic Stimulation"},{"DescriptorName":"Treatment Outcome"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2010","Month":"6","Day":"25","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2010","Month":"6","Day":"25","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2011","Month":"8","Day":"20","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["20574108","jnnp.2009.197848","10.1136\/jnnp.2009.197848"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"20061630","DateCompleted":{"Year":"2010","Month":"08","Day":"10"},"DateRevised":{"Year":"2010","Month":"10","Day":"22"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1875-8908","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"19","Issue":"1","PubDate":{"Year":"2010"}},"Title":"Journal of Alzheimer's disease : JAD","ISOAbbreviation":"J Alzheimers Dis"},"ArticleTitle":"Is frontotemporal lobar degeneration a rare disorder? Evidence from a preliminary study in Brescia county, Italy.","Pagination":{"MedlinePgn":"111-6"},"ELocationID":"10.3233\/JAD-2010-1208","Abstract":{"AbstractText":"Frontotemporal Lobar Degeneration (FTLD) has always been considered a rare disorder, but only a few epidemiologic studies are available. The aim of the present work was to ascertain all FTLD patients in a Northern Italy area from January 2001 to December 2008, and to estimate the disease prevalence. On the census day, 213 FTD patients were still alive, resulting in an overall prevalence of 17.6 per 100,000 inhabitants. The prevalence of FTLD in patients aged 45-65 years was 22 per 100,000 inhabitants (95% CI=17-27). The prevalence of FTLD was the highest in patients aged 66-75 (78 per 100,000 inhabitants, 95% CI=56-100), and it was still high over 75 years (54 per 100,000 inhabitants, 95% CI=36-69). FTLD is a more common form of dementia than previously recognized. Our results claimed that FTLD is not only an early-onset disorder, but it is frequent in advanced age as well."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Borroni","ForeName":"Barbara","Initials":"B","AffiliationInfo":{"Affiliation":"Department of Neurology, University of Brescia, Brescia, Italy. bborroni@inwind.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Alberici","ForeName":"Antonella","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Grassi","ForeName":"Mario","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Turla","ForeName":"Marinella","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bianchetti","ForeName":"Angelo","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Dalla Volta","ForeName":"Giorgio","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Rozzini","ForeName":"Renzo","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gilberti","ForeName":"Nicola","Initials":"N"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bellelli","ForeName":"Giuseppe","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Padovani","ForeName":"Alessandro","Initials":"A"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Comparative Study","Journal Article","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"J Alzheimers Dis","NlmUniqueID":"9814863","ISSNLinking":"1387-2877"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Female"},{"DescriptorName":"Frontotemporal Lobar Degeneration","QualifierName":["diagnosis","epidemiology","genetics"]},{"DescriptorName":"Humans"},{"DescriptorName":"Italy","QualifierName":"epidemiology"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Rare Diseases","QualifierName":["diagnosis","epidemiology","genetics"]}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2010","Month":"1","Day":"12","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2010","Month":"1","Day":"12","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2010","Month":"8","Day":"11","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["20061630","A115853R07N58754","10.3233\/JAD-2010-1208"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"20009237","DateCompleted":{"Year":"2010","Month":"09","Day":"16"},"DateRevised":{"Year":"2019","Month":"12","Day":"10"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1875-8908","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"18","Issue":"4","PubDate":{"Year":"2009"}},"Title":"Journal of Alzheimer's disease : JAD","ISOAbbreviation":"J Alzheimers Dis"},"ArticleTitle":"Genetic variation in the G720\/G30 gene locus (DAOA) influences the occurrence of psychotic symptoms in patients with Alzheimer's disease.","Pagination":{"MedlinePgn":"953-60"},"ELocationID":"10.3233\/JAD-2009-1194","Abstract":{"AbstractText":"The occurrence of neuropsychiatric symptoms in patients with Alzheimer's disease hampers the clinical management and exacerbates the burden for caregivers. To what extent psychotic symptoms are genetically determined and which are the genes involved has to be established. We tested the hypothesis that the occurrence of delusions and hallucinations in AD is associated with variations in the G72\/DAOA gene, which is supposed to play a key role in the glutamate pathway regulated through the NMDA receptors. A panel of single nucleotide polymorphisms were genotyped in a cohort of 185 Alzheimer's disease patients. The analysis demonstrated a nominally significant association (p< 0.05) with one single nucleotide polymorphism (rs2153674). In addition, multivariate regression showed that the rs2153674 genotype accounts for up to 15% of the variance in delusions severity, as assessed by using the Neuropsychiatric Inventory. If the results from the present study will be replicated, the glutamate hypothesis could be invoked to explain the occurrence of psychosis in neurodegenerative disorders."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Di Maria","ForeName":"Emilio","Initials":"E","AffiliationInfo":{"Affiliation":"Department of Neuroscience, Ophthalmology and Genetics, University of Genova, Genova, Italy. emilio.dimaria@unige.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonvicini","ForeName":"Cristian","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonomini","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Alberici","ForeName":"Antonella","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gennarelli","ForeName":"Massimo","Initials":"M"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"J Alzheimers Dis","NlmUniqueID":"9814863","ISSNLinking":"1387-2877"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Carrier Proteins"},{"RegistryNumber":"0","NameOfSubstance":"DAOA protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Genetic Markers"},{"RegistryNumber":"0","NameOfSubstance":"Intracellular Signaling Peptides and Proteins"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":["complications","genetics"]},{"DescriptorName":"Carrier Proteins","QualifierName":"genetics"},{"DescriptorName":"Chromosome Mapping"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"Delusions","QualifierName":["genetics","psychology"]},{"DescriptorName":"Female"},{"DescriptorName":"Genetic Markers"},{"DescriptorName":"Genetic Predisposition to Disease","QualifierName":"genetics"},{"DescriptorName":"Genotype"},{"DescriptorName":"Hallucinations","QualifierName":["genetics","psychology"]},{"DescriptorName":"Humans"},{"DescriptorName":"Intracellular Signaling Peptides and Proteins"},{"DescriptorName":"Male"},{"DescriptorName":"Multivariate Analysis"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Polymorphism, Single Nucleotide"},{"DescriptorName":"Psychotic Disorders","QualifierName":["etiology","genetics"]}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2009","Month":"12","Day":"17","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2009","Month":"12","Day":"17","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2010","Month":"9","Day":"18","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["20009237","030T8786H273421Q","10.3233\/JAD-2009-1194"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"19560101","DateCompleted":{"Year":"2009","Month":"09","Day":"22"},"DateRevised":{"Year":"2016","Month":"11","Day":"25"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1552-5279","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"5","Issue":"4","PubDate":{"Year":"2009","Month":"Jul"}},"Title":"Alzheimer's & dementia : the journal of the Alzheimer's Association","ISOAbbreviation":"Alzheimers Dement"},"ArticleTitle":"Markers of Alzheimer's disease in a population attending a memory clinic.","Pagination":{"MedlinePgn":"307-17"},"ELocationID":"10.1016\/j.jalz.2009.04.1235","Abstract":{"AbstractText":["New marker-based criteria for the diagnosis of Alzheimer's disease (AD) were recently proposed. We describe their operational translation in 144 consecutive patients referred to our Memory Clinic.","Visual ratings of hippocampal atrophy and of cortical glucose hypometabolism in magnetic resonance imaging and positron emission tomography, and concentrations of total tau and Abeta1-42 in cerebrospinal fluid were assessed in 12 patients with subjective memory complaints (SMCs) (Mini-Mental State Examination [MMSE] score, 28.0 +\/- 1.1 [mean +\/- SD]), 37 with mild cognitive impairment (MCI) (MMSE, 25.1 +\/- 3.6), 55 with AD (MMSE, 21.1 +\/- 3.5), and 40 with non-AD dementia (MMSE, 21.6 +\/- 5.5).","The sensitivity for AD of each individual biomarker was higher (65% to 87%) than for MCI (18% to 50%). Each biomarker's specificity for SMC and non-AD dementias was good to moderate (83% and 53%). Positivity for at least one marker increased the probability 38 times of belonging to the AD group (P < 0.0001).","The new diagnostic criteria can be operationalized in clinical routines, but longitudinal studies of MCI patients will need to assess the criteria's prognostic value."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB","AffiliationInfo":{"Affiliation":"Laboratory of Epidemiology Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio FBF, Brescia, Italy. gfrisoni@fatebenefratelli.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Prestia","ForeName":"Annapaola","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Galluzzi","ForeName":"Samantha","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Romano","ForeName":"Melissa","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cotelli","ForeName":"Maria","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gennarelli","ForeName":"Massimo","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Binetti","ForeName":"Giuliano","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bocchio","ForeName":"Luisella","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Paghera","ForeName":"Barbara","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Amicucci","ForeName":"Giovanni","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonetti","ForeName":"Matteo","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Benussi","ForeName":"Luisa","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ghidoni","ForeName":"Roberta","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Geroldi","ForeName":"Cristina","Initials":"C"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Alzheimers Dement","NlmUniqueID":"101231978","ISSNLinking":"1552-5260"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"},{"RegistryNumber":"0","NameOfSubstance":"Peptide Fragments"},{"RegistryNumber":"0","NameOfSubstance":"amyloid beta-protein (1-42)"},{"RegistryNumber":"0","NameOfSubstance":"tau Proteins"},{"RegistryNumber":"IY9XDZ35W2","NameOfSubstance":"Glucose"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":["cerebrospinal fluid","diagnostic imaging","pathology"]},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":["analysis","cerebrospinal fluid"]},{"DescriptorName":"Atrophy","QualifierName":["cerebrospinal fluid","diagnostic imaging","pathology"]},{"DescriptorName":"Biomarkers","QualifierName":["analysis","cerebrospinal fluid"]},{"DescriptorName":"Cerebral Cortex","QualifierName":["diagnostic imaging","metabolism","physiopathology"]},{"DescriptorName":"Cognition Disorders","QualifierName":["cerebrospinal fluid","diagnostic imaging","pathology"]},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"Female"},{"DescriptorName":"Glucose","QualifierName":"metabolism"},{"DescriptorName":"Hippocampus","QualifierName":["diagnostic imaging","metabolism","pathology"]},{"DescriptorName":"Humans"},{"DescriptorName":"Magnetic Resonance Imaging"},{"DescriptorName":"Male"},{"DescriptorName":"Memory Disorders","QualifierName":["cerebrospinal fluid","diagnostic imaging","pathology"]},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Peptide Fragments","QualifierName":["analysis","cerebrospinal fluid"]},{"DescriptorName":"Positron-Emission Tomography"},{"DescriptorName":"Predictive Value of Tests"},{"DescriptorName":"Sensitivity and Specificity"},{"DescriptorName":"tau Proteins","QualifierName":["analysis","cerebrospinal fluid"]}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2008","Month":"11","Day":"24"},{"@attributes":{"PubStatus":"revised"},"Year":"2009","Month":"03","Day":"27"},{"@attributes":{"PubStatus":"accepted"},"Year":"2009","Month":"04","Day":"20"},{"@attributes":{"PubStatus":"entrez"},"Year":"2009","Month":"6","Day":"30","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2009","Month":"6","Day":"30","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2009","Month":"9","Day":"23","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["19560101","S1552-5260(09)00102-2","10.1016\/j.jalz.2009.04.1235"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"19448381","DateCompleted":{"Year":"2009","Month":"07","Day":"13"},"DateRevised":{"Year":"2019","Month":"11","Day":"11"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1594-0667","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"21","Issue":"2","PubDate":{"Year":"2009","Month":"Apr"}},"Title":"Aging clinical and experimental research","ISOAbbreviation":"Aging Clin Exp Res"},"ArticleTitle":"A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease.","Pagination":{"MedlinePgn":"102-10"},"Abstract":{"AbstractText":["Epidemiological studies have examined the association between the use of non-steroidal anti-inflammatory drugs (NSAIDs) and the risk of Alzheimer's disease (AD). Recently, a variety of experimental studies indicates that a subset of NSAIDs, such as ibuprofen or flurbiprofen, also have Abeta-lowering properties in both AD transgenic mice and cell cultures of peripheral, glial and neuronal origin. In this trial, we evaluated whether the non-selective NSAID ibuprofen slows disease progression in patients with mild to moderate AD.","This was a 12-month multicenter, randomized, double-blind, placebo-controlled, parallel group trial. Participants with mild-moderate AD (Mini-Mental State Examination score >15, <26; Clinical Dementia Rating= 0.5-1), 65 years or older, with reliable caregivers, were recruited between April 2003 and September 2004. Seven AD Outpatient Treatment Centers screened 530 patients, 132 of whom were enrolled. Intervention consisted of 400 mg ibuprofen twice a day or placebo, together with 20 mg once a day of esomeprazol, or placebo. The primary measure was any one-year change in the Alzheimer Disease Assessment Scale- Cognitive (ADAS-Cog) subscale score. Secondary measures included changes in MMSE, CDR, Basic and Instrumental Activities of Daily Living scales, and Neuropsychiatric Inventory (NPI).","Fifty-one patients (77%) in the ibuprofen vs 46 (70%) in the placebo group completed the protocol (p>0.20). In intention-to- treat analysis, ADAS-Cog score worsening was similar in the two groups (p=0.951, treatment difference= 0.1, CI -2.7; 2.9). No differences were found for any secondary outcomes. In a subsample of genotyped patients, ApoE epsilon4 carriers treated with ibuprofen (n=27) were the only group without significant cognitive decline.","Ibuprofen, if used for relatively short periods of time and although well tolerated thanks to gastroprotection, does not seem to be effective in tertiary prevention of mild-moderate AD. Our results suggest the need to examine whether differences in the response to NSAIDs exist, based on ApoE epsilon4 carrier status."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Pasqualetti","ForeName":"Patrizio","Initials":"P","AffiliationInfo":{"Affiliation":"Medical Statistics & Information Technology, Fatebenefratelli Association for Research, Isola Tiberina, Rome, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonomini","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Dal Forno","ForeName":"Gloria","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Paulon","ForeName":"Luca","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sinforiani","ForeName":"Elena","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Marra","ForeName":"Camillo","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Rossini","ForeName":"Paolo Maria","Initials":"PM"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Multicenter Study","Randomized Controlled Trial","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"Germany","MedlineTA":"Aging Clin Exp Res","NlmUniqueID":"101132995","ISSNLinking":"1594-0667"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Anti-Inflammatory Agents, Non-Steroidal"},{"RegistryNumber":"0","NameOfSubstance":"Apolipoprotein E4"},{"RegistryNumber":"WK2XYI10QM","NameOfSubstance":"Ibuprofen"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":["drug therapy","genetics"]},{"DescriptorName":"Anti-Inflammatory Agents, Non-Steroidal","QualifierName":"administration & dosage"},{"DescriptorName":"Apolipoprotein E4","QualifierName":"genetics"},{"DescriptorName":"Cognition Disorders","QualifierName":["drug therapy","genetics"]},{"DescriptorName":"Disease Progression"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Ibuprofen","QualifierName":"administration & dosage"},{"DescriptorName":"Male"},{"DescriptorName":"Severity of Illness Index"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2009","Month":"5","Day":"19","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2009","Month":"5","Day":"19","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2009","Month":"7","Day":"14","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["19448381","6262","10.1007\/BF03325217"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"19339096","DateCompleted":{"Year":"2009","Month":"08","Day":"11"},"DateRevised":{"Year":"2019","Month":"12","Day":"10"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1090-2147","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"70","Issue":"3","PubDate":{"Year":"2009","Month":"Aug"}},"Title":"Brain and cognition","ISOAbbreviation":"Brain Cogn"},"ArticleTitle":"Empathy and emotion recognition in semantic dementia: a case report.","Pagination":{"MedlinePgn":"247-52"},"ELocationID":"10.1016\/j.bandc.2009.02.009","Abstract":{"AbstractText":"Recent studies have demonstrated that patients suffering from frontotemporal lobar degeneration (FTLD) show impairments in empathy and emotional processing. In this study, we examined two different aspects of these abilities in a patient with semantic dementia (SD), a variant of FTLD. The first aspect was the assessment of the cognitive and emotional components of empathy through the Interpersonal Reactivity Index. The second was the naming and comprehension of emotions using the Ekman 60 Faces Test. The patient's emotion word knowledge was spared and the emotional aspects of empathy preserved. Conversely, the patient performed below average for all of the basic emotions when an emotion word had to be matched with a picture. When picture-to-picture matching was tested, however, the patient was able to recognize happiness. This case is a good example of a dissociation of covert and overt emotional functioning in SD. Results are discussed in terms of the impaired empathic behavior and emotional functioning in FTLD."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Calabria","ForeName":"Marco","Initials":"M","AffiliationInfo":{"Affiliation":"IRCCS San Giovanni di Dio - Fatebenefratelli, Via Piastroni, 4 25125 Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Cotelli","ForeName":"Maria","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Adenzato","ForeName":"Mauro","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Miniussi","ForeName":"Carlo","Initials":"C"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Case Reports","Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2009","Month":"03","Day":"31"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Brain Cogn","NlmUniqueID":"8218014","ISSNLinking":"0278-2626"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Comprehension"},{"DescriptorName":"Dementia","QualifierName":["pathology","psychology"]},{"DescriptorName":"Emotions"},{"DescriptorName":"Empathy"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Magnetic Resonance Imaging"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Pattern Recognition, Visual"},{"DescriptorName":"Photic Stimulation","QualifierName":"methods"},{"DescriptorName":"Recognition, Psychology"},{"DescriptorName":"Social Perception"},{"DescriptorName":"Temporal Lobe","QualifierName":"pathology"},{"DescriptorName":"Verbal Learning"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2008","Month":"09","Day":"05"},{"@attributes":{"PubStatus":"revised"},"Year":"2009","Month":"02","Day":"10"},{"@attributes":{"PubStatus":"accepted"},"Year":"2009","Month":"02","Day":"19"},{"@attributes":{"PubStatus":"entrez"},"Year":"2009","Month":"4","Day":"3","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2009","Month":"4","Day":"3","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2009","Month":"8","Day":"12","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["19339096","S0278-2626(09)00038-4","10.1016\/j.bandc.2009.02.009"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"19324592","DateCompleted":{"Year":"2009","Month":"04","Day":"30"},"DateRevised":{"Year":"2013","Month":"11","Day":"21"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1872-8952","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"120","Issue":"4","PubDate":{"Year":"2009","Month":"Apr"}},"Title":"Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology","ISOAbbreviation":"Clin Neurophysiol"},"ArticleTitle":"Ibuprofen treatment modifies cortical sources of EEG rhythms in mild Alzheimer's disease.","Pagination":{"MedlinePgn":"709-18"},"ELocationID":"10.1016\/j.clinph.2009.02.005","Abstract":{"AbstractText":["Non-steroidal anti-inflammatory drugs such as ibuprofen have a protective role on risk of Alzheimer's disease (AD). Here we evaluated the hypothesis that long-term ibuprofen treatment affects cortical sources of resting electroencephalographic (EEG) rhythms in mild AD patients.","Twenty-three AD patients (13 treated AD IBUPROFEN; 10 untreated AD PLACEBO) were enrolled. Resting EEG data were recorded before and 1 year after the ibuprofen\/placebo treatment. EEG rhythms were delta (2-4 Hz), theta (4-8 Hz), alpha 1 (8-10.5 Hz), alpha 2 (10.5-13 Hz), beta 1 (13-20 Hz), and beta 2 (20-30 Hz). LORETA was used for EEG source analysis.","In the AD PLACEBO group, amplitude of delta sources was globally greater at follow-up than baseline. Instead, amplitude of delta sources remained stable or decreased in the majority of the AD IBUPROFEN patients. Clinical (CDR) but not global cognitive status (MMSE) reflected EEG results.","These results suggest that in mild AD patients, a long-term ibuprofen treatment slightly slows down the progressive increment of delta rhythms as a sign of contrast against the neurodegenerative processes.","They motivate future investigations with larger population and extended neuropsychological testing, to study the relationships among ibuprofen treatment, delta cortical sources, and higher order functions."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Babiloni","ForeName":"Claudio","Initials":"C","AffiliationInfo":{"Affiliation":"Department of Biomedical Sciences, University of Foggia, Viale Pinto 7, Foggia I-71100, Italy. c.babiloni@unifg.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB"},{"@attributes":{"ValidYN":"Y"},"LastName":"Del Percio","ForeName":"Claudio","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonomini","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cassetta","ForeName":"Emanuele","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Pasqualetti","ForeName":"Patrizio","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Miniussi","ForeName":"Carlo","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"De Rosas","ForeName":"Mario","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Valenzano","ForeName":"Anna","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cibelli","ForeName":"Giuseppe","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Eusebi","ForeName":"Fabrizio","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Rossini","ForeName":"Paolo M","Initials":"PM"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Controlled Clinical Trial","Journal Article","Multicenter Study","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2009","Month":"03","Day":"25"}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"Clin Neurophysiol","NlmUniqueID":"100883319","ISSNLinking":"1388-2457"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Anti-Inflammatory Agents, Non-Steroidal"},{"RegistryNumber":"WK2XYI10QM","NameOfSubstance":"Ibuprofen"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":["drug therapy","pathology","physiopathology","prevention & control"]},{"DescriptorName":"Analysis of Variance"},{"DescriptorName":"Anti-Inflammatory Agents, Non-Steroidal","QualifierName":["pharmacology","therapeutic use"]},{"DescriptorName":"Brain Mapping"},{"DescriptorName":"Case-Control Studies"},{"DescriptorName":"Cerebral Cortex","QualifierName":"drug effects"},{"DescriptorName":"Electroencephalography","QualifierName":"drug effects"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Ibuprofen","QualifierName":["pharmacology","therapeutic use"]},{"DescriptorName":"Imaging, Three-Dimensional"},{"DescriptorName":"Longitudinal Studies"},{"DescriptorName":"Magnetic Resonance Imaging","QualifierName":"methods"},{"DescriptorName":"Male"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Reference Values"},{"DescriptorName":"Spectrum Analysis"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2008","Month":"07","Day":"22"},{"@attributes":{"PubStatus":"revised"},"Year":"2009","Month":"01","Day":"12"},{"@attributes":{"PubStatus":"accepted"},"Year":"2009","Month":"02","Day":"03"},{"@attributes":{"PubStatus":"entrez"},"Year":"2009","Month":"3","Day":"28","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2009","Month":"3","Day":"28","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2009","Month":"5","Day":"1","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["19324592","S1388-2457(09)00043-1","10.1016\/j.clinph.2009.02.005"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"19285772","DateCompleted":{"Year":"2009","Month":"06","Day":"18"},"DateRevised":{"Year":"2009","Month":"04","Day":"27"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1090-2147","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"70","Issue":"2","PubDate":{"Year":"2009","Month":"Jul"}},"Title":"Brain and cognition","ISOAbbreviation":"Brain Cogn"},"ArticleTitle":"Face-name repetition priming in semantic dementia: a case report.","Pagination":{"MedlinePgn":"231-7"},"ELocationID":"10.1016\/j.bandc.2009.02.005","Abstract":{"AbstractText":"Repetition priming (RP) has been employed as a measure of implicit processing in patients suffering from a breakdown of semantic memory, as in the case of semantic dementia (SD), a subtype of frontotemporal lobar degeneration (FTLD). Here, we investigated face-name representation in a case of SD using a paradigm of within- and cross-domain repetition priming. Compared to ten healthy participants, SD patient did not show any facilitation when a famous name was primed by its own face (cross-domain) or when the prime was the same proper name (within-domain). Results are discussed within the hypothesis of a degradation of face and name representation, one of the most consistent accounts explaining semantic deficits in SD."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Calabria","ForeName":"Marco","Initials":"M","AffiliationInfo":{"Affiliation":"IRCCS San Giovanni di Dio Fatebenefratelli, Via Piastroni, 4 25125 Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Miniussi","ForeName":"Carlo","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bisiacchi","ForeName":"Patrizia S","Initials":"PS"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cotelli","ForeName":"Maria","Initials":"M"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Case Reports","Journal Article"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2009","Month":"03","Day":"13"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Brain Cogn","NlmUniqueID":"8218014","ISSNLinking":"0278-2626"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Brain","QualifierName":"pathology"},{"DescriptorName":"Dementia","QualifierName":"psychology"},{"DescriptorName":"Face"},{"DescriptorName":"Famous Persons"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Learning"},{"DescriptorName":"Magnetic Resonance Imaging"},{"DescriptorName":"Memory"},{"DescriptorName":"Names"},{"DescriptorName":"Pattern Recognition, Visual"},{"DescriptorName":"Reaction Time"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2008","Month":"10","Day":"23"},{"@attributes":{"PubStatus":"revised"},"Year":"2009","Month":"01","Day":"26"},{"@attributes":{"PubStatus":"accepted"},"Year":"2009","Month":"02","Day":"05"},{"@attributes":{"PubStatus":"entrez"},"Year":"2009","Month":"3","Day":"17","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2009","Month":"3","Day":"17","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2009","Month":"6","Day":"19","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["19285772","S0278-2626(09)00029-3","10.1016\/j.bandc.2009.02.005"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"19101631","DateCompleted":{"Year":"2009","Month":"03","Day":"10"},"DateRevised":{"Year":"2018","Month":"12","Day":"01"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1095-953X","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"33","Issue":"3","PubDate":{"Year":"2009","Month":"Mar"}},"Title":"Neurobiology of disease","ISOAbbreviation":"Neurobiol Dis"},"ArticleTitle":"Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide.","Pagination":{"MedlinePgn":"379-85"},"ELocationID":"10.1016\/j.nbd.2008.11.008","Abstract":{"AbstractText":"Mutations in the progranulin gene (PGRN) are a major cause of frontotemporal lobar degeneration (FTLD). Herein we estimated the contribution of the PGRN Leu271LeufsX10 mutation to FTLD and related disorders in the Brescia cohort. The PGRN Leu271LeufsX10 mutation was found in 31% of corticobasal syndrome (CBS), 29% of frontotemporal dementia with motorneuron disease (FTD-MND), 15% of behavioral variant frontotemporal dementia (FTD), 9.5% of primary progressive aphasia (PPA), 2% dementia with Lewy bodies and 0% of progressive supranuclear palsy and multiple system atrophy cases. The prevalence strongly increased in familial forms (75% CBS, 50% FTD-MND, 27% FTD, 18% PPA): in our cohort this mutation is a major disease determinant for FTLD-related disorders with a prominent motor component. MAPT haplotype was demonstrated to be a disease modifier in PGRN Leu271LeufsX10 carriers: in H1H2 subjects the disease onset was earlier than in H2H2 individuals. Sequencing of the whole PGRN gene disclosed a previously described mutation (c.2T>C, Met1X) and three novel ones (c.709-3; c.1011delG, His340ThrfsX21; c.1021C>T, Gln341X) in single families. In the Brescia cohort, while MAPT mutations have low prevalence, mutations in PGRN were shown in 28% of familial FTLD and 75% of familial CBS cases. The PGRN Leu271LeufsX10 mutation becomes one of the most common mutations worldwide, since it was identified in 38 patients belonging to 27 unrelated families."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Benussi","ForeName":"Luisa","Initials":"L","AffiliationInfo":{"Affiliation":"NeuroBioGen Lab-Memory Clinic, IRCCS S. Giovanni di Dio-FBF, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ghidoni","ForeName":"Roberta","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Pegoiani","ForeName":"Eleonora","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Moretti","ForeName":"Davide V","Initials":"DV"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Binetti","ForeName":"Giuliano","Initials":"G"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2008","Month":"12","Day":"06"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Neurobiol Dis","NlmUniqueID":"9500169","ISSNLinking":"0969-9961"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"GRN protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Intercellular Signaling Peptides and Proteins"},{"RegistryNumber":"0","NameOfSubstance":"MAPT protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Progranulins"},{"RegistryNumber":"0","NameOfSubstance":"tau Proteins"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aphasia","QualifierName":"genetics"},{"DescriptorName":"Behavior"},{"DescriptorName":"Cognition"},{"DescriptorName":"DNA Mutational Analysis"},{"DescriptorName":"Dementia","QualifierName":["genetics","physiopathology","psychology"]},{"DescriptorName":"Family"},{"DescriptorName":"Female"},{"DescriptorName":"Gene Frequency"},{"DescriptorName":"Haplotypes"},{"DescriptorName":"Humans"},{"DescriptorName":"Intercellular Signaling Peptides and Proteins","QualifierName":"genetics"},{"DescriptorName":"Italy"},{"DescriptorName":"Language"},{"DescriptorName":"Male"},{"DescriptorName":"Memory"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Motor Neuron Disease","QualifierName":["genetics","physiopathology","psychology"]},{"DescriptorName":"Mutation"},{"DescriptorName":"Neurodegenerative Diseases","QualifierName":["genetics","physiopathology","psychology"]},{"DescriptorName":"Progranulins"},{"DescriptorName":"tau Proteins","QualifierName":"genetics"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2008","Month":"07","Day":"15"},{"@attributes":{"PubStatus":"revised"},"Year":"2008","Month":"10","Day":"28"},{"@attributes":{"PubStatus":"accepted"},"Year":"2008","Month":"11","Day":"07"},{"@attributes":{"PubStatus":"entrez"},"Year":"2008","Month":"12","Day":"23","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2008","Month":"12","Day":"23","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2009","Month":"3","Day":"11","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["19101631","S0969-9961(08)00279-9","10.1016\/j.nbd.2008.11.008"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"19068498","DateCompleted":{"Year":"2009","Month":"02","Day":"17"},"DateRevised":{"Year":"2019","Month":"11","Day":"11"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1546-4156","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"22","Issue":"4","PubDate":{"MedlineDate":"2008 Oct-Dec"}},"Title":"Alzheimer disease and associated disorders","ISOAbbreviation":"Alzheimer Dis Assoc Disord"},"ArticleTitle":"The added value of neuropsychologic tests and structural imaging for the etiologic diagnosis of dementia in italian expert centers.","Pagination":{"MedlinePgn":"309-20"},"Abstract":{"AbstractText":"Aim of the study was to assess the added diagnostic value of neuropsychologic tests and structural neuroimaging (computed tomography or magnetic resonance) in the routine clinical assessment of demented patients in Italian expert centers. Nine centers were involved, located across the whole country (3 in Northern, 3 in Central, and 3 in Southern Italy). Diagnostic pathways were tracked for 474 patients with an expert diagnosis of neurodegenerative or vascular dementia (age 76+\/-8; 62% females; Mini-Mental State Examination 17.70+\/-5.7). The contribution of neuropsychology and structural neuroimaging to diagnosis was estimated as \"number needed to test\" (NNT), denoting the number of patients who need to undergo such procedures to improve expert diagnosis of 1 unit. Expert physicians reached their diagnosis without resorting to structural imaging examinations and neuropsychologic tests in 93% of Alzheimer disease (AD) and 76% of non-AD dementias. The completion of the extended assessment led to improvement of diagnostic accuracy in both cases: the NNT was 15.3 (95% confidence interval: 10.4-29.1) and 4.1 (3.0 to 6.5) for AD and non-AD diagnoses. The added value of structural imaging and neuropsychologic testing in the routine clinical assessment of demented patients is substantial in both AD and non-AD cases."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Geroldi","ForeName":"Cristina","Initials":"C","AffiliationInfo":{"Affiliation":"Laboratory of Epidemiology, Neuroimaging and Telemedicine, Scientific Institute for Research and Care (IRCCS) San Giovanni di Dio, FBF, Brescia, Italy. cgeroldi@fatebenefratelli.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Canu","ForeName":"Elisa","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bruni","ForeName":"Amalia C","Initials":"AC"},{"@attributes":{"ValidYN":"Y"},"LastName":"Dal Forno","ForeName":"Gloria","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ferri","ForeName":"Raffaele","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gabelli","ForeName":"Carlo","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Perri","ForeName":"Roberta","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Iapaolo","ForeName":"David","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Scarpino","ForeName":"Osvaldo","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sinforiani","ForeName":"Elena","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Multicenter Study","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Alzheimer Dis Assoc Disord","NlmUniqueID":"8704771","ISSNLinking":"0893-0341"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Dementia","QualifierName":["diagnosis","etiology"]},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Italy"},{"DescriptorName":"Magnetic Resonance Imaging"},{"DescriptorName":"Male"},{"DescriptorName":"Medical History Taking"},{"DescriptorName":"Neurologic Examination"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Tomography, X-Ray Computed"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2008","Month":"12","Day":"11","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2009","Month":"2","Day":"20","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2008","Month":"12","Day":"11","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["19068498","10.1097\/wad.0b013e3181871a47"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"18768226","DateCompleted":{"Year":"2009","Month":"08","Day":"14"},"DateRevised":{"Year":"2009","Month":"05","Day":"18"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1872-6976","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"49","Issue":"1","PubDate":{"MedlineDate":"2009 Jul-Aug"}},"Title":"Archives of gerontology and geriatrics","ISOAbbreviation":"Arch Gerontol Geriatr"},"ArticleTitle":"Efficacy of acetyl-cholinesterase-inhibitor (ACHEI) treatment in Alzheimer's disease: a 21-month follow-up \"real world\" study.","Pagination":{"MedlinePgn":"e6-11"},"ELocationID":"10.1016\/j.archger.2008.07.006","Abstract":{"AbstractText":"Long-term efficacy of acetyl-cholinesterase-inhibitor (ACHEI) treatment in mild-to-moderate Alzheimer's disease (AD) is of great relevance for clinical routine and has been investigated over a 21-month period of treatment in a \"real word\" population. We investigated cognitive (mini mental state examination=MMSE) and functional (instrumental activities of daily living=IADL; activities of daily living=ADL) outcomes in 427 AD patients throughout the above period. At the end of the study, first-time drug takers (naives) declined by 1.2 MMSE points, whereas non-naives by 3.8 points. Predictors of responsiveness for first-time drug takers were MMSE score at baseline and MMSE points gained at 3 months of treatment. Further investigations are needed to shed light on the characteristics of responsiveness to a tailored ACHEI treatment for dementia."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Calabria","ForeName":"Marco","Initials":"M","AffiliationInfo":{"Affiliation":"U.O. Alzheimer, IRCCS San Giovanni di Dio Fatebenefratelli, Via Pilastroni 4, I-25123 Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Geroldi","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Lussignoli","ForeName":"Giulia","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Sabbatini","ForeName":"Federica","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2008","Month":"09","Day":"02"}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"Arch Gerontol Geriatr","NlmUniqueID":"8214379","ISSNLinking":"0167-4943"},"ChemicalList":{"Chemical":{"RegistryNumber":"0","NameOfSubstance":"Cholinesterase Inhibitors"}},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":"drug therapy"},{"DescriptorName":"Cholinesterase Inhibitors","QualifierName":"therapeutic use"},{"DescriptorName":"Cognition Disorders","QualifierName":["diagnosis","drug therapy"]},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Severity of Illness Index"},{"DescriptorName":"Treatment Outcome"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2008","Month":"03","Day":"18"},{"@attributes":{"PubStatus":"revised"},"Year":"2008","Month":"07","Day":"03"},{"@attributes":{"PubStatus":"accepted"},"Year":"2008","Month":"07","Day":"05"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2008","Month":"9","Day":"5","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2009","Month":"8","Day":"15","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2008","Month":"9","Day":"5","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["18768226","S0167-4943(08)00153-2","10.1016\/j.archger.2008.07.006"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"18430983","DateCompleted":{"Year":"2008","Month":"05","Day":"22"},"DateRevised":{"Year":"2019","Month":"11","Day":"10"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"0953-4180","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"18","Issue":"4","PubDate":{"Year":"2007"}},"Title":"Behavioural neurology","ISOAbbreviation":"Behav Neurol"},"ArticleTitle":"Right hemisphere involvement in non-fluent primary progressive aphasia.","Pagination":{"MedlinePgn":"239-43"},"Abstract":{"AbstractText":"We described a 56-years-old man with a diagnosis of \"non-fluent primary progressive aphasia\" (NfPPA). An accurate neuropsychological, neurological and neuroimaging evaluation was performed in order to assess clinical and behavioural features of the patient. From a neuropsychological point of view, the patient showed a typical cognitive profile of subjects affected by NfPPA: a prominent language deficit, associated with impairments in several cognitive domains after three years from the onset of the symptomatology. The most intriguing feature is that SPECT revealed hypoperfusion in the right frontal cortex, albeit the patient is right-handed. This unexpected finding shows that NfPPA may arise not only from cortical abnormalities in the language-dominant left hemisphere, but also from right hemisphere involvement in a right hander (crossed aphasia)."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Repetto","ForeName":"Claudia","Initials":"C","AffiliationInfo":{"Affiliation":"IRCCS S. Giovanni di Dio Fatebenefratelli, Brescia, Italy. claudia.repetto@cognitiveneuroscience.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Manenti","ForeName":"Rosa","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cotelli","ForeName":"Maria","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Calabria","ForeName":"Marco","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Borroni","ForeName":"Barbara","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Padovani","ForeName":"Alessandro","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Miniussi","ForeName":"Carlo","Initials":"C"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Case Reports","Journal Article"]}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"Behav Neurol","NlmUniqueID":"8914585","ISSNLinking":"0953-4180"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aphasia, Primary Progressive","QualifierName":["diagnosis","pathology"]},{"DescriptorName":"Frontal Lobe","QualifierName":["blood supply","pathology"]},{"DescriptorName":"Functional Laterality"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Tomography, Emission-Computed, Single-Photon"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2008","Month":"4","Day":"24","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2008","Month":"5","Day":"23","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2008","Month":"4","Day":"24","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["18430983","PMC5469964","10.1155\/2007\/423631"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"18007112","DateCompleted":{"Year":"2008","Month":"02","Day":"15"},"DateRevised":{"Year":"2019","Month":"11","Day":"10"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1594-0667","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"19","Issue":"5","PubDate":{"Year":"2007","Month":"Oct"}},"Title":"Aging clinical and experimental research","ISOAbbreviation":"Aging Clin Exp Res"},"ArticleTitle":"Prescription patterns and efficacy of drugs for patients with dementia: physicians' perspective in Italy.","Pagination":{"MedlinePgn":"349-55"},"Abstract":{"AbstractText":["The aim of this study was to assess the prescription practices and judgment of efficacy of physicians of drugs used for the cognitive and non-cognitive symptoms of dementia.","Physicians from 88 Italian Alzheimer Evaluation Units were surveyed by means of a structured questionnaire assessing the proportion of patients with four different types of dementia prescribed with drugs for cognitive and non-cognitive symptoms, and physicians' perceived efficacy of cholinesterase inhibitors. The Units prescribed cholinesterase inhibitors for 73 patients per year on average.","Cholinesterase inhibitors are prescribed to 90% of patients with Alzheimer's disease (AD), 80% with with Lewy body dementia (LBD), and 35-45% with vascular dementia (VD) and frontotemporal lobar degeneration (FTLD). Selective serotonin uptake inhibitors (SSRIs) are prescribed for 28-45% of patients with all dementias except LBD (16%). Atypical neuroleptics were prescribed for 23-31% of patients, with no difference across types of dementia. Other drugs, such as ginkgo and nootropics, were prescribed less frequently, except in VD (20%). The perceived efficacy on cognitive and non-cognitive symptoms, assessed on a 0-to-10 ordinal scale, was highest in AD (4.3-6.1), intermediate in LBD (3.5-5.3) and VD (3.3- 4.7), and lowest in FTLD (2.0-2.7).","The data indicate that, in specialized Italian centers, cholinesterase inhibitors and atypical neuroleptics are largely used in patients with AD and LBD, but the former are prescribed off-label to a remarkable proportion of patients with VD and FTLD. The efficacy of cholinesterase inhibitors is perceived to be highest in AD and poorest in FTLD. Perceived efficacy is affected more by whom is treated than by what is used."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB","AffiliationInfo":{"Affiliation":"Laboratory of Epidemiology Neuroimaging and Telemedicine, IRCCS San Giovanni di Dio-FBF, Via Pilastroni 4, 25125 Brescia, Italy. papers@centroAlzheimer.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Canu","ForeName":"Elisa","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Geroldi","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Brignoli","ForeName":"Barbara","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Anglani","ForeName":"Livio","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Galluzzi","ForeName":"Samantha","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zacchi","ForeName":"Valeria","Initials":"V"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"Germany","MedlineTA":"Aging Clin Exp Res","NlmUniqueID":"101132995","ISSNLinking":"1594-0667"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Cholinesterase Inhibitors"},{"RegistryNumber":"0","NameOfSubstance":"Serotonin Uptake Inhibitors"}]},"CitationSubset":"IM","CommentsCorrectionsList":{"CommentsCorrections":{"@attributes":{"RefType":"CommentIn"},"RefSource":"Aging Clin Exp Res. 2007 Oct;19(5):341-3","PMID":"18007110"}},"MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":"drug therapy"},{"DescriptorName":"Cholinesterase Inhibitors","QualifierName":"therapeutic use"},{"DescriptorName":"Clinical Trials as Topic"},{"DescriptorName":"Dementia","QualifierName":"drug therapy"},{"DescriptorName":"Dementia, Vascular","QualifierName":"drug therapy"},{"DescriptorName":"Drug Prescriptions"},{"DescriptorName":"Drug Utilization"},{"DescriptorName":"Humans"},{"DescriptorName":"Lewy Body Disease","QualifierName":"drug therapy"},{"DescriptorName":"Physicians, Family"},{"DescriptorName":"Practice Patterns, Physicians'"},{"DescriptorName":"Serotonin Uptake Inhibitors","QualifierName":"therapeutic use"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2007","Month":"11","Day":"17","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2008","Month":"2","Day":"19","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2007","Month":"11","Day":"17","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["18007112","4174","10.1007\/BF03324714"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"17640688","DateCompleted":{"Year":"2007","Month":"12","Day":"13"},"DateRevised":{"Year":"2009","Month":"11","Day":"11"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"0028-3932","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"45","Issue":"13","PubDate":{"Year":"2007","Month":"Oct","Day":"01"}},"Title":"Neuropsychologia","ISOAbbreviation":"Neuropsychologia"},"ArticleTitle":"Universal grammar in the frontotemporal dementia spectrum: evidence of a selective disorder in the corticobasal degeneration syndrome.","Pagination":{"MedlinePgn":"3015-23"},"Abstract":{"AbstractText":["While sentence comprehension has been reported to be defective in frontotemporal dementia (FTD), it is still unclear if this disorder reflects the presence of syntactic impairment, or may be attributed to other factors, such as executive or working memory dysfunction. In order to assess the status of syntactic knowledge in a group of patients belonging to the FTD spectrum, we investigated their ability to detect violations of Universal Grammar principles in a sentence judgement task.","The group included four semantic dementia patients (SD), nine frontal variant of FTD patients (FvFTD), 15 progressive supranuclear palsy (PSP) patients, and 11 corticobasal degeneration syndrome (CBDS) patients. Their performance was compared to a group of 10 patients with mild probable Alzheimer disease (AD) and to 10 healthy volunteers. The patients underwent a standard aphasia test and a sentence comprehension test. The experimental study included five kinds of violations: semantic coherence (SC), verb-subject agreement (VSAgr), pronominalization involving clitic movement (ClM), interrogatives (WhS) and contrastive focus constructions (CFC).","The FTD patients performed within normal range in the aphasia test, and in the sentence comprehension test. Within the FTD subgroups, only patients with CBDS were significantly impaired in detecting three of the five kinds of violations. AD patients were also impaired in the detection of WhS and SC anomalies and in sentence comprehension.","The present findings indicate that, within the FTD spectrum, an impairment of syntactic knowledge can be found only in CBDS patients, even in the absence of clinical evidence of aphasia."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Cotelli","ForeName":"Maria","Initials":"M","AffiliationInfo":{"Affiliation":"IRCCS, S. Giovanni di Dio-Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Borroni","ForeName":"Barbara","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Manenti","ForeName":"Rosa","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ginex","ForeName":"Valeria","Initials":"V"},{"@attributes":{"ValidYN":"Y"},"LastName":"Calabria","ForeName":"Marco","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Moro","ForeName":"Andrea","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Alberici","ForeName":"Antonella","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Marina","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cappa","ForeName":"Stefano F","Initials":"SF"},{"@attributes":{"ValidYN":"Y"},"LastName":"Padovani","ForeName":"Alessandro","Initials":"A"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Comparative Study","Journal Article"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2007","Month":"06","Day":"08"}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"Neuropsychologia","NlmUniqueID":"0020713","ISSNLinking":"0028-3932"},"CitationSubset":"IM","CommentsCorrectionsList":{"CommentsCorrections":{"@attributes":{"RefType":"ErratumIn"},"RefSource":"Neuropsychologia. 2008 Oct;46(12):3019"}},"MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":["diagnosis","psychology"]},{"DescriptorName":"Analysis of Variance"},{"DescriptorName":"Aphasia","QualifierName":["diagnosis","pathology","psychology"]},{"DescriptorName":"Basal Ganglia","QualifierName":"pathology"},{"DescriptorName":"Case-Control Studies"},{"DescriptorName":"Cerebral Cortex","QualifierName":"pathology"},{"DescriptorName":"Dementia","QualifierName":["classification","diagnosis","pathology","psychology"]},{"DescriptorName":"Diagnosis, Differential"},{"DescriptorName":"Frontal Lobe","QualifierName":"pathology"},{"DescriptorName":"Humans"},{"DescriptorName":"Language Tests"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neurodegenerative Diseases","QualifierName":["classification","diagnosis","pathology","psychology"]},{"DescriptorName":"Reference Values"},{"DescriptorName":"Semantics"},{"DescriptorName":"Syndrome"},{"DescriptorName":"Temporal Lobe","QualifierName":"pathology"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2006","Month":"12","Day":"06"},{"@attributes":{"PubStatus":"revised"},"Year":"2007","Month":"04","Day":"20"},{"@attributes":{"PubStatus":"accepted"},"Year":"2007","Month":"05","Day":"29"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2007","Month":"7","Day":"21","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2007","Month":"12","Day":"14","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2007","Month":"7","Day":"21","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["17640688","S0028-3932(07)00211-4","10.1016\/j.neuropsychologia.2007.05.012"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"17101829","DateCompleted":{"Year":"2006","Month":"12","Day":"12"},"DateRevised":{"Year":"2006","Month":"11","Day":"14"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"0003-9942","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"63","Issue":"11","PubDate":{"Year":"2006","Month":"Nov"}},"Title":"Archives of neurology","ISOAbbreviation":"Arch Neurol"},"ArticleTitle":"Effect of transcranial magnetic stimulation on action naming in patients with Alzheimer disease.","Pagination":{"MedlinePgn":"1602-4"},"Abstract":{"AbstractText":["To assess the effect of repetitive transcranial magnetic stimulation (rTMS) to the dorsolateral prefrontal cortex (DLPFC) on picture naming in patients with Alzheimer disease (AD).","Experimental study. Patients with AD underwent rTMS in real and control conditions during picture-naming tasks.","San Giovanni di Dio Fatebenefratelli Scientific Institute in Brescia, Italy. Patients Fifteen patients with probable AD. Intervention High-frequency rTMS was applied to the left and right DLPFC during object and action naming.","Language ability was assessed by accuracy of verbal response during online rTMS.","Stimulation to the left and right DLPFC improved accuracy in action naming.","These findings indicate that rTMS to the DLPFC, which speeds up action naming in normal controls, improves performance in patients with AD. While the mechanisms of rTMS-induced naming facilitation in these patients are unknown, the procedure may be worth testing as a novel approach to the treatment of language dysfunction."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Cotelli","ForeName":"Maria","Initials":"M","AffiliationInfo":{"Affiliation":"Istituto di Recovero e Cura a Carattere Scientifico San Giovanni di Dio Fatebenefratelli, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Manenti","ForeName":"Rosa","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cappa","ForeName":"Stefano F","Initials":"SF"},{"@attributes":{"ValidYN":"Y"},"LastName":"Geroldi","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Rossini","ForeName":"Paolo M","Initials":"PM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Miniussi","ForeName":"Carlo","Initials":"C"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Comparative Study","Journal Article","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Arch Neurol","NlmUniqueID":"0372436","ISSNLinking":"0003-9942"},"CitationSubset":["AIM","IM"],"MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Alzheimer Disease","QualifierName":["pathology","physiopathology"]},{"DescriptorName":"Brain Mapping"},{"DescriptorName":"Humans"},{"DescriptorName":"Italy"},{"DescriptorName":"Names"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Photic Stimulation","QualifierName":"methods"},{"DescriptorName":"Prefrontal Cortex","QualifierName":["physiopathology","radiation effects"]},{"DescriptorName":"Reaction Time","QualifierName":"physiology"},{"DescriptorName":"Transcranial Magnetic Stimulation"},{"DescriptorName":"Verbal Behavior","QualifierName":"physiology"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2006","Month":"11","Day":"15","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2006","Month":"12","Day":"13","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2006","Month":"11","Day":"15","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["17101829","63\/11\/1602","10.1001\/archneur.63.11.1602"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"16955446","DateCompleted":{"Year":"2007","Month":"09","Day":"21"},"DateRevised":{"Year":"2015","Month":"11","Day":"19"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"0885-6230","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"21","Issue":"11","PubDate":{"Year":"2006","Month":"Nov"}},"Title":"International journal of geriatric psychiatry","ISOAbbreviation":"Int J Geriatr Psychiatry"},"ArticleTitle":"Drug prescription in mild cognitive impairment: the physicians' perspective in Italy.","Pagination":{"MedlinePgn":"1071-7"},"Abstract":{"AbstractText":["Today there are no data on the type of drugs prescribed to MCI patients nor the prevalence of their prescription. The aim of this study was to describe which drugs were prescribed in 2004 for cognitive and non cognitive disturbances of patients with MCI in a sizable group of Italian expert centers for the diagnosis and treatment of Alzheimer's disease.","Eighty-eight of the 314 contacted UVAs (28%) agreed to take part to the present study. The physicians were surveyed with a structured questionnaire assessing questions related to prescription of drug therapy based on their subjective judgement.","Cholinesterase inhibitors are prescribed to 90% of patients with AD but, interestingly, to about one in four patients with MCI (27%). Gingko and nootropics are prescribed infrequently, but in MCI two to three times more often than in AD. About one in four (27%) and one in ten (9%) MCI patient are prescribed SSRIs and benzodiazepines, a proportion similar to that of AD (28% and 10%), while atypical and traditional neuroleptics are virtually never used in MCI patients. Vitamin E is prescribed to more than half of MCI (57%) and in about half as many AD patients (27%).","These data suggest that lacking approved or clearly effective drugs for cognitive symptoms, physicians respond with 'analogy treatments' and by increasing the prescription of 'accessory drugs'. Non cognitive symptoms in MCI are managed virtually exclusively with SSRIs and benzodiazepines."],"CopyrightInformation":"Copyright (c) 2006 John Wiley & Sons, Ltd."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB","AffiliationInfo":{"Affiliation":"Laboratory of Epidemiology Neuroimaging & Telemedicine, IRCCS San Giovanni di Dio-FBF, Brescia, Italy. papers@centroAlzheimer.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Canu","ForeName":"Elisa","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Geroldi","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zacchi","ForeName":"Valeria","Initials":"V"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"Int J Geriatr Psychiatry","NlmUniqueID":"8710629","ISSNLinking":"0885-6230"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Cholinesterase Inhibitors"},{"RegistryNumber":"0","NameOfSubstance":"Nootropic Agents"},{"RegistryNumber":"0","NameOfSubstance":"Vitamins"},{"RegistryNumber":"1406-18-4","NameOfSubstance":"Vitamin E"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":"drug therapy"},{"DescriptorName":"Cholinesterase Inhibitors","QualifierName":"therapeutic use"},{"DescriptorName":"Cognition Disorders","QualifierName":"drug therapy"},{"DescriptorName":"Female"},{"DescriptorName":"Ginkgo biloba"},{"DescriptorName":"Humans"},{"DescriptorName":"Italy"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Nootropic Agents","QualifierName":"therapeutic use"},{"DescriptorName":"Practice Patterns, Physicians'"},{"DescriptorName":"Surveys and Questionnaires"},{"DescriptorName":"Vitamin E","QualifierName":"therapeutic use"},{"DescriptorName":"Vitamins","QualifierName":"therapeutic use"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2006","Month":"9","Day":"7","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2007","Month":"9","Day":"22","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2006","Month":"9","Day":"7","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["16955446","10.1002\/gps.1609"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"16702783","DateCompleted":{"Year":"2006","Month":"07","Day":"20"},"DateRevised":{"Year":"2019","Month":"11","Day":"09"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1594-0667","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"18","Issue":"2","PubDate":{"Year":"2006","Month":"Apr"}},"Title":"Aging clinical and experimental research","ISOAbbreviation":"Aging Clin Exp Res"},"ArticleTitle":"Cognitive rehabilitation in Alzheimer's Disease.","Pagination":{"MedlinePgn":"141-3"},"Abstract":{"AbstractText":"Non-pharmacological treatment in Alzheimer's Disease has gained great attention in recent years. The limited efficacy of drug therapy and the plasticity of human central nervous system are the two main reasons that explain this growing interest in rehabilitation. Different approaches have been developed. Here we discuss the efficacy of non-pharmacological therapy in the frame of two main approaches: Multistrategy Approaches (Reality Orientation, Reminiscence Therapy and Validation Therapy) and Cognitive Methods."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Cotelli","ForeName":"Maria","Initials":"M","AffiliationInfo":{"Affiliation":"UO Alzheimer, Centro per la Memoria, IRCCS Centro S. Giovanni di Dio FBF, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Calabria","ForeName":"Marco","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Review"]}},"MedlineJournalInfo":{"Country":"Germany","MedlineTA":"Aging Clin Exp Res","NlmUniqueID":"101132995","ISSNLinking":"1594-0667"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":"rehabilitation"},{"DescriptorName":"Cognition","QualifierName":"physiology"},{"DescriptorName":"Cognitive Behavioral Therapy","QualifierName":"methods"},{"DescriptorName":"Humans"},{"DescriptorName":"Memory"},{"DescriptorName":"Reality Therapy"},{"DescriptorName":"Rehabilitation","QualifierName":"methods"}]},"NumberOfReferences":"13"},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2006","Month":"5","Day":"17","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2006","Month":"7","Day":"21","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2006","Month":"5","Day":"17","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["16702783","1807","10.1007\/BF03327429"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"16600641","DateCompleted":{"Year":"2006","Month":"08","Day":"09"},"DateRevised":{"Year":"2018","Month":"12","Day":"01"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1053-8119","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"31","Issue":"4","PubDate":{"Year":"2006","Month":"Jul","Day":"15"}},"Title":"NeuroImage","ISOAbbreviation":"Neuroimage"},"ArticleTitle":"Donepezil effects on sources of cortical rhythms in mild Alzheimer's disease: Responders vs. Non-Responders.","Pagination":{"MedlinePgn":"1650-65"},"Abstract":{"AbstractText":"Acetylcholinesterase inhibitors (AChEI) such as donepezil act in mild Alzheimer's disease (AD) by increasing cholinergic tone. Differences in the clinical response in patients who do or do not benefit from therapy may be due to different functional features of the central neural systems. We tested this hypothesis using cortical electroencephalographic (EEG) rhythmicity. Resting eyes-closed EEG data were recorded in 58 mild AD patients (Mini Mental State Examination [MMSE] range 17-24) before and approximately 1 year after standard donepezil treatment. Based on changes of MMSE scores between baseline and follow-up, 28 patients were classified as \"Responders\" (MMSEvar >or=0) and 30 patients as \"Non-Responders\" (MMSEvar <0). EEG rhythms of interest were delta (2-4 Hz), theta (4-8 Hz), alpha 1 (8-10.5 Hz), alpha 2 (10.5-13 Hz), beta 1 (13-20 Hz), and beta 2 (20-30 Hz). Cortical EEG sources were studied with low-resolution brain electromagnetic tomography (LORETA). Before treatment, posterior sources of delta, alpha 1 and alpha 2 frequencies were greater in amplitude in Non-Responders. After treatment, a lesser magnitude reduction of occipital and temporal alpha 1 sources characterized Responders. These results suggest that Responders and Non-Responders had different EEG cortical rhythms. Donepezil could act by reactivating existing yet functionally silent cortical synapses in Responders, restoring temporal and occipital alpha rhythms."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Babiloni","ForeName":"Claudio","Initials":"C","AffiliationInfo":{"Affiliation":"Dip. Fisiologia Umana e Farmacologia, Univ. La Sapienza, Rome, Italy. claudio.babiloni@uniroma1.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Cassetta","ForeName":"Emanuele","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Dal Forno","ForeName":"Gloria","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Del Percio","ForeName":"Claudio","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ferreri","ForeName":"Florinda","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ferri","ForeName":"Raffaele","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Lanuzza","ForeName":"Bartolo","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Miniussi","ForeName":"Carlo","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Moretti","ForeName":"Davide V","Initials":"DV"},{"@attributes":{"ValidYN":"Y"},"LastName":"Nobili","ForeName":"Flavio","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Pascual-Marqui","ForeName":"Roberto D","Initials":"RD"},{"@attributes":{"ValidYN":"Y"},"LastName":"Rodriguez","ForeName":"Guido","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Luca Romani","ForeName":"Gian","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Salinari","ForeName":"Serenella","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Rossini","ForeName":"Paolo M","Initials":"PM"}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":{"GrantID":"E.C0985","Agency":"Telethon","Country":"Italy"}},"PublicationTypeList":{"PublicationType":["Clinical Trial","Journal Article","Multicenter Study","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2006","Month":"04","Day":"05"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Neuroimage","NlmUniqueID":"9215515","ISSNLinking":"1053-8119"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Indans"},{"RegistryNumber":"0","NameOfSubstance":"Nootropic Agents"},{"RegistryNumber":"0","NameOfSubstance":"Piperidines"},{"RegistryNumber":"8SSC91326P","NameOfSubstance":"Donepezil"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":["drug therapy","physiopathology"]},{"DescriptorName":"Brain Mapping"},{"DescriptorName":"Cerebral Cortex","QualifierName":"physiopathology"},{"DescriptorName":"Data Interpretation, Statistical"},{"DescriptorName":"Donepezil"},{"DescriptorName":"Electroencephalography","QualifierName":"drug effects"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Indans","QualifierName":"therapeutic use"},{"DescriptorName":"Magnetoencephalography","QualifierName":"drug effects"},{"DescriptorName":"Male"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Nootropic Agents","QualifierName":"therapeutic use"},{"DescriptorName":"Piperidines","QualifierName":"therapeutic use"},{"DescriptorName":"Psychiatric Status Rating Scales"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2005","Month":"10","Day":"17"},{"@attributes":{"PubStatus":"revised"},"Year":"2006","Month":"02","Day":"01"},{"@attributes":{"PubStatus":"accepted"},"Year":"2006","Month":"02","Day":"03"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2006","Month":"4","Day":"8","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2006","Month":"8","Day":"10","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2006","Month":"4","Day":"8","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["16600641","S1053-8119(06)00104-2","10.1016\/j.neuroimage.2006.02.015"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"16463757","DateCompleted":{"Year":"2006","Month":"03","Day":"21"},"DateRevised":{"Year":"2006","Month":"02","Day":"08"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"0896-4289","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"28","Issue":"3","PubDate":{"Year":"2002","Season":"Fall"}},"Title":"Behavioral medicine (Washington, D.C.)","ISOAbbreviation":"Behav Med"},"ArticleTitle":"Caregiver's distress is associated with delusions in Alzheimer's patients.","Pagination":{"MedlinePgn":"92-8"},"Abstract":{"AbstractText":"Behavioral disturbances in Alzheimer's (AD) patients might be caused by environmental factors. The authors tested the hypothesis that delusions in AD might be a result of caregiver's distress. Participants were 22 delusional and 21 nondelusional mild AD patients and their caregivers. Those who cared for nondelusional patients, compared with the delusional patients' caregivers, reported higher levels of distress because of behavioral disturbances other than delusions. When patients were stratified into 2 groups according to median distress value, 64% of the delusional patients and 33% of the nondelusional patients showed a high level of caregiver's distress, chi2(1, N = 43) = 3.94, p = .047. Although final conclusions about the causal direction of the association cannot be drawn, these findings are consistent with the hypothesis that distressed caregivers might use inappropriate coping strategies that, in turn, might favor the development of delusions."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Riello","ForeName":"Roberta","Initials":"R","AffiliationInfo":{"Affiliation":"Laboratory of Epidemiology and Neuroimaging, IRCCS San Giovanni di Dio, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Geroldi","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB"}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Behav Med","NlmUniqueID":"8804264","ISSNLinking":"0896-4289"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":"psychology"},{"DescriptorName":"Caregivers","QualifierName":["psychology","statistics & numerical data"]},{"DescriptorName":"Cross-Sectional Studies"},{"DescriptorName":"Delusions","QualifierName":["diagnosis","epidemiology","etiology"]},{"DescriptorName":"Depression","QualifierName":["diagnosis","epidemiology","psychology"]},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Severity of Illness Index"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2006","Month":"2","Day":"9","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2006","Month":"3","Day":"22","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2006","Month":"2","Day":"9","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["16463757","10.1080\/08964280209596047"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"16275848","DateCompleted":{"Year":"2006","Month":"04","Day":"12"},"DateRevised":{"Year":"2016","Month":"11","Day":"24"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1526-632X","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"65","Issue":"9","PubDate":{"Year":"2005","Month":"Nov","Day":"08"}},"Title":"Neurology","ISOAbbreviation":"Neurology"},"ArticleTitle":"Extensive brain calcification and dementia in postsurgical hypoparathyroidism.","Pagination":{"MedlinePgn":"1501"},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Adorni","ForeName":"Andrea","Initials":"A","AffiliationInfo":{"Affiliation":"Alzheimer's Unit-Memory Clinic, IRCCS, Centro S. Giovanni di Dio-Fatebenefratelli, Brescia, Italy. aadorni@fatebenefratelli.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lussignoli","ForeName":"Giulia","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Geroldi","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Case Reports","Journal Article"]}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Neurology","NlmUniqueID":"0401060","ISSNLinking":"0028-3878"},"ChemicalList":{"Chemical":{"RegistryNumber":"0","NameOfSubstance":"Parathyroid Hormone"}},"CitationSubset":["AIM","IM"],"MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Brain","QualifierName":["diagnostic imaging","pathology","physiopathology"]},{"DescriptorName":"Calcinosis","QualifierName":["diagnostic imaging","etiology","physiopathology"]},{"DescriptorName":"Dementia","QualifierName":["diagnostic imaging","etiology","physiopathology"]},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Hypocalcemia","QualifierName":["complications","physiopathology"]},{"DescriptorName":"Hypoparathyroidism","QualifierName":["complications","physiopathology"]},{"DescriptorName":"Mental Disorders","QualifierName":["etiology","physiopathology"]},{"DescriptorName":"Movement Disorders","QualifierName":["diagnostic imaging","etiology","physiopathology"]},{"DescriptorName":"Parathyroid Hormone","QualifierName":"deficiency"},{"DescriptorName":"Reflex, Abnormal","QualifierName":"physiology"},{"DescriptorName":"Thyroidectomy","QualifierName":"adverse effects"},{"DescriptorName":"Tomography, X-Ray Computed"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2005","Month":"11","Day":"9","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2006","Month":"4","Day":"13","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2005","Month":"11","Day":"9","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["16275848","65\/9\/1501","10.1212\/01.wnl.0000182293.34015.a9"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"16260821","DateCompleted":{"Year":"2006","Month":"01","Day":"13"},"DateRevised":{"Year":"2018","Month":"12","Day":"01"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"0007-1250","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"187","PubDate":{"Year":"2005","Month":"Nov"}},"Title":"The British journal of psychiatry : the journal of mental science","ISOAbbreviation":"Br J Psychiatry"},"ArticleTitle":"Reality orientation therapy combined with cholinesterase inhibitors in Alzheimer's disease: randomised controlled trial.","Pagination":{"MedlinePgn":"450-5"},"Abstract":{"AbstractText":["Reality orientation therapy combined with cholinesterase inhibitors has not been evaluated in patients with Alzheimer's disease.","To perform such an evaluation.","We randomly assigned 79 of 156 patients treated with donepezil to receive a reality orientation programme. Caregivers of the treatment group were trained to offer the programme at home 3 days a week, 30 min\/day, for 25 consecutive weeks, and were invited to stimulate and involve patients in reality-based communication.","The treatment group showed a slight improvement in Mini-Mental State Examination (MMSE) scores (mean change +0.2, s.e.=0.4) compared with a decline in the control group (mean change -1.1, s.e.=0.4; P=0.02). Similarly for the Alzheimer's Disease Assessment Scale--Cognition (treatment group mean change +0.4, s.e.=0.8; control group -2.5, s.e.=0.8; P=0.01). The intervention had an equal effect on cognition in those with mild (MMSE score > or = 20) and moderate (score <20) dementia. No significant effect was observed for behavioural and functional outcomes.","Reality orientation enhances the effects of donepezil on cognition in Alzheimer's disease."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Onder","ForeName":"Graziano","Initials":"G","AffiliationInfo":{"Affiliation":"Department of Gerontology, Geriatrics and Psychiatry, Catholic University, Rome. graziano_onder@rm.unicatt.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Giacobini","ForeName":"Ezio","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bartorelli","ForeName":"Luisa","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Carbone","ForeName":"Gabriele","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Lambertucci","ForeName":"Paola","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Silveri","ForeName":"Maria Caterina","Initials":"MC"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bernabei","ForeName":"Roberto","Initials":"R"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Multicenter Study","Randomized Controlled Trial","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"Br J Psychiatry","NlmUniqueID":"0342367","ISSNLinking":"0007-1250"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Cholinesterase Inhibitors"},{"RegistryNumber":"0","NameOfSubstance":"Indans"},{"RegistryNumber":"0","NameOfSubstance":"Piperidines"},{"RegistryNumber":"8SSC91326P","NameOfSubstance":"Donepezil"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Adult"},{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":["drug therapy","therapy"]},{"DescriptorName":"Caregivers","QualifierName":["education","psychology"]},{"DescriptorName":"Cholinesterase Inhibitors","QualifierName":"therapeutic use"},{"DescriptorName":"Cognition"},{"DescriptorName":"Combined Modality Therapy"},{"DescriptorName":"Donepezil"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Indans","QualifierName":"therapeutic use"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Piperidines","QualifierName":"therapeutic use"},{"DescriptorName":"Psychiatric Status Rating Scales"},{"DescriptorName":"Quality of Life"},{"DescriptorName":"Reality Therapy","QualifierName":"education"},{"DescriptorName":"Treatment Outcome"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2005","Month":"11","Day":"2","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2006","Month":"1","Day":"18","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2005","Month":"11","Day":"2","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["16260821","S0007125000168394","10.1192\/bjp.187.5.450"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"15799080","DateCompleted":{"Year":"2005","Month":"08","Day":"11"},"DateRevised":{"Year":"2018","Month":"12","Day":"01"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"0885-6230","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"20","Issue":"4","PubDate":{"Year":"2005","Month":"Apr"}},"Title":"International journal of geriatric psychiatry","ISOAbbreviation":"Int J Geriatr Psychiatry"},"ArticleTitle":"Factors affecting timely recognition and diagnosis of dementia across Europe: from awareness to stigma.","Pagination":{"MedlinePgn":"377-86"},"Abstract":{"AbstractText":["Timely recognition and diagnosis of dementia is the pre-condition for improving dementia care, but diagnosis often occurs late in the disease process.","To compare facilitators and obstacles to the timely recognition of dementia across eight European Union states, in order to implement established policies for earlier diagnosis.","A modified focus group technique, including a pre and posterior procedure.","Twenty-three participants from different disciplines, purposively sampled for professional expertise in dementia research and innovative practice, attended two focus groups. Stigma in ageing and dementia, accompanied by a sense that there is little to offer until later on in the disease, underpinned the widespread reluctance of GPs to recognise dementia at an early stage and were major obstacles to the timely diagnosis of dementia across all eight countries. Dementia care services varied widely across Europe. Countries with the greatest development of dementia health care services were characterised by national guidelines, GPs fulfilling a gatekeeper function, multi-disciplinary memory clinics and innovative programmes that stimulated practice and new services. Dementia-related stigma was perceived as being less prominent in these countries.","Overcome of delays in the timely diagnosis of dementia needs more than specialist services. They should address the processes associated with stigma, age and dementia, especially where these relate to physician practice and diagnostic disclosure. Stigma is perceived as variable across European States, with a promising finding that its impact is relatively small in countries with the widest range of dementia care services."],"CopyrightInformation":"Copyright 2005 John Wiley & Sons, Ltd."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Vernooij-Dassen","ForeName":"Myrra J F J","Initials":"MJ","AffiliationInfo":{"Affiliation":"Alzheimer Centre\/Centre for Quality of Care Research\/Vocational training General Practitioners of University Medical Centre Nijmegen, The Netherlands. m.vernooy-dassen@voha.umcn.nl"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Moniz-Cook","ForeName":"Esme D","Initials":"ED"},{"@attributes":{"ValidYN":"Y"},"LastName":"Woods","ForeName":"Robert T","Initials":"RT"},{"@attributes":{"ValidYN":"Y"},"LastName":"De Lepeleire","ForeName":"Jan","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Leuschner","ForeName":"Antonio","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"de Rotrou","ForeName":"Joycelyn","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kenny","ForeName":"Geraldine","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Franco","ForeName":"Manuel","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Peters","ForeName":"Vincent","Initials":"V"},{"@attributes":{"ValidYN":"Y"},"LastName":"Iliffe","ForeName":"Steve","Initials":"S"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Multicenter Study","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"Int J Geriatr Psychiatry","NlmUniqueID":"8710629","ISSNLinking":"0885-6230"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Dementia","QualifierName":["diagnosis","psychology"]},{"DescriptorName":"Early Diagnosis"},{"DescriptorName":"Education, Medical, Continuing"},{"DescriptorName":"Europe"},{"DescriptorName":"Family Practice","QualifierName":"education"},{"DescriptorName":"Focus Groups"},{"DescriptorName":"Home Care Services","QualifierName":"organization & administration"},{"DescriptorName":"Humans"},{"DescriptorName":"Mental Health Services","QualifierName":["standards","statistics & numerical data"]},{"DescriptorName":"Practice Guidelines as Topic"},{"DescriptorName":"Quality of Health Care"},{"DescriptorName":"Referral and Consultation","QualifierName":"organization & administration"},{"DescriptorName":"Residential Facilities"},{"DescriptorName":"Respite Care","QualifierName":["statistics & numerical data","supply & distribution"]},{"DescriptorName":"Stereotyping"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2005","Month":"3","Day":"31","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2005","Month":"8","Day":"12","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2005","Month":"3","Day":"31","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["15799080","10.1002\/gps.1302"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"15642866","DateCompleted":{"Year":"2005","Month":"03","Day":"07"},"DateRevised":{"Year":"2005","Month":"01","Day":"11"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"0003-9942","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"62","Issue":"1","PubDate":{"Year":"2005","Month":"Jan"}},"Title":"Archives of neurology","ISOAbbreviation":"Arch Neurol"},"ArticleTitle":"The heterogeneity and natural history of mild cognitive impairment.","Pagination":{"MedlinePgn":"163; author reply 163-4"},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB"},{"@attributes":{"ValidYN":"Y"},"LastName":"Geroldi","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Binetti","ForeName":"Giuliano","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Comment","Letter"]}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Arch Neurol","NlmUniqueID":"0372436","ISSNLinking":"0003-9942"},"ChemicalList":{"Chemical":{"RegistryNumber":"0","NameOfSubstance":"tau Proteins"}},"CitationSubset":["AIM","IM"],"CommentsCorrectionsList":{"CommentsCorrections":{"@attributes":{"RefType":"CommentOn"},"RefSource":"Arch Neurol. 2004 May;61(5):716-20","PMID":"15148149"}},"MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aging","QualifierName":"physiology"},{"DescriptorName":"Alzheimer Disease","QualifierName":["cerebrospinal fluid","pathology","physiopathology"]},{"DescriptorName":"Cognition Disorders","QualifierName":["cerebrospinal fluid","etiology","pathology","physiopathology"]},{"DescriptorName":"Humans"},{"DescriptorName":"Neuropsychological Tests","QualifierName":"statistics & numerical data"},{"DescriptorName":"Risk Factors"},{"DescriptorName":"tau Proteins","QualifierName":"cerebrospinal fluid"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2005","Month":"1","Day":"12","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2005","Month":"3","Day":"8","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2005","Month":"1","Day":"12","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["15642866","62\/1\/163","10.1001\/archneur.62.1.163-a"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"15109997","DateCompleted":{"Year":"2004","Month":"06","Day":"18"},"DateRevised":{"Year":"2017","Month":"09","Day":"22"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1053-8119","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"22","Issue":"1","PubDate":{"Year":"2004","Month":"May"}},"Title":"NeuroImage","ISOAbbreviation":"Neuroimage"},"ArticleTitle":"Mapping distributed sources of cortical rhythms in mild Alzheimer's disease. A multicentric EEG study.","Pagination":{"MedlinePgn":"57-67"},"Abstract":{"AbstractText":"The study aimed at mapping (i) the distributed electroencephalographic (EEG) sources specific for mild Alzheimer's disease (AD) compared to vascular dementia (VaD) or normal elderly people (Nold) and (ii) the distributed EEG sources sensitive to the mild AD at different stages of severity. Resting EEG (10-20 electrode montage) was recorded from 48 mild AD, 20 VaD, and 38 Nold subjects. Both AD and VaD patients had 24-17 of mini mental state examination (MMSE). EEG rhythms were delta (2-4 Hz), theta (4-8 Hz), alpha 1 (8-10.5 Hz), alpha 2 (10.5-13 Hz), beta 1 (13-20 Hz), and beta 2 (20-30 Hz). Cortical EEG sources were modeled by low resolution brain electromagnetic tomography (LORETA). Regarding issue i, there was a decline of central, parietal, temporal, and limbic alpha 1 (low alpha) sources specific for mild AD group with respect to Nold and VaD groups. Furthermore, occipital alpha 1 sources showed a strong decline in mild AD compared to VaD group. Finally, distributed theta sources were largely abnormal in VaD but not in mild AD group. Regarding issue ii, there was a lower power of occipital alpha 1 sources in mild AD subgroup having more severe disease. Compared to previous field studies, this was the first investigation that illustrated the power spectrum profiles at the level of cortical (macroregions) EEG sources in mild AD patients having different severity of the disease with respect to VaD and normal subjects. Future studies should evaluate the clinical usefulness of this approach in early differential diagnosis, disease staging, and therapy monitoring."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Babiloni","ForeName":"Claudio","Initials":"C","AffiliationInfo":{"Affiliation":"Dipartimento di Fisiologia Umana e Farmacologia, Sezione di EEG ad Alta Risoluzione, Universita degli Studi di Roma La Sapienza, Rome, Italy. claudio.babiloni@uniroma1.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Binetti","ForeName":"Giuliano","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cassetta","ForeName":"Emanuele","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cerboneschi","ForeName":"Daniele","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Dal Forno","ForeName":"Gloria","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Del Percio","ForeName":"Claudio","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ferreri","ForeName":"Florinda","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ferri","ForeName":"Raffaele","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Lanuzza","ForeName":"Bartolo","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Miniussi","ForeName":"Carlo","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Moretti","ForeName":"Davide V","Initials":"DV"},{"@attributes":{"ValidYN":"Y"},"LastName":"Nobili","ForeName":"Flavio","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Pascual-Marqui","ForeName":"Roberto D","Initials":"RD"},{"@attributes":{"ValidYN":"Y"},"LastName":"Rodriguez","ForeName":"Guido","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Romani","ForeName":"Gian Luca","Initials":"GL"},{"@attributes":{"ValidYN":"Y"},"LastName":"Salinari","ForeName":"Serenella","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Tecchio","ForeName":"Franca","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Vitali","ForeName":"Paolo","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zappasodi","ForeName":"Filippo","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Rossini","ForeName":"Paolo M","Initials":"PM"}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":{"GrantID":"E.C0985","Agency":"Telethon","Country":"Italy"}},"PublicationTypeList":{"PublicationType":["Clinical Trial","Journal Article","Multicenter Study","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Neuroimage","NlmUniqueID":"9215515","ISSNLinking":"1053-8119"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":"physiopathology"},{"DescriptorName":"Brain Mapping"},{"DescriptorName":"Cerebral Cortex","QualifierName":"physiopathology"},{"DescriptorName":"Dementia, Vascular","QualifierName":"physiopathology"},{"DescriptorName":"Electroencephalography"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Neuropsychological Tests"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2003","Month":"04","Day":"17"},{"@attributes":{"PubStatus":"revised"},"Year":"2003","Month":"09","Day":"10"},{"@attributes":{"PubStatus":"accepted"},"Year":"2003","Month":"09","Day":"10"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2004","Month":"4","Day":"28","Hour":"5","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2004","Month":"6","Day":"23","Hour":"5","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2004","Month":"4","Day":"28","Hour":"5","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["15109997","10.1016\/j.neuroimage.2003.09.028","S1053811903005743"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"14746878","DateCompleted":{"Year":"2004","Month":"03","Day":"10"},"DateRevised":{"Year":"2019","Month":"07","Day":"01"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"0304-3940","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"356","Issue":"2","PubDate":{"Year":"2004","Month":"Feb","Day":"12"}},"Title":"Neuroscience letters","ISOAbbreviation":"Neurosci Lett"},"ArticleTitle":"Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease.","Pagination":{"MedlinePgn":"119-22"},"Abstract":{"AbstractText":"Clinical and immunopathological evidence support a potential role of the pro- and anti-inflammatory cytokine network in neurodegeneration of Alzheimer's disease (AD). Moreover, association studies suggest a possible involvement of cytokine-related genes in the susceptibility to sporadic AD. Since conflicting results are associated with the pro-inflammatory pathway, we investigated a putative effect of the anti-inflammatory counterpart focusing on the interleukin-10 (IL-10) gene. The 5' flanking region contains numerous polymorphisms; in particular, three single nucleotide polymorphisms (-1082 G\/A, -819 T\/C, -592 C\/A) are in linkage disequilibrium resulting in three haplotypes GCC, ACC and ATA. We analyzed the IL-10 haplotype distributions in 215 Italian sporadic AD patients and 153 controls in an association case-control study. Haplotype frequencies did not reveal differences between the two samples, however the genotype GCC\/ACC was more represented in AD patients (OR 1.91, 95% CI: 1.18-3.07). This putative risk factor could be independent of the presence of the ApoE epsilon 4 allele. Our results provide new insights on a possible involvement of the IL-10 gene in susceptibility to sporadic AD even though further functional and genetic investigations are necessary to clarify its role in AD."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Scassellati","ForeName":"Catia","Initials":"C","AffiliationInfo":{"Affiliation":"Genetics Unit, I.R.C.C.S. Centro San Giovanni di Dio-Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanardini","ForeName":"Roberta","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Squitti","ForeName":"Rosanna","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bocchio-Chiavetto","ForeName":"Luisella","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonvicini","ForeName":"Cristian","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Binetti","ForeName":"Giuliano","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cassetta","ForeName":"Emanuele","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gennarelli","ForeName":"Massimo","Initials":"M"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"Ireland","MedlineTA":"Neurosci Lett","NlmUniqueID":"7600130","ISSNLinking":"0304-3940"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Apolipoprotein E4"},{"RegistryNumber":"0","NameOfSubstance":"Apolipoproteins E"},{"RegistryNumber":"0","NameOfSubstance":"DNA Primers"},{"RegistryNumber":"130068-27-8","NameOfSubstance":"Interleukin-10"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":["genetics","immunology"]},{"DescriptorName":"Apolipoprotein E4"},{"DescriptorName":"Apolipoproteins E","QualifierName":"genetics"},{"DescriptorName":"Case-Control Studies"},{"DescriptorName":"DNA Primers"},{"DescriptorName":"Female"},{"DescriptorName":"Genetic Predisposition to Disease"},{"DescriptorName":"Haplotypes"},{"DescriptorName":"Humans"},{"DescriptorName":"Interleukin-10","QualifierName":"genetics"},{"DescriptorName":"Italy"},{"DescriptorName":"Male"},{"DescriptorName":"Polymerase Chain Reaction"},{"DescriptorName":"Polymorphism, Genetic"},{"DescriptorName":"Promoter Regions, Genetic","QualifierName":"genetics"},{"DescriptorName":"Risk Factors"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2004","Month":"1","Day":"30","Hour":"5","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2004","Month":"3","Day":"11","Hour":"5","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2004","Month":"1","Day":"30","Hour":"5","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["14746878","S0304394003013600","10.1016\/j.neulet.2003.11.033"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"14681895","DateCompleted":{"Year":"2004","Month":"01","Day":"14"},"DateRevised":{"Year":"2006","Month":"11","Day":"15"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"0364-5134","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"54","Issue":"6","PubDate":{"Year":"2003","Month":"Dec"}},"Title":"Annals of neurology","ISOAbbreviation":"Ann Neurol"},"ArticleTitle":"Atypical dementia associated with a novel presenilin-2 mutation.","Pagination":{"MedlinePgn":"832-6"},"Abstract":{"AbstractText":"We describe an Italian pedigree with hereditary dementia associated with a novel T122R mutation in the presenilin-2 gene (PSEN2). The clinical history, symptom presentation, and structural neuroimaging were consistent with an atypical form of dementia. Disease expression varied within family members. One in a pair of mutated monozygotic twins had evident signs of disease, whereas the other did not, even if her functional neuroimaging investigations, cerebrospinal fluid levels of Abeta1-42, and Tau protein were able to provide markers for future disease development. These observations suggest the importance of still unknown biological and perhaps environmental factors in the disease determination."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Binetti","ForeName":"Giuliano","Initials":"G","AffiliationInfo":{"Affiliation":"Neurobiology Lab and Memory Clinic, IRCCS-Fatebenefratelli, via Pilastroni 4, 25123 Brescia, Italy. gbinetti@oh-fbf.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Signorini","ForeName":"Simona","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Squitti","ForeName":"Rosanna","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Alberici","ForeName":"Antonella","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Benussi","ForeName":"Luisa","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cassetta","ForeName":"Emanuele","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni Battista","Initials":"GB"},{"@attributes":{"ValidYN":"Y"},"LastName":"Barbiero","ForeName":"Laura","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Feudatari","ForeName":"Enrica","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Nicosia","ForeName":"Francesca","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Testa","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gennarelli","ForeName":"Massimo","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Perani","ForeName":"Daniela","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Anchisi","ForeName":"Davide","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ghidoni","ForeName":"Roberta","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Rossini","ForeName":"Paolo Maria","Initials":"PM"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Case Reports","Journal Article","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Ann Neurol","NlmUniqueID":"7707449","ISSNLinking":"0364-5134"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Membrane Proteins"},{"RegistryNumber":"0","NameOfSubstance":"PSEN2 protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Presenilin-2"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Brain","QualifierName":"pathology"},{"DescriptorName":"Dementia","QualifierName":["cerebrospinal fluid","genetics","pathology","psychology"]},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Membrane Proteins","QualifierName":"genetics"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Mutation"},{"DescriptorName":"Pedigree"},{"DescriptorName":"Presenilin-2"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2003","Month":"12","Day":"19","Hour":"5","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2004","Month":"1","Day":"15","Hour":"5","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2003","Month":"12","Day":"19","Hour":"5","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["14681895","10.1002\/ana.10760"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"12835442","DateCompleted":{"Year":"2003","Month":"08","Day":"14"},"DateRevised":{"Year":"2020","Month":"06","Day":"11"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"0141-0768","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"96","Issue":"7","PubDate":{"Year":"2003","Month":"Jul"}},"Title":"Journal of the Royal Society of Medicine","ISOAbbreviation":"J R Soc Med"},"ArticleTitle":"Dementia: issues in early recognition and intervention in primary care.","Pagination":{"MedlinePgn":"320-4"},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Woods","ForeName":"R T","Initials":"RT","AffiliationInfo":{"Affiliation":"Dementia Services Development Centre, University of Wales, Bangor LL57 2PX, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Moniz-Cook","ForeName":"Esme","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Iliffe","ForeName":"Steve","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Campion","ForeName":"Peter","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Vernooij-Dassen","ForeName":"Myrra","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Franco","ForeName":"Manuel","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"INTERDEM (Early Detection and Intervention in Dementia) Group"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Review"]}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"J R Soc Med","NlmUniqueID":"7802879","ISSNLinking":"0141-0768"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Ambulatory Care Facilities"},{"DescriptorName":"Dementia","QualifierName":["diagnosis","therapy"]},{"DescriptorName":"Family Health"},{"DescriptorName":"Humans"},{"DescriptorName":"Primary Health Care","QualifierName":"methods"},{"DescriptorName":"Social Support"},{"DescriptorName":"Truth Disclosure"}]},"NumberOfReferences":"50"},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2003","Month":"7","Day":"2","Hour":"5","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2003","Month":"8","Day":"15","Hour":"5","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2003","Month":"7","Day":"2","Hour":"5","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["12835442","PMC539533","10.1258\/jrsm.96.7.320"]},"ReferenceList":{"Reference":[{"Citation":"Aging Ment Health. 2003 Jan;7(1):28-33","ArticleIdList":{"ArticleId":"12554312"}},{"Citation":"Br J Gen Pract. 2002 Dec;52(485):1002-3","ArticleIdList":{"ArticleId":"12528587"}},{"Citation":"Psychol Med. 1998 Mar;28(2):319-35","ArticleIdList":{"ArticleId":"9572090"}},{"Citation":"BMJ. 1998 Sep 19;317(7161):802-8","ArticleIdList":{"ArticleId":"9740574"}},{"Citation":"Neurology. 1999 Jan 15;52(2):224-7","ArticleIdList":{"ArticleId":"9932934"}},{"Citation":"BMJ. 1999 Jul 17;319(7203):190","ArticleIdList":{"ArticleId":"10406773"}},{"Citation":"Theor Med Bioeth. 1999 Jun;20(3):215-28","ArticleIdList":{"ArticleId":"10474309"}},{"Citation":"Int J Geriatr Psychiatry. 1999 Aug;14(8):626-32","ArticleIdList":{"ArticleId":"10489653"}},{"Citation":"Int J Geriatr Psychiatry. 1999 Nov;14(11):936-40","ArticleIdList":{"ArticleId":"10556864"}},{"Citation":"Am J Epidemiol. 1999 Nov 15;150(10):1031-44","ArticleIdList":{"ArticleId":"10568618"}},{"Citation":"Br J Gen Pract. 1993 May;43(370):185-8","ArticleIdList":{"ArticleId":"8347384"}},{"Citation":"Gerontologist. 1993 Dec;33(6):730-40","ArticleIdList":{"ArticleId":"8314099"}},{"Citation":"Br J Nurs. 1995 Mar 23-Apr 12;4(6):309-14","ArticleIdList":{"ArticleId":"7727947"}},{"Citation":"Br J Gen Pract. 1994 Nov;44(388):503-7","ArticleIdList":{"ArticleId":"7748646"}},{"Citation":"J Am Geriatr Soc. 1995 Jun;43(6):656-61","ArticleIdList":{"ArticleId":"7775725"}},{"Citation":"J Am Geriatr Soc. 1996 Apr;44(4):400-3","ArticleIdList":{"ArticleId":"8636584"}},{"Citation":"BMJ. 1996 Aug 31;313(7056):529-30","ArticleIdList":{"ArticleId":"8789979"}},{"Citation":"JAMA. 1996 Dec 4;276(21):1725-31","ArticleIdList":{"ArticleId":"8940320"}},{"Citation":"Int J Geriatr Psychiatry. 1997 Feb;12(2):183-92","ArticleIdList":{"ArticleId":"9097211"}},{"Citation":"J Gerontol B Psychol Sci Soc Sci. 1997 Jul;52(4):P159-66","ArticleIdList":{"ArticleId":"9224439"}},{"Citation":"BMJ. 1997 Oct 25;315(7115):1053-4","ArticleIdList":{"ArticleId":"9366730"}},{"Citation":"Int J Geriatr Psychiatry. 1997 Dec;12(12):1143-5","ArticleIdList":{"ArticleId":"9444536"}},{"Citation":"Int J Geriatr Psychiatry. 2000 Mar;15(3):203-7","ArticleIdList":{"ArticleId":"10713577"}},{"Citation":"Gerontologist. 2000 Apr;40(2):206-12","ArticleIdList":{"ArticleId":"10820923"}},{"Citation":"Patient Educ Couns. 2000 Feb;39(2-3):219-25","ArticleIdList":{"ArticleId":"11040721"}},{"Citation":"Br J Gen Pract. 2001 Jan;51(462):37-8","ArticleIdList":{"ArticleId":"11271871"}},{"Citation":"Int J Aging Hum Dev. 2000;51(4):259-74","ArticleIdList":{"ArticleId":"11246648"}},{"Citation":"Neurology. 2001 May 8;56(9):1133-42","ArticleIdList":{"ArticleId":"11342677"}},{"Citation":"Aging (Milano). 2001 Jun;13(3):183-202","ArticleIdList":{"ArticleId":"11442301"}},{"Citation":"Aging Ment Health. 2001 May;5(2):107-19","ArticleIdList":{"ArticleId":"11511058"}},{"Citation":"Int J Geriatr Psychiatry. 2001 Aug;16(8):794-809","ArticleIdList":{"ArticleId":"11536347"}},{"Citation":"Int J Geriatr Psychiatry. 1994 Jun;9(6):467-71","ArticleIdList":{"ArticleId":"11654255"}},{"Citation":"Methods Inf Med. 2002;41(2):98-104","ArticleIdList":{"ArticleId":"12061130"}},{"Citation":"J Am Geriatr Soc. 1992 Nov;40(11):1129-34","ArticleIdList":{"ArticleId":"1401698"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"12736535","DateCompleted":{"Year":"2003","Month":"07","Day":"03"},"DateRevised":{"Year":"2019","Month":"12","Day":"10"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"0014-3022","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"49","Issue":"4","PubDate":{"Year":"2003"}},"Title":"European neurology","ISOAbbreviation":"Eur Neurol"},"ArticleTitle":"Validation study of a CT-based weighted rating scale for subcortical ischemic vascular disease in patients with mild cognitive deterioration.","Pagination":{"MedlinePgn":"193-209"},"Abstract":{"AbstractText":["Subcortical ischemic vascular disease (SIVD) is frequently associated with cognitive impairment. Rating scales to grade cerebrovascular disease are available, but their sensitivity to the clinical features of mild SIVD is unclear. The aim of the study is to devise and validate a computed tomography (CT)-based visual rating scale sensitive to SIVD in patients with mild cognitive deterioration.","Subjects were 122 consecutive outpatients of a memory clinic (mean age +\/- SD 77 +\/- 8 years, 71% females, mean +\/- SD score of mental state exam 22 +\/- 3, 61% with clinical dementia rating of 0.5 and 39% of 1). Diffuse leukoaraiosis, fuzzy and patchy lesions, and lacunes were assessed on ordinary CT films and weights were computed based on clinical indicators of SIVD. A continuous score and an ordinal class (0-3) with higher values indicating higher vascular damage were derived.","Intraclass correlation coefficients for intra- and interrater reliability of the subcortical vascular score and class ranged from 0.84 to 0.88. Convergent validity versus the scale of Wahlund et al. was good (Spearman's correlation coefficient between 0.53 and 0.73, p < 0.0005). Known-group validity was assessed versus clinical diagnoses of degenerative (mild cognitive impairment determined by Petersen et al. and NINCDS-ADRDA probable Alzheimer's disease; n = 58), mixed (possible Alzheimer's disease with cerebrovascular disease; n = 21), and vascular cognitive impairment (criteria of Erkinjuntti et al. for subcortical vascular dementia and cognitive impairment; n = 43). Patients with degenerative cognitive impairment were more often in the lower subcortical vascular classes (43% in class 0, 43% in class 1, 14% in class 2, and 0% in class 3), while patients with mixed (0, 24, 24, and 52%) and vascular cognitive impairment were in increasingly higher subcortical vascular classes (0, 12, 35, 53%; p < 0.00005). Criterion-related validity was assessed versus clinical indicators of cerebrovascular disease. Hypertension, platelet aggregation inhibitor use, balance, gait, and bradykinesia increased linearly with increasing subcortical vascular class (p for trend <0.02).","This rating scale is valid and sensitive to capture different degrees of SIVD associated with mild cognitive deterioration."],"CopyrightInformation":"Copyright 2003 S. Karger AG, Basel"},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Geroldi","ForeName":"Cristina","Initials":"C","AffiliationInfo":{"Affiliation":"Laboratory of Epidemiology and Neuroimaging, IRCCS San Giovanni di Dio - FBF, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Galluzzi","ForeName":"Samantha","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Testa","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Evaluation Study","Journal Article"]}},"MedlineJournalInfo":{"Country":"Switzerland","MedlineTA":"Eur Neurol","NlmUniqueID":"0150760","ISSNLinking":"0014-3022"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Brain","QualifierName":["blood supply","diagnostic imaging","pathology"]},{"DescriptorName":"Cerebrovascular Disorders","QualifierName":["complications","diagnostic imaging","physiopathology"]},{"DescriptorName":"Cognition Disorders","QualifierName":["etiology","physiopathology"]},{"DescriptorName":"Dementia, Vascular","QualifierName":["diagnostic imaging","etiology","physiopathology"]},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Psychiatric Status Rating Scales"},{"DescriptorName":"Reproducibility of Results"},{"DescriptorName":"Sensitivity and Specificity"},{"DescriptorName":"Tomography, X-Ray Computed","QualifierName":"methods"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2002","Month":"03","Day":"27"},{"@attributes":{"PubStatus":"accepted"},"Year":"2002","Month":"12","Day":"11"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2003","Month":"5","Day":"9","Hour":"5","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2003","Month":"7","Day":"4","Hour":"5","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2003","Month":"5","Day":"9","Hour":"5","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["12736535","10.1159\/000070183","70183"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"12670058","DateCompleted":{"Year":"2003","Month":"06","Day":"06"},"DateRevised":{"Year":"2019","Month":"11","Day":"07"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1041-6102","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"14","Issue":"4","PubDate":{"Year":"2002","Month":"Dec"}},"Title":"International psychogeriatrics","ISOAbbreviation":"Int Psychogeriatr"},"ArticleTitle":"Regional brain atrophy in patients with mild Alzheimer's disease and delusions.","Pagination":{"MedlinePgn":"365-78"},"Abstract":{"AbstractText":["The pathophysiology and the neurobiology of the behavioral disturbances in Alzheimer's disease (AD) are far from understood. The aim of the study was to assess whether delusional AD patients have a specific pattern of regional brain atrophy.","The setting of the study was the outpatient facility of a memory clinic. Subjects were 41 AD patients with mild dementia severity (Mini-Mental State Exam score of 22 +\/- 3, range 18 to 27). Delusions were assessed with the pertinent subscale of the UCLA Neuropsychiatric Inventory (NPI). Nondelusional (n = 22) AD and delusional (n = 19) AD were defined on the basis of absence (NPI delusions subscale = 0) or presence (NPI delusions subscale = 1 or higher) of delusions. Thirteen (68%) of the delusional patients had isolated theft delusions, and 6 (32%) had theft associated with another paranoid delusion (of jealousy or persecution). None of the patients had misidentifications or other delusions of nonparanoid content. Temporal lobe and frontal lobe atrophy were assessed with linear measures (radial width of the temporal horn, rWTH, and frontal index, FI) taken from computed tomographic films. Temporal and frontal asymmetries were computed as right\/left ratio of the rWTH and FI.","AD patients without delusions had symmetrical enlargement of both temporal (8.1 +\/- 3.9 vs. 8.5 +\/- 4.5) and frontal horns (35.8 +\/- 4.8 vs. 35.9 +\/- 4.6). On the contrary, AD with delusions showed temporal horns larger to the right (9.1 +\/- 3.3 vs. 7.7 +\/- 3.1, p = .06) and the frontal horn to the left (35.7 +\/- 4.3 vs. 37.5 +\/- 4.2, p = .02). This different pattern was confirmed with a gender-adjusted repeated measures analysis of variance model interaction term between asymmetry and group: F1,38 = 5.5, p = .03).","AD patients with delusions are characterized by a specific pattern of frontal and temporal asymmetry of brain atrophy, whereas nondelusional patients are symmetric. Because the asymmetry pattern of the delusional patients is similar to the physiological pattern of asymmetry of individuals without dementia, the data indicate that the absence of theft delusions in the mild stage of AD rather than their presence is associated with an abnormal asymmetry pattern."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Geroldi","ForeName":"Cristina","Initials":"C","AffiliationInfo":{"Affiliation":"Laboratory of Epidemiology & Neuroimaging, IRCCS San Giovanni di Dio-FBF, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bresciani","ForeName":"Lorena","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB"}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"Int Psychogeriatr","NlmUniqueID":"9007918","ISSNLinking":"1041-6102"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":["diagnosis","physiopathology","psychology"]},{"DescriptorName":"Atrophy"},{"DescriptorName":"Cerebral Ventricles","QualifierName":"pathology"},{"DescriptorName":"Delusions","QualifierName":["diagnosis","physiopathology","psychology"]},{"DescriptorName":"Dominance, Cerebral","QualifierName":"physiology"},{"DescriptorName":"Female"},{"DescriptorName":"Frontal Lobe","QualifierName":"pathology"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Temporal Lobe","QualifierName":"pathology"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2003","Month":"4","Day":"3","Hour":"5","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2003","Month":"6","Day":"7","Hour":"5","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2003","Month":"4","Day":"3","Hour":"5","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["12670058","10.1017\/s1041610202008566"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"12565146","DateCompleted":{"Year":"2003","Month":"04","Day":"10"},"DateRevised":{"Year":"2019","Month":"07","Day":"01"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"0304-3940","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"338","Issue":"1","PubDate":{"Year":"2003","Month":"Feb","Day":"20"}},"Title":"Neuroscience letters","ISOAbbreviation":"Neurosci Lett"},"ArticleTitle":"Prevalence of TAU mutations in an Italian clinical series of familial frontotemporal patients.","Pagination":{"MedlinePgn":"85-7"},"Abstract":{"AbstractText":"Frontotemporal dementia (FTD) is a clinical entity grouping different diagnostic conditions. FTD can occur in a sporadic form; however in 30-50% of cases a familial form of FTD has been observed. Mutations in the TAU gene were associated to familial FTD linked to chromosome 17. Our aim was to investigated the proportion of FTD cases attributable to TAU gene mutations in an Italian clinical series. We analyzed 38 patients with FTD; of these, 13 had a positive family history of FTD. All TAU gene exons and flanking intronic regions were sequenced. In our familial FTD sample the estimation of TAU gene mutations accounted for a relative low prevalence (7.6%); based on our results we could argue the existence of other mutations in regulatory regions in the TAU gene or, on the other hand, other genes might be responsible for the most cases of familial FTD.","CopyrightInformation":"Copyright 2002 Elsevier Science Ireland Ltd."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Binetti","ForeName":"Giuliano","Initials":"G","AffiliationInfo":{"Affiliation":"Neurobiology Laboratory, IRCCS Centro S Giovanni di Dio-FBF, Via Pilastroni 4, 25123 Brescia, Italy. gbinetti@oh-fb.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Nicosia","ForeName":"Francesca","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Benussi","ForeName":"Luisa","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ghidoni","ForeName":"Roberta","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"Feudatari","ForeName":"Enrica","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Barbiero","ForeName":"Laura","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Signorini","ForeName":"Simona","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Villa","ForeName":"Aldo","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Mattioli","ForeName":"Flavia","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Alberici","ForeName":"Antonella","Initials":"A"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Comparative Study","Journal Article","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"Ireland","MedlineTA":"Neurosci Lett","NlmUniqueID":"7600130","ISSNLinking":"0304-3940"},"ChemicalList":{"Chemical":{"RegistryNumber":"0","NameOfSubstance":"tau Proteins"}},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Dementia","QualifierName":["epidemiology","genetics"]},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Italy","QualifierName":"epidemiology"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Mutation"},{"DescriptorName":"Prevalence"},{"DescriptorName":"tau Proteins","QualifierName":"genetics"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2003","Month":"2","Day":"5","Hour":"4","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2003","Month":"4","Day":"11","Hour":"5","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2003","Month":"2","Day":"5","Hour":"4","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["12565146","S0304394002013307","10.1016\/s0304-3940(02)01330-7"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"12382161","DateCompleted":{"Year":"2003","Month":"03","Day":"17"},"DateRevised":{"Year":"2006","Month":"11","Day":"15"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"0340-5354","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"249","Issue":"10","PubDate":{"Year":"2002","Month":"Oct"}},"Title":"Journal of neurology","ISOAbbreviation":"J Neurol"},"ArticleTitle":"Mild cognitive impairment with subcortical vascular features: clinical characteristics and outcome.","Pagination":{"MedlinePgn":"1423-32"},"Abstract":{"AbstractText":["To identify non-demented individuals with cognitive impairment due to a cerebrovascular etiology among those coming to observation of a memory clinic and to describe their clinical features and outcome.","Patients were enrolled in a prospective study on early cognitive impairment carried out in a Memory Clinic. Mild cognitive impairment of the vascular type (MCI-V) was defined based on modified criteria for subcortical vascular dementia (SVD) by Erkinjuntti and colleagues. Twenty-nine patients with MCI-V (age 78 +\/- 7, Mini Mental State Exam (MMSE) 24 +\/- 3) were compared with 14 with mild cognitive impairment of degenerative etiology (MCI) based on the Mayo Clinic criteria (age 72 +\/- 9, MMSE 25 +\/- 2), and to 21 patients with frank SVD (age 80 +\/- 6, MMSE 21 +\/- 3). Patients were followed over time for 32 +\/- 8 months.","MCI-V patients had a neuropsychological profile characterized by poor performance on frontal tests (Wisconsin card sorting and word fluency) and neurological features of parkinsonism without tremor (impairment of balance and gait). Of those followed for at least 40 months, 50 % of patients with MCI-V and SVD had died, while all MCI patients were still alive ( P = 0.03). Of those alive, 68 % of the MCI-V, 52 % of the SVD, and 17 % of the MCI patients had reached one of the following outcomes at 40 months: nursing home placement, functional loss, and cognitive deterioration ( P = 0.02).","Patients with MCI-V have a distinctive clinical picture and can be identified in a clinical setting. Because of the high frequency of adverse outcomes, very early preventive measures need to be devised."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB","AffiliationInfo":{"Affiliation":"Laboratory of Epidemiology & Neuroimaging, IRCCS San Giovanni di Dio--FBF, via Pilastroni 4, 25125 Brescia, Italy. papers@centroAlzheimer.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Galluzzi","ForeName":"Samantha","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bresciani","ForeName":"Lorena","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Geroldi","ForeName":"Cristina","Initials":"C"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Comparative Study","Journal Article"]}},"MedlineJournalInfo":{"Country":"Germany","MedlineTA":"J Neurol","NlmUniqueID":"0423161","ISSNLinking":"0340-5354"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":["mortality","physiopathology"]},{"DescriptorName":"Cognition Disorders","QualifierName":["classification","diagnosis","mortality","physiopathology"]},{"DescriptorName":"Dementia, Vascular","QualifierName":["diagnosis","mortality","physiopathology"]},{"DescriptorName":"Disease Progression"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Prospective Studies"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2002","Month":"10","Day":"17","Hour":"4","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2003","Month":"3","Day":"18","Hour":"4","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2002","Month":"10","Day":"17","Hour":"4","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["12382161","10.1007\/s00415-002-0861-7"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"12006308","DateCompleted":{"Year":"2002","Month":"09","Day":"24"},"DateRevised":{"Year":"2019","Month":"05","Day":"13"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"0002-0729","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"31","Issue":"3","PubDate":{"Year":"2002","Month":"May"}},"Title":"Age and ageing","ISOAbbreviation":"Age Ageing"},"ArticleTitle":"Predictors of cognitive improvement after reality orientation in Alzheimer's disease.","Pagination":{"MedlinePgn":"193-6"},"Abstract":{"AbstractText":["there is increasing evidence to support the efficacy of reality orientation in cognitive deficits in patients with Alzheimer's disease. The clinical characteristics of patients who respond to reality orientation are poorly understood; this knowledge could be important, given that the provision of reality orientation therapy is labour-intensive and may provoke emotional distress.","to evaluate retrospectively which demographic and clinical characteristics of Alzheimer's patients predict cognitive outcomes.","we analysed 38 mild-to-moderately demented outpatients who regularly attended a one-month formal reality orientation programme. The mini mental state examination score changes from baseline-and immediately after-reality orientation were correlated with demographic and pre-treatment clinical characteristics by a linear regression analysis.","short-term responsiveness to reality orientation was significantly predicted by a lower level of cognitive functioning (as measured by the mini mental state examination) at baseline and by the absence of euphoria, accounting together for 57.6% of variance.","a lower mini mental state examination and the absence of euphoric behaviour in patients with mild-to-moderate Alzheimer's disease may predict a good cognitive outcome of reality orientation therapy."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O","AffiliationInfo":{"Affiliation":"I.R.C.C.S. S. Giovanni di Dio, Fatebenefratelli, Brescia, Italy. ozanetti@oh-fbf.it"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Oriani","ForeName":"Monica","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Geroldi","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Binetti","ForeName":"Giuliano","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB"},{"@attributes":{"ValidYN":"Y"},"LastName":"Di Giovanni","ForeName":"Giuseppina","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"De Vreese","ForeName":"Luc P","Initials":"LP"}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"Age Ageing","NlmUniqueID":"0375655","ISSNLinking":"0002-0729"},"CitationSubset":"IM","CommentsCorrectionsList":{"CommentsCorrections":{"@attributes":{"RefType":"CommentIn"},"RefSource":"Age Ageing. 2002 May;31(3):155-6","PMID":"12006300"}},"MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":"psychology"},{"DescriptorName":"Cognition"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Predictive Value of Tests"},{"DescriptorName":"Retrospective Studies"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2002","Month":"5","Day":"15","Hour":"10","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2002","Month":"9","Day":"25","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2002","Month":"5","Day":"15","Hour":"10","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["12006308","10.1093\/ageing\/31.3.193"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"11827874","DateCompleted":{"Year":"2002","Month":"03","Day":"25"},"DateRevised":{"Year":"2008","Month":"02","Day":"14"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"0195-6108","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"23","Issue":"1","PubDate":{"Year":"2002","Month":"Jan"}},"Title":"AJNR. American journal of neuroradiology","ISOAbbreviation":"AJNR Am J Neuroradiol"},"ArticleTitle":"Radial width of the temporal horn: a sensitive measure in Alzheimer disease.","Pagination":{"MedlinePgn":"35-47"},"Abstract":{"AbstractText":["Atrophy in the medial temporal lobe (MTL) structures depicted with brain imaging is one of the most accurate markers of Alzheimer disease (AD), but practical considerations have thus far limited their routine clinical use. The aim of this study was to explore the validity of a CT- and MR-based measure of MTL atrophy that would be feasible for routine clinical use.","We acquired brain CT scans in the temporal lobe plane with thin sections in 42 patients with AD and in 29 control patients without dementia. We also acquired MR images (according to a 3D magnetization-prepared rapid gradient-echo protocol) in 28 patients with AD and in 28 control subjects without dementia. The radial width of the temporal horn (rWTH) of the lateral ventricle was measured with a precision caliper at the tip of the horn on CT scans or high-quality MR images. The validity of the rWTH variable was assessed by test-retest and interrater reliability, convergent and discriminant validity compared with progressively distant brain regions, and known-group validity (accuracy of the separation of patients with AD from control subjects). Convergent and discriminant validity compared with volumetric measures was tested in the patients who underwent MR imaging.","Intraclass correlation coefficients for inter- and intrarater reliability were between 0.94 and 0.98. On CT scans, Pearson's correlation of the rWTH with the transverse width of the temporal horn was between 0.60 and 0.79; with Jobst's minimum thickness of the MTL, between 0.63 and 0.78 (interuncal distance approximately 0.50); and with an index of frontal atrophy, between 0.35 and 0.42. On MR images, the correlation with volumetric MR measures was 0.80 in the temporal horn, 0.74 in the hippocampus, 0.68 in the temporal lobe, 0.58 in the entorhinal cortex, and 0.49 in the frontal lobe. On CT scans (cutoff value for AD, >5.3 mm; age range of subjects, 50-90 y), the rWTH measure was a sensitive marker for AD in 39 of 42 patients with AD (sensitivity, 93%) and was a specific marker in 28 of the 29 control patients (specificity, 97%). On MR images (cutoff 3.6-6.7 mm; age range of subject, 50-90 y), the rWTH was a sensitive marker for AD in 21 of 28 patients with AD (sensitivity, 75%) and was a specific marker in 26 of 28 control subjects (specificity, 93%). The accuracy of other linear CT-based measures of MTL atrophy and linear and volumetric MR-based measures was lower. With specificity set to 95%, sensitivity ranged from 57% to 74% for CT-based measures and from 52% to 74% for MR-based measures.","The rWTH is an accurate marker of AD that could be used in routine clinical settings."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni B","Initials":"GB","AffiliationInfo":{"Affiliation":"Laboratory of Epidemiology and Neuroimaging, IRCCS San Giovanni di Dio-FBF, via Pilastroni 4, I-25123 Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Geroldi","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Beltramello","ForeName":"Alberto","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bianchetti","ForeName":"Angelo","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Binetti","ForeName":"Giuliano","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bordiga","ForeName":"Giovanni","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"DeCarli","ForeName":"Charles","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Laakso","ForeName":"Mikko P","Initials":"MP"},{"@attributes":{"ValidYN":"Y"},"LastName":"Soininen","ForeName":"Hilkka","Initials":"H"},{"@attributes":{"ValidYN":"Y"},"LastName":"Testa","ForeName":"Cristina","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zanetti","ForeName":"Orazio","Initials":"O"},{"@attributes":{"ValidYN":"Y"},"LastName":"Trabucchi","ForeName":"Marco","Initials":"M"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"AJNR Am J Neuroradiol","NlmUniqueID":"8003708","ISSNLinking":"0195-6108"},"CitationSubset":"IM","CommentsCorrectionsList":{"CommentsCorrections":{"@attributes":{"RefType":"CommentIn"},"RefSource":"AJNR Am J Neuroradiol. 2004 Jan;25(1):158-9; author reply 159","PMID":"14729549"}},"MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":"diagnosis"},{"DescriptorName":"Atrophy"},{"DescriptorName":"Feasibility Studies"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Magnetic Resonance Imaging"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Reference Values"},{"DescriptorName":"Reproducibility of Results"},{"DescriptorName":"Temporal Lobe","QualifierName":"pathology"},{"DescriptorName":"Tomography, X-Ray Computed"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2002","Month":"2","Day":"6","Hour":"10","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2002","Month":"3","Day":"26","Hour":"10","Minute":"1"},{"@attributes":{"PubStatus":"entrez"},"Year":"2002","Month":"2","Day":"6","Hour":"10","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":"11827874"}}}]}